Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRP,Agouti-related protein,40058,0.303589420925644,0.00476116807667059,0.294257531495369,0.312921310355918,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL27,C-C motif chemokine 27,39868,0.27187896334147,0.00584537850161147,0.260422021478311,0.283335905204628,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN1,CCN family member 1,39758,0.393644720676622,0.0069269646196399,0.380067870022128,0.407221571331117,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.109413749065373,0.00274399451738159,0.104035519811305,0.114791978319441,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES1,Liver carboxylesterase 1,39854,0.335749809786306,0.00747755305178396,0.321093805804809,0.350405813767802,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F7,Coagulation factor VII,39899,0.124774984397224,0.00281291944731099,0.119261662280494,0.130288306513953,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FURIN,Furin,39913,0.137739624070194,0.00319231911993029,0.131482678595131,0.143996569545257,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCG,Pro-glucagon,39477,0.548991518027032,0.0114156287137964,0.526616885747991,0.571366150306073,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHR,Growth hormone receptor,37124,0.113507025565439,0.00269754811825515,0.108219831253659,0.118794219877219,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.305952973021647,0.0071882779244259,0.291863948289772,0.320041997753522,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF9,Protein turtle homolog A,37437,0.34311657929424,0.00768334109458172,0.32805723074886,0.358175927839621,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBC,Inhibin beta C chain,39858,0.158198370030892,0.00393543829593474,0.15048491097086,0.165911829090924,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0829483119664214,0.00206167415169352,0.0789074306291021,0.0869891933037407,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLR,Low-density lipoprotein receptor,39882,0.431466306165783,0.00396990649684196,0.423685289431973,0.439247322899593,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPL,Lipoprotein lipase,39868,-0.200050217681466,0.00443731055060269,-0.208747346360647,-0.191353089002284,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFGE8,Lactadherin,39858,0.268014893640757,0.00380972108399714,0.260547840316122,0.275481946965391,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPY,Pro-neuropeptide Y,40030,0.383842373048918,0.00586723499582511,0.372342592457101,0.395342153640735,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.170694241002776,0.00374469449779527,0.163354639787098,0.178033842218455,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH,Parathyroid hormone,37039,0.317223528341055,0.00747165811964911,0.302579078426543,0.331867978255567,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.2012391020914,0.00442347704598838,0.192569087081263,0.209909117101537,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.136921045919821,0.00307239255181953,0.130899156518255,0.142942935321388,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.157113037628436,0.00404881977704018,0.149177350865437,0.165048724391435,1.11253722770692e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.191391745087339,0.00504565117410984,0.181502268786084,0.201281221388594,1.43251905735373e-301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPM,Carboxypeptidase M,39955,0.124643930940685,0.00328773222317878,0.118199975783255,0.131087886098116,2.46777355106627e-301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR37,Prosaposin receptor GPR37,39585,0.232375665322365,0.00613504758360754,0.220350972058494,0.244400358586235,1.63717804517324e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADIPOQ,Adiponectin,37453,-0.237455307795885,0.00626926985784734,-0.249743076717266,-0.225167538874505,1.55919110673622e-298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS15,Enteropeptidase,39788,0.319703192125704,0.00849523155128344,0.303052538285188,0.336353845966219,5.24560636109217e-297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.302458628623444,0.00807078120820793,0.286639897455356,0.318277359791531,1.72332553204268e-294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.291630996541038,0.00789978675336528,0.276147414504442,0.307114578577634,4.24820717189885e-286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROC,Vitamin K-dependent protein C,39908,0.0897716938473456,0.00246565325338512,0.0849390134707108,0.0946043742239804,5.99411598601193e-279
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL23,C-C motif chemokine 23,39931,0.142563119562387,0.00393959670371191,0.134841510023112,0.150284729101663,9.86763411549371e-276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.30017299573631,0.00830415316964308,0.283896855523809,0.31644913594881,4.65186555840813e-275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP1,Neuropilin-1,39949,-0.0955400091762926,0.00265305930291678,-0.100740005410009,-0.0903400129425757,3.4408663532224e-273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.496983691466734,0.0138432268361221,0.469850966867935,0.524116416065534,2.33276808894268e-271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG2,Desmoglein-2,39858,-0.091702020985728,0.00255747367668211,-0.0967146693920249,-0.0866893725794311,6.7866045202274e-271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0994143935076104,0.00278742779128912,0.0939510350366838,0.104877751978537,4.48391753770864e-268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APCS,Serum amyloid P-component,37333,0.118305290172982,0.00332232682452438,0.111793529596915,0.12481705074905,1.66562319414954e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.413803479261691,0.0118033503556468,-0.436938045958758,-0.390668912564623,1.40288023439629e-259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA1,Glutathione S-transferase A1,39841,0.285834272500645,0.0081524345708941,0.269855500741692,0.301813044259597,1.60296422320968e-259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.266570236372092,0.00761513670436745,0.251644568431532,0.281495904312653,1.062357200755e-258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.220875700603964,0.00638213110562487,0.208366723636939,0.233384677570988,4.0351634783276e-253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY1,Aminoacylase-1,39868,0.202967696123554,0.00593705092416819,0.191331076312185,0.214604315934924,2.71843816117424e-247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTR,Transthyretin,37309,0.0826235796879969,0.00240961953049983,0.0779007254082172,0.0873464339677766,4.21989568185927e-247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.110562071497686,0.00326149187962649,0.104169547413618,0.116954595581754,2.07885128814993e-243
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0916305926886523,0.00270941997508198,-0.096941055839813,-0.0863201295374917,2.92613755829562e-242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.344509683730938,0.0102414801940359,0.324436382550627,0.364582984911248,1.02356811155986e-239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9,Complement component C9,37445,-0.170444309699434,0.00508361852802085,-0.180408202014355,-0.160480417384513,7.32971117667937e-237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.199675348908685,0.00598594811252944,-0.211407807209243,-0.187942890608127,5.3644876197575e-236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLTP,Phospholipid transfer protein,39976,-0.115289123734752,0.00346148827803168,-0.122073640759694,-0.108504606709809,2.75061767906344e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIP2,Cysteine-rich protein 2,39749,0.114755728498812,0.00345677453566628,0.107980450408906,0.121531006588718,1.04564960513591e-233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA3,Glutathione S-transferase A3,39477,0.244608635095142,0.00736644592413054,0.230170401083846,0.259046869106438,1.09104846678812e-233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0897124504176754,0.00270985741360877,0.0844011298870022,0.0950237709483486,1.31875676197981e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.081080921532258,0.00245244414719404,0.0762741310037576,0.0858877120607583,1.71860745556541e-230
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP5,Retinol-binding protein 5,39788,0.177293582345965,0.00538821123886986,0.16673268831778,0.18785447637415,8.81040135030548e-230
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0951544650677198,0.00288516026583745,-0.100809379188761,-0.0894995509466784,2.45510367720432e-229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUSB,Beta-glucuronidase,39919,0.186025950630703,0.00566302154653408,0.174926428399496,0.19712547286191,4.15067303456114e-229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F9,Coagulation factor IX,39908,0.0575148629433601,0.00175235786242164,0.0540802415330137,0.0609494843537065,9.8908680771871e-229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.0961694551514329,0.002938049303159,0.0904108785172413,0.101928031785625,1.60697682399453e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.242240011936282,0.00740609510572023,0.22772406552907,0.256755958343494,2.75889664364247e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0974391807437614,0.00299856881350755,0.0915619858692866,0.103316375618236,2.0897906145063e-224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAT,Tissue-type plasminogen activator,40002,0.155499761034945,0.00478829158493541,0.146114709528471,0.164884812541418,3.67359291981152e-224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCHE,Cholinesterase,37208,0.0859805656912591,0.00265135047668735,0.0807839187569519,0.0911772126255663,3.94757958638692e-222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFI,Complement factor I,37453,0.062093139124669,0.00191869822673052,0.0583324906002772,0.0658537876490608,2.10564788943255e-221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPB1,Beta-ureidopropionase,37437,0.285133432871788,0.00885698527701156,0.267773741728845,0.30249312401473,3.4344798450052e-219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.183122070282675,0.00571622891295539,0.171918261613283,0.194325878952068,3.7525219334323e-218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.157476771692271,0.00493192800876068,0.1478101927951,0.167143350589442,8.80295590746274e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0925045252204498,0.00291848752352543,0.0867842896743399,0.0982247607665596,6.77601085639849e-214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFM,Afamin,37453,0.0578677056799181,0.00182629348730558,0.0542881704447992,0.0614472409150371,1.19436095120309e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFH,Complement factor H,36763,0.0717568498868834,0.00226276719503616,0.0673218261846125,0.0761918735891542,1.36304640748879e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA4,Kallistatin,37241,0.0708415940031864,0.00225439287415472,0.0664229839698432,0.0752602040365297,3.46202315041349e-209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.254430094048966,0.00813680657644147,0.238481953159141,0.270378234938791,2.7388845178579e-207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.095759216770671,0.00306595516630281,0.0897499446447175,0.101768488896624,8.65682953319941e-207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPIND1,Heparin cofactor 2,37424,0.0846195346605135,0.00271432077413335,0.0792994659432122,0.0899396033778149,3.9508868803549e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHBG,Sex hormone-binding globulin,37445,-0.154726696103213,0.00496788562993841,-0.164463751937892,-0.144989640268534,9.18753472626073e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN3,Contactin-3,39858,0.0979507568338558,0.00315935346229227,0.091758424047763,0.104143089619949,5.34910317972987e-205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.339763988990513,0.010975604450147,0.318251804268225,0.361276173712802,2.14506844415694e-204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.156378263450986,0.00506356962871064,0.146453666978713,0.166302859923259,1.59609986209039e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYNU,Kynureninase,40058,0.135393901098691,0.00440244899890315,0.126765101060841,0.144022701136541,6.54372108442604e-202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0573631017745043,0.0018664035146376,0.0537049508858146,0.061021252663194,1.41510498857105e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.101072354296464,0.0032897956285918,-0.107520353728503,-0.0946243548644236,1.63037422669381e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.1609817992749,0.00528510538052413,0.150622992729073,0.171340605820728,4.83207973734119e-198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL16,C-C motif chemokine 16,40052,0.15297078287481,0.00505328135990696,0.143066351409392,0.162875214340227,7.45508960776103e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.107283850872835,0.00354960286559438,-0.1142410724894,-0.10032662925627,3.35359089034893e-195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.16587596947836,0.00547883979734621,0.155137443475562,0.176614495481159,6.6666112131057e-195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBP,Protein AMBP,40003,0.056545227965696,0.00187285174657205,0.0528744385424147,0.0602160173889772,7.54486339481604e-195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0562409749523217,0.00186596972102821,0.0525836742991064,0.059898275605537,5.31803567937767e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.319403540204354,0.0106775598468652,0.298475522904498,0.34033155750421,3.11098139459061e-191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRP,Gastrin-releasing peptide,37043,0.150397979602228,0.00503961929754309,0.140520325779043,0.160275633425412,1.99250920947082e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.079926096947353,0.00268724126629189,0.0746591040654209,0.0851930898292851,2.93027883206305e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.133988743018036,0.00450526258135705,0.125158428358576,0.142819057677496,3.54792782528111e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR3,Anterior gradient protein 3,39464,0.169833668130768,0.00572042116330639,0.158621642650688,0.181045693610849,1.77685678386551e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.206643521039297,0.00698361785242241,0.19295563004855,0.220331412030045,2.41293020545305e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0862203158057227,0.00291657147320905,0.080503835718233,0.0919367958932124,4.95611903711392e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF21,Fibroblast growth factor 21,40011,0.340697830341262,0.0115649236011606,0.318030580082987,0.363365080599536,7.5428932530076e-186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.178186690059777,0.00605807777302358,0.166312857624651,0.190060522494904,4.00989637480415e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS8,Prostasin,39805,0.114368326584497,0.00388976814494336,0.106744381020408,0.121992272148586,4.29822865358532e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR2,Cadherin-related family member 2,39788,0.207194542330946,0.00706983471834163,0.193337666282997,0.221051418378896,6.23421008585818e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCA,Alpha-synuclein,37124,0.327234394218625,0.0112257466696931,0.305231930746027,0.349236857691224,3.98660312707165e-181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELN,Elastin,37437,0.0946630347785659,0.00325275844772124,0.0882876282210323,0.1010384413361,1.11281637716472e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0795409300454723,0.00273527522333486,0.0741797906077359,0.0849020694832086,2.07386991820764e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.208351442579663,0.00719022580322825,0.194258600005335,0.22244428515399,5.93294983672057e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F10,Coagulation factor X,37445,0.0742595132787038,0.00256640154832755,0.0692293662439818,0.0792896603134258,1.06876525514249e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFP,Properdin,37453,0.064437069075785,0.0022415933123504,0.0600435461835783,0.0688305919679918,1.82490665429166e-176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0598294223555515,0.00209479588086318,0.0557236224290597,0.0639352222820434,4.74887314186389e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPC,C-type natriuretic peptide,39866,0.125875805820105,0.00444434729559435,0.11716488512074,0.13458672651947,3.12172946017648e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MME,Neprilysin,39788,0.215762513599432,0.00763871899255421,0.200790624374025,0.230734402824838,2.59142326629213e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEG1,Protein HEG homolog 1,37124,0.074315704350799,0.00262597372019386,0.069168795859219,0.079462612842379,3.95036175359344e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.185501153490787,0.00657369556449051,0.172616710184386,0.198385596797188,6.49166151143007e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO3,Beta-enolase,37043,0.164936388997953,0.0058607503327877,0.153449318345689,0.176423459650217,2.82900435236777e-169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKB,Creatine kinase B-type,37437,-0.158159061874033,0.00564461289231478,-0.16922250314297,-0.147095620605096,5.40413904663302e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.0854321312064195,0.00305681722440377,0.0794407694465881,0.0914234929662508,7.36431797572751e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH1,Somatotropin,39846,-0.490300157577036,0.017565108701283,-0.524727770631551,-0.455872544522521,1.85784534594761e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0904898608196512,0.0032473600290518,0.0841250351627097,0.0968546864765927,6.39637662041683e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCLY,Selenocysteine lyase,39984,0.133324375364327,0.00478664410301502,0.123942552922417,0.142706197806236,8.48279309924132e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0677341133034656,0.00243892113767934,0.0629538278736141,0.0725143987333172,7.63710955276508e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAB2,Stabilin-2,37437,0.0756122532730839,0.0027215566542428,0.070278002230768,0.0809465043153998,2.8143149966622e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0699780069623952,0.00252742940285634,0.0650242453327967,0.0749317685919936,7.84412739726642e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0658956504216839,0.00237677858893699,0.0612371643873674,0.0705541364560004,1.27647753040618e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MVK,Mevalonate kinase,39587,0.212866520889099,0.00770368107482414,0.197767305982443,0.227965735795754,3.74712151063457e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS1,Protein MTSS 1,37382,0.29661363792502,0.0107196778455884,0.275603069347666,0.317624206502373,5.66555128576785e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.186246220430248,0.00673419593575512,0.173047196396168,0.199445244464328,8.09799938918918e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.230800994715863,0.00835605243639462,0.214423131940529,0.247178857491196,2.6334551066642e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.173077258458745,0.00626886962807249,0.160790273987723,0.185364242929767,2.68965780286868e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0566501252576759,0.00206328596394015,0.0526060847683532,0.0606941657469986,3.05023214987259e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.13282486595177,0.00483754402726345,0.123343279658333,0.142306452245206,3.27111170482744e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLA,Alpha-galactosidase A,37088,0.100602096985095,0.00366846970640973,0.0934118963605324,0.107792297609659,4.40536525572819e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.201247679449781,0.00735629408485235,0.18682934304347,0.215666015856091,2.39343030741775e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11R,Junctional adhesion molecule A,39858,0.150224262938814,0.00550938528631913,0.139425867777629,0.1610226581,4.66048314112206e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.155419434518265,0.00573242493460134,0.144183881646446,0.166654987390084,2.41959616177713e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOST,Sclerostin,39846,0.101083828482568,0.00372795778063639,0.0937770312325205,0.108390625732615,2.44310834860477e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYY,Peptide YY,37021,0.243224953262848,0.00897018548549773,0.225643389711272,0.260806516814423,1.34965842045101e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.327239157742852,0.0121122347012457,0.30349917772841,0.350979137757293,3.1727011386425e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPY30,Protein dpy-30 homolog,39979,0.155798758084025,0.00577040381714167,0.144488766602427,0.167108749565622,4.55699026744715e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL16,Pro-interleukin-16,40058,0.108329223560673,0.00401285338231775,0.10046403093133,0.116194416190016,4.87399016825361e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORD,Sorbitol dehydrogenase,39963,0.180041244975143,0.00667398893911427,0.166960226654479,0.193122263295807,8.33877633394772e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0724257747207239,0.00269640367478754,0.0671408235181404,0.0777107259233075,1.70567941151712e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.139978902009854,0.00521336519527776,0.12976070622711,0.150197097792599,2.33456140151667e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTYMK,Thymidylate kinase,37437,0.179258155085623,0.0066781536328121,0.166168973965312,0.192347336205935,1.08505601682676e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHK,Ketohexokinase,37043,0.169084490809111,0.00630115230332072,0.156734232294602,0.181434749323619,1.76330980878274e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUMB,Protein numb homolog,37056,0.220472312022536,0.00822452062471692,0.204352251598091,0.236592372446981,3.49290923177642e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH9,Myosin-9,37437,0.289541096958624,0.0108381737686487,0.268298276372072,0.310783917545175,2.79416520688112e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,P4HB,Protein disulfide-isomerase,39776,0.100916261081507,0.00379118423239301,0.0934855399860171,0.108346982176998,8.94612803674905e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EEF1D,Elongation factor 1-delta,37437,0.236647587119131,0.00888020082995686,0.219242393492416,0.254052780745847,1.49393366459845e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOMO1,Nodal modulator 1,39858,0.061505556517728,0.00231279356548675,0.056972481129374,0.0660386319060821,1.63125513711068e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPY,Pancreatic prohormone,39826,0.259338198665991,0.00975521536515369,0.24021797655029,0.278458420781693,2.08545027907588e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.129090716827638,0.0048639738508241,0.119557328080023,0.138624105575253,7.23233730497851e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0992688291173593,0.00374662738266582,-0.106612218787384,-0.0919254394473343,1.91831461192107e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.149599240690173,0.00563940022839583,0.138546016242518,0.160652465137829,3.27852027540137e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.126356585686283,0.00476191715387762,0.117023228064683,0.135689943307883,3.28130971856965e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.234922413904906,0.00889961218099751,0.217479174030151,0.252365653779661,2.36089046596078e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORT1,Sortilin,39846,0.095731435779794,0.00363864745873744,0.0885996867606686,0.102863184798919,2.21366778678849e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3F,Semaphorin-3F,39868,0.0654305415440323,0.0024904681211789,0.0605492240265217,0.070311859061543,5.61057375486187e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.142677017031898,0.00542772479357037,0.1320386764365,0.153315357627296,1.43653871521225e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.133739131837368,0.00509741388624927,0.12374820062032,0.143730063054417,5.0251796219648e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0831399864373795,0.00317559665109149,0.0769158170012401,0.0893641558735188,5.17702720656496e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0651303563675136,0.00248964572288209,0.0602506507506647,0.0700100619843625,9.2020185929648e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.174274807964416,0.00664918387740503,0.161242407564702,0.18730720836413,1.21563689118966e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4R,Reticulon-4 receptor,40030,0.0841523018530345,0.00323342437421755,0.0778147900795681,0.0904898136265009,2.56725980387369e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.357270747865531,0.0137265217348557,0.330366765265213,0.384174730465848,9.06817194470688e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.215752578036088,0.00832501490625092,0.199435548819837,0.23206960725234,4.77096496789705e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLUL1,Clusterin-like protein 1,39840,-0.114243622851205,0.00441376343654336,-0.12289459918683,-0.10559264651558,9.66429057191817e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLN,Promotilin,39866,0.225085176237601,0.00869689553747393,0.208039260984152,0.24213109149105,1.01484607725073e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.119246053639182,0.00461625069100617,0.11019820228481,0.128293904993554,1.35183820514889e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.109482724424994,0.00425385449850073,0.101145169607932,0.117820279242055,3.71486819993734e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.144291080651683,0.00559448918735978,0.133325881844458,0.155256279458908,3.78848384567897e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0539858656059728,0.00210488013738225,0.0498603005367035,0.058111430675242,1.22648357043934e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.284392053006489,0.0111165166703314,0.262603680332639,0.306180425680338,1.68043449240037e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.199592439211658,0.00779424272594878,0.184315723468798,0.214869154954518,2.86161733112723e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.301127124652417,0.0117733930526312,0.27805127426926,0.324202975035574,7.31041965611142e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0562702099772817,0.00220564717300765,0.0519471415181867,0.0605932784363767,9.22305594594777e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.170027063842379,0.0066678219849092,0.156958132751957,0.183095994932801,1.2981797275369e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.136093968523389,0.00534781708468254,0.125612247037411,0.146575690009367,4.92554069963804e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSD,Cathepsin D,38721,0.0972851252649766,0.00382837733134305,0.0897815056955442,0.104788744834409,1.75388376458177e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0968904578326438,0.0038180486626612,0.0894070824538279,0.10437383321146,2.61695008187681e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRN,"Attractin, Isoform 2",37453,0.0403347234994715,0.0015872038007855,0.037223804049932,0.0434456429490111,3.18840583753636e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.10598837509281,0.00419318174285315,0.0977697388768179,0.114207011308802,2.7474622163058e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0721754839791862,0.00285569829465352,0.0665783153216653,0.0777726526367071,9.17002851443408e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL22,C-C motif chemokine 22,39686,0.123976027166617,0.00491869450418988,0.114335385938405,0.133616668394829,1.78898186938249e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0683522896600752,0.00271895720185319,0.0630231335444429,0.0736814457757075,8.26345448592435e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FYB1,FYN-binding protein 1,39836,0.225199397001968,0.0089681401344615,0.207621842338423,0.242776951665512,1.65014924054202e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.199083258764876,0.00793633674439042,0.183528038745871,0.214638478783881,3.15137206001395e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0781334917085288,0.00310792734682478,0.0720419541087522,0.0842250293083054,3.20869196980058e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR5,Cadherin-related family member 5,39868,0.0940941653739208,0.0037931088831614,0.0866596719629245,0.101528658784917,2.47638960881201e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.205942871888754,0.00829193904682971,0.189690671356968,0.22219507242054,4.05146939341993e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYAP1,Synapse-associated protein 1,37124,0.139323215186595,0.00561040222283646,0.128326826829836,0.150319603543354,4.22336141252331e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.152660811789338,0.00619309163972437,-0.164799271403198,-0.140522352175478,1.06393592157993e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK1,Dickkopf-related protein 1,40009,0.143645131523858,0.00584122981733451,0.132196321081882,0.155093941965834,3.96752428822182e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCXR,L-xylulose reductase,39913,0.129388191665417,0.00526686807081774,0.119065130246615,0.13971125308422,7.44280632700791e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGF,Hepatocyte growth factor,40058,0.0815004927569866,0.0033228821215424,0.0749876437987635,0.0880133417152097,1.80382425726538e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEP,Leptin,39868,0.162540165010902,0.00662981698209025,0.149545723726005,0.175534606295799,2.46467178718534e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRN,Agrin,39931,0.0781934728710297,0.00318971500305777,0.0719416314650365,0.084445314277023,2.547451853348e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.214578082701253,0.00875426618359739,0.197419720981402,0.231736444421104,2.93660709804049e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN2,Ficolin-2,39810,0.0969015090245322,0.00396035259707822,0.0891392179342589,0.104663800114806,7.93804518779607e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.130604692318834,0.00533663684500512,0.120144884102624,0.141064500535044,8.01115483871544e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HJV,Hemojuvelin,37411,0.10591074852043,0.00433206952652516,0.0974198922484403,0.114401604792419,3.25514061240476e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0829860759647766,0.0034055405667583,0.0763112164539304,0.0896609354756229,8.09707781495294e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.260924885324537,0.0106993821939434,0.239954096224408,0.281895674424666,1.37725631222131e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLKB1,Plasma kallikrein,37187,0.0594111529598395,0.00243973244655342,0.0546292773645948,0.0641930285550842,3.46185216908489e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSO,Cathepsin O,40058,0.0707648847100645,0.00292977861566666,0.0650225186233578,0.0765072507967711,1.17582504074849e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0470957122357759,0.00194969824841284,0.0432743036688867,0.050917120802665,1.21895732040764e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.215139413301682,0.00891869735148001,0.197658766492781,0.232620060110583,2.84211233335717e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.061051076467984,0.00253387004387267,0.0560846911819935,0.0660174617539744,1.26116390222483e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.170514608430953,0.00708966956480271,0.15661885608394,0.184410360777966,1.3122586861495e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP20,Centrosomal protein 20,39477,0.173831777043414,0.00723298541388995,0.15965512563219,0.188008428454638,2.33837005498768e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.12129479606599,0.00504984035830623,0.11139710896371,0.131192483168271,3.19880604389585e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THOP1,Thimet oligopeptidase,39798,0.0714603564217771,0.00297873865070879,0.0656220286663879,0.0772986841771664,5.73235303823034e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EZR,Ezrin,40009,0.0563742934388939,0.00235262449660022,0.0517631494255575,0.0609854374522303,1.02451467517981e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0922835546745257,0.00385290849534472,0.08473185402365,0.0998352553254013,1.36479270053314e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2AP,CD2-associated protein,39868,0.148218636658206,0.00620373805067935,0.136059310078875,0.160377963237538,5.4634705027806e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.137740119039005,0.00577582809388445,-0.149060742103019,-0.126419495974992,1.56987229743681e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FN1,Fibronectin,37453,0.0619727338835228,0.00260249884551427,0.0568718361463149,0.0670736316207308,7.92995263490089e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTD,Biotinidase,37453,0.0476448504909624,0.00200614785474603,0.0437128006956602,0.0515769002862646,3.37764703369607e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUOM,Fucose mutarotase,37124,0.147386159971137,0.00620458153583558,0.1352251801609,0.159547139781375,3.4598776478165e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXLNA,Alpha-taxilin,39749,0.206490904960914,0.00873006804799427,0.189379971586845,0.223601838334982,1.3807641607776e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0311573871712729,0.00131859469990639,0.0285729415594563,0.0337418327830894,5.73761213921547e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0947271880137261,0.0040308308934994,0.0868267594624673,0.102627616564985,9.90377792601519e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.188019874705545,0.00802220466592085,0.17229635356034,0.20374339585075,4.16791372048583e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.220797122927021,0.0094382102155984,0.202298230904448,0.239296014949594,4.6646762792885e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJAP1,Tight junction-associated protein 1,39913,0.190180338387086,0.00813216374043078,0.174241297455842,0.20611937931833,5.71273401988041e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0676199736815123,0.00289832467216959,0.0619392573240599,0.0733006900389647,4.57906188086504e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPL,N-acetylneuraminate lyase,37437,0.100423321013323,0.00430590944039086,0.0919837385101571,0.108862903516489,5.42692518950018e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES3,Carboxylesterase 3,39788,0.156680716777904,0.00673565924798729,0.143478824651849,0.169882608903959,9.92767042067999e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0628403432515783,0.00270146169276213,0.0575454783337645,0.068135208169392,2.23099626175342e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.107065047793129,0.00460616726511966,0.0980369599534944,0.116093135632763,3.2059705321821e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.221253904559892,0.00955439883261074,0.202527282847975,0.239980526271809,1.03195253681026e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0635680653434307,0.00274689735123717,0.0581841465350059,0.0689519841518556,1.43263158060549e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0916596312673507,0.0039635865637318,0.0838910016024363,0.099428260932265,2.06462838580141e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXT,Oxytocin-neurophysin 1,40009,0.314172889161132,0.0135870512435342,0.287542268723804,0.340803509598459,2.10051956485891e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHBP1,EH domain-binding protein 1,37437,0.169878266859095,0.00734977131212869,0.155472715087322,0.184283818630867,5.79838380903079e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.160465626373952,0.00695738295233889,0.146829155787368,0.174102096960536,9.06462820020512e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.16065980054956,0.00695782363965367,0.147022466215839,0.174297134883281,9.65222449710391e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL17,C-C motif chemokine 17,39836,0.203395171784513,0.00883858630177325,0.186071542633037,0.220718800935988,2.62039452841652e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.234937361922013,0.0102190885178521,0.214907948427023,0.254966775417003,4.3767490077899e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUCB2,Nucleobindin-2,39995,0.08440699499618,0.00367365268293686,0.0772066357376238,0.0916073542547363,5.59516534694833e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.185405042607933,0.00807145795242102,0.169584985021187,0.201225100194678,6.35300207656077e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD63,CD63 antigen,39720,0.115833343447508,0.00504358930315345,0.105947908413327,0.125718778481688,7.48990950963551e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.17832482628827,0.00780953279771503,0.163018142004748,0.193631510571791,1.49983807818167e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN1,Dynactin subunit 1,40030,0.145435511410618,0.00637454907684632,0.132941395219999,0.157929627601237,1.99637897429629e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0860644806911489,0.00377364065001081,0.0786681450171277,0.0934608163651701,2.39196114177633e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.119354531283027,0.0052364157462328,0.109091156420411,0.129617906145643,3.47673264107775e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BECN1,Beclin-1,37043,0.135320864665278,0.00593377265834729,0.123690670254918,0.146951059075639,6.15034155078356e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.136654538720947,0.00600445507905461,0.124885806766,0.148423270675894,1.71554874425043e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELP,P-selectin,39931,0.127439709138547,0.00562367694247799,0.11641730233129,0.138462115945804,6.09277993670668e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.216825374326889,0.00957171887688457,0.198064805328195,0.235585943325583,1.5273146277426e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.25068804060019,0.0110897652448364,0.228952100720311,0.27242398048007,4.67320616324071e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.148803598125472,0.00659738969813816,0.135872714317121,0.161734481933823,7.04378494744481e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0810920927912223,0.00360935394188056,0.0740177590651364,0.0881664265173082,4.3509742899826e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0819944913521779,0.00364412652170822,0.0748520033696298,0.089136979334726,4.6554485779298e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.182087078244933,0.00809410170104614,0.166222638910882,0.197951517578983,5.09817239730105e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.140801376161642,0.00626810442452355,0.128515891489576,0.153086860833709,5.22900219190898e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARF6,ADP-ribosylation factor 6,37382,0.234010599853378,0.0104247481398066,0.213578093499357,0.254443106207399,1.34259716887307e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0862254726475353,0.00384844436144708,-0.0937684235959716,-0.078682521699099,1.68096700733733e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS2,Protein MTSS 2,37368,0.219196184449309,0.0097744650546806,0.200038232942135,0.238354135956483,2.18296205486111e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN1,Perilipin-1,39489,0.0759824459130349,0.00339807527078361,0.0693222183822991,0.0826426734437708,4.87141997936937e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0952731571400214,0.00426296864732735,0.0869177385912597,0.103628575688783,5.70143387240883e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.21519187983666,0.00962893121274442,0.196319174659681,0.234064585013639,5.76952067540211e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC1,Stanniocalcin-1,40009,0.0916174707093284,0.00411435434536255,0.0835533361924178,0.099681605226239,3.21177475116126e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.181478528427227,0.00814780528561763,0.165508830067417,0.197448226787038,3.22842219615387e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREG1,Protein CREG1,39660,0.0821107660200821,0.00368889321937911,0.0748805353100991,0.0893409967300652,4.21744211355124e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.117562497821412,0.00528743269250044,-0.127925865898713,-0.107199129744111,7.20323916513014e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FETUB,Fetuin-B,39908,0.0733120152946895,0.00330080117991712,0.0668424449820519,0.0797815856073271,1.13661587802436e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE4,Ribonuclease 4,37051,0.056601382152087,0.00254540868629522,0.0516123811269484,0.0615903831772256,1.42213099198007e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.231005404158686,0.0104365174562175,0.2105498299445,0.251460978372872,5.90933543133681e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.279741797050598,0.0126529724419728,0.254941971064331,0.304541623036865,9.87216962052075e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0849881563396494,0.00384930917703745,0.077443510352656,0.0925328023266428,1.87096006733928e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.142621781003212,0.00646688950341038,0.129946677576527,0.155296884429896,3.26152053113881e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNA4,Plexin-A4,39866,0.175759655516829,0.00797275671939832,0.160133052346808,0.19138625868685,4.02406001330724e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.157247310280495,0.00713672132958206,0.143259336474514,0.171235284086476,1.09765771319454e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELE,E-selectin,40052,0.107498518001677,0.00488848350840428,0.0979170903252048,0.11707994567815,1.25140308073326e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXIN1,Axin-1,39866,0.206062913091201,0.0093706768521401,0.187696386461006,0.224429439721396,1.30234505030654e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0843596262425947,0.00383646749198991,-0.0918791025268949,-0.0768401499582945,1.33858341954997e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.23391089868736,0.0106416129468976,0.213053337311441,0.25476846006328,3.02724517681364e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAXX,Protein PAXX,37124,0.0989988999414895,0.00450452866889767,0.0901700237504501,0.107827776132529,3.51329376087363e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.104488268183994,0.00476582798066367,0.0951472453418929,0.113829291026095,5.09208118179782e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST3,Cystatin-C,39897,0.0571243064477442,0.00260662564991286,0.052015320173915,0.0622332927215734,6.43753911779776e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5E,5'-nucleotidase,39913,0.11863180622571,0.00542604150504894,0.107996764875814,0.129266847575606,1.92636653210339e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.135584605334541,0.006207650151639,0.123417611037329,0.147751599631754,3.09881019066386e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.233948891335493,0.0107055887490926,0.212965937387272,0.254931845283715,4.59388069178086e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL5,C-C motif chemokine 5,39931,0.216079097159499,0.00990782031298241,0.196659769346053,0.235498424972945,6.10679667409625e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.118669125996529,0.00545357682510818,0.107980115419317,0.129358136573741,1.73523711814338e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A4,Protein S100-A4,39913,0.120907111693424,0.00558017603859249,0.109969966657783,0.131844256729066,1.22907956577134e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH2,Cadherin-2,39868,0.074622514381676,0.00344718804032156,0.0678660258226457,0.0813790029407062,1.88735669861441e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD6,T-cell differentiation antigen CD6,40040,0.111344004406945,0.0051483652649738,0.101253208487596,0.121434800326293,2.79461573549121e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN2,CCN family member 2,39880,0.124013744946226,0.00574051359337403,0.112762338303213,0.135265151589239,4.76589968927707e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBIN,Erbin,39788,0.21748494505336,0.0100768189198228,0.197734379970508,0.237235510136213,7.48205542082348e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.104410839354381,0.00484513747719456,0.0949143698990794,0.113907308809682,1.59968906987469e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.240886663550388,0.0111917730075699,0.218950788455551,0.262822538645225,2.58017378329212e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCTN3,Tectonic-3,37437,0.0622901004771645,0.00289470859969176,0.0566164716217687,0.0679637293325604,5.03465736640656e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAB2,Disabled homolog 2,40030,0.235214483615229,0.0109538811713754,0.213744876519333,0.256684090711124,7.08466026125718e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.14260530866649,0.00664856428673214,0.129574122664495,0.155636494668485,1.16830773952491e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.140726867470891,0.00656160591817959,0.127866119871259,0.153587615070523,1.2290402662749e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD5,Programmed cell death protein 5,40009,0.122012457939361,0.00569687619770339,0.110846580591863,0.13317833528686,2.2798009379202e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.176787679139845,0.00829267336156812,0.160534039351172,0.193041318928519,1.86629829480171e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZN,Kazrin,37382,0.218227134170166,0.0102257931301024,0.198184579635165,0.238269688705167,2.05184028129635e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0490695518699373,0.00230684893144665,0.0445481279643019,0.0535909757755727,4.91215051473967e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0427262768288506,0.00201189190140596,0.0387829687020949,0.0466695849556063,1.01499777030837e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.155321828452051,0.00732705289780246,0.140960804772358,0.169682852131743,4.24860368837797e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.178959636597793,0.00844437964827853,0.162408652487168,0.195510620708419,4.35160686000497e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0913053372835144,0.00432199828339883,0.0828342206480526,0.0997764539189761,1.00705189445671e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.262123046467264,0.0124090317299954,0.237801344276473,0.286444748658055,1.0247445789221e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCR,Breakpoint cluster region protein,39866,0.190854476833891,0.00903636020221072,0.173143210837558,0.208565742830224,1.09989509833607e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM1,Isthmin-1,39866,0.0827510660095107,0.00391951371223337,0.0750688191335333,0.0904333128854881,1.30058783439489e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL13,C-C motif chemokine 13,40024,0.142661414879068,0.0067625134327441,0.12940688855089,0.155915941207247,1.77989554554237e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.182939150074188,0.00866059586211795,0.165964382184437,0.199913917963939,1.81264457979987e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.180347122313556,0.00855100853208853,0.163587145590662,0.197107099036449,2.037803958059e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.155130425237264,0.00734638300412375,0.140731514549182,0.169529335925347,2.28939956590884e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC13,Mucin-13,39489,0.104869063684269,0.00498023410890104,0.0951078048308232,0.114630322537715,4.37661724988285e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0864898042185755,0.00411305469995731,0.0784282170066592,0.0945513914304918,7.77453531178938e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0555195547098873,0.00264268158473707,0.0503398988038026,0.0606992106159719,1.06768203340762e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.117597737427429,0.00560355837632062,0.10661476300984,0.128580711845017,1.6995411908699e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.126928191004545,0.00605163384035559,0.115066988677448,0.138789393331642,2.38896969172847e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINH1,Serpin H1,37169,0.264625886404855,0.0126022928870188,0.239925392346298,0.289326380463412,2.46529281550014e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGLN1,Egl nine homolog 1,39866,0.109822994559265,0.00524557342817581,0.0995416706400407,0.12010431847849,4.82913574867899e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.122413264908099,0.00584488069228862,0.110957298751214,0.133869231064985,7.09869504284915e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BACH1,Transcription regulator protein BACH1,39866,0.152160063746791,0.0072902988612827,0.137871077978677,0.166449049514906,1.80829031606687e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.155378897921624,0.00745769187549932,0.140761821845645,0.169995973997603,3.70126281296027e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.193738196867722,0.00930073975650488,0.175508746944972,0.211967646790471,4.1444116955723e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGF,Placenta growth factor,40058,0.0526196668729405,0.00252879053321017,0.0476632374278486,0.0575760963180324,6.34032321446609e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.137662012570407,0.00661048042068776,0.124705470945859,0.150618554194955,8.64588473050151e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R9B,Neurabin-2,40058,0.19344823431334,0.00931102401230483,0.175198627249223,0.211697841377458,1.21339834641111e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0871798201370473,0.00419633260669908,0.0789550082279171,0.0954046320461775,1.2487806851237e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB2,Carboxypeptidase B2,37424,0.0460890153925526,0.00221689829836908,0.0417438947277492,0.050434136057356,1.58186720748878e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.118397343882741,0.00570332286719118,0.107218831063047,0.129575856702436,1.8040921763866e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0753745624335203,0.00363114106235138,0.0682575259513116,0.082491598915729,1.8650951054903e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP5,Fatty acid-binding protein 5,39972,0.138653611864723,0.00670917598918252,0.125503626925926,0.151803596803521,1.13984268625425e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0592002236194445,0.00286893941073264,0.0535771023744086,0.0648233448644805,2.34019366148259e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.201751725834177,0.00979643428822002,0.182550714629266,0.220952737039088,4.77911277133547e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.210470616258199,0.010220291955175,0.190438844026056,0.230502388490342,5.03622164902858e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPK2,SRSF protein kinase 2,39866,0.170340616882527,0.00827213081137683,0.154127240492228,0.186553993272825,5.16927238293751e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXN,Paxillin,39489,0.104712907754078,0.00508647151775846,0.0947434235792719,0.114682391928885,6.17244749799179e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.1424792487544,0.00692661826163212,0.128903076961601,0.156055420547199,8.49028434977769e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANG,Angiogenin,39843,0.0681543966222081,0.00332019677758795,0.0616468109381357,0.0746619823062805,1.90965682874069e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0880569391780594,0.0042898257928134,0.0796488806241451,0.0964649977319736,3.39758022110806e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.142837171625552,0.00696952742611776,0.129176897870361,0.156497445380743,3.83945477191703e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.130710349578497,0.00637860580582547,0.118208282199079,0.143212416957915,4.11721717624911e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.129105588048482,0.00630324448704606,0.116751228853872,0.141459947243093,7.55723487682955e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA5,Integrin alpha-5,39858,0.0498013691462913,0.0024385159219248,0.0450218779393187,0.0545808603532639,1.53680412230754e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0747267724280576,0.00366390236645391,0.067545523789808,0.0819080210663073,2.58150446091235e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.27567153943891,0.0135200228416355,0.249172294669304,0.302170784208515,2.99834515073654e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.153159844334925,0.00750519027087243,0.138449671404015,0.167870017265835,3.35093893269494e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.216001769266714,0.0105868206422067,0.195251600807989,0.236751937725439,3.64922878174154e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.159473164518561,0.00782025966268534,0.144145455579698,0.174800873457424,4.91916171091205e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.184410635867731,0.00906671616621077,0.166639872181958,0.202181399553504,8.09753544327525e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.122672848815684,0.00603562630337083,0.110843021261077,0.134502676370291,1.15214243707819e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMIP,C-Maf-inducing protein,37368,0.165826746834054,0.00815605758923177,0.14984087395916,0.181812619708948,1.51783095644006e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLA2,Src-like-adapter 2,37411,0.210398546341406,0.0103576782445642,0.19009749698206,0.230699595700752,2.16420719204904e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.17093043705811,0.00842618498545768,0.154415114486613,0.187445759629607,2.32552567196207e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0661602094756736,0.00326518741031998,0.0597604421514464,0.0725599767999007,3.69901602508804e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.192705122191074,0.0095433954461385,0.174000067116642,0.211410177265505,1.5508764547876e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.12715116675891,0.00629215907506679,0.114818534971779,0.139483798546041,1.71912459890209e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.167877268119913,0.00830918508385281,0.151591265355561,0.184163270884264,1.87249925566192e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0796136725530404,0.00394824605298518,0.0718751102891894,0.0873522348168913,4.09422662213466e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.204471540002843,0.0101437873239096,0.184589716847981,0.224353363157706,5.06643526652028e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0572507594897904,0.00284966805434833,0.0516654101032676,0.0628361088763131,1.0778307575816e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0649322030704498,0.00323469982058306,0.058592191422107,0.0712722147187926,1.50693381659357e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0537822104862796,0.00267912444515184,0.048531126573782,0.0590332943987772,1.60427981226875e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.186398862453476,0.00930398911480287,0.168163043788462,0.204634681118489,3.38931416028018e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.208945680050533,0.0104501537986652,0.188463378605149,0.229427981495917,7.18216615562997e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0695983429026186,0.00348173799269736,0.0627741364369317,0.0764225493683054,8.08830870358718e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.100167767309712,0.00500818511277351,0.0903517244886755,0.109983810130748,1.08864503349511e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.143596089213881,0.00721456072170409,0.129455550199341,0.157736628228421,4.45673503066224e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDUA,Alpha-L-iduronidase,40030,0.089736830967593,0.00451533995352186,0.0808867646586901,0.0985868972764958,7.4569778781128e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0441803704852138,0.00222621089544987,0.039816997130132,0.0485437438402955,1.37620918377188e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLM2,Protein GOLM2,40009,0.043203588236159,0.00217951038363755,0.0389317478842294,0.0474754285880886,2.0205141596517e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F13B,Coagulation factor XIII B chain,37380,0.049746294599844,0.00250713151812182,0.0448323168243253,0.0546602723753628,2.18452982816904e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.223453788469008,0.0112646686839092,0.201375037848546,0.24553253908947,2.42248365358766e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEXIM1,Protein HEXIM1,39866,0.159107291961305,0.00803842705535349,0.143351974932812,0.174862608989798,3.63852846196395e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AAMDC,Mth938 domain-containing protein,37043,0.104220205204821,0.00526620161715495,0.0938984500351971,0.114541960374444,6.33569977102203e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.150630296682793,0.00761990357844029,0.13569528566905,0.165565307696536,9.03668824150921e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.104112450552531,0.00527221288983012,0.0937789132884639,0.114445987816598,1.41193186813245e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.176046783832474,0.00892627037587337,0.158551293895762,0.193542273769186,2.18656319006949e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP43,Centrosomal protein 43,39476,0.135683704011117,0.00688835818468322,0.122182521969138,0.149184886053096,2.45330712833105e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.134639384926742,0.00682909591074853,0.121254356941675,0.148024412911809,2.49046982319048e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK2,Docking protein 2,39868,0.237698069930051,0.0120826436919059,0.214016088293915,0.261380051566187,3.73922467676896e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.100750074199797,0.00512216047654814,0.0907106396657625,0.110789508733831,3.95729437127414e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.104529983669239,0.00531728858406519,0.0941080980444709,0.114951869294006,4.99664002255459e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINK1,Misshapen-like kinase 1,37388,0.179459521203428,0.00914416746262429,0.161536952976684,0.197382089430172,1.39795602229008e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO1,Forkhead box protein O1,39866,0.165808381382271,0.00846854007286076,0.149210042839464,0.182406719925078,2.24853611111513e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.101246004370207,0.00517463857085276,0.0911037127713352,0.111388295969078,2.91700936167697e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGFR,Opioid growth factor receptor,39788,0.0627405534822637,0.0032140523473642,0.0564410108814299,0.0690400960830976,6.98369855030287e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USO1,General vesicular transport factor p115,39788,0.172111348210473,0.00882432488802746,0.154815671429939,0.189407024991007,9.57309775703618e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN1,Pantetheinase,37445,0.139120827185783,0.00712809690029557,0.125149757261204,0.153091897110362,1.09262954317888e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.114363098458615,0.00586651848462905,0.102864722228742,0.125861474688488,1.15854421542919e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1A,Meprin A subunit alpha,37382,0.137487888909949,0.00704636256170072,0.123677018289015,0.151298759530882,1.2244328907041e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.108565277167412,0.00557239766325397,0.0976433777474343,0.11948717658739,1.42789249294702e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.129172657443412,0.00663308456049644,0.116171811704839,0.142173503181985,1.77674505145618e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.110209406259099,0.00566343049625675,0.0991090824864355,0.121309730031762,2.17438898199761e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.146856730390201,0.00754788740748563,0.132062871071529,0.161650589708873,2.37039096234469e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.134342757684733,0.00689751651263036,0.120823625319978,0.147861890049489,2.54112716020014e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.114124684174136,0.00587428126820276,0.102611092888458,0.125638275459813,6.03931612614483e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS9,Galectin-9,39859,0.0601594043445332,0.00310034011112887,0.0540827377267207,0.0662360709623458,6.38034937628135e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.206274411424971,0.0106596237815109,0.18538154881321,0.227167274036732,2.5840234282871e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIAE,Sialate O-acetylesterase,39875,0.0897624950366426,0.00464723351302295,0.0806539173511176,0.0988710727221675,3.43570204186088e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QDPR,Dihydropteridine reductase,39790,0.0826493967384121,0.00428430529585444,0.0742521583585374,0.0910466351182868,5.47619767328934e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEC31A,Protein transport protein Sec31A,37043,0.146524959378693,0.00759416558735797,0.131640394827471,0.161409523929915,8.00566158753401e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0644784830627906,0.0033552659912901,-0.0710548044057192,-0.057902161719862,2.19565907795152e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.037100901068182,0.00193088387598674,0.033316368671248,0.040885433465116,2.31699275730407e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.106033886192977,0.00551922340460086,0.0952162083199598,0.116851564065995,2.36860216679692e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BID,BH3-interacting domain death agonist,39866,0.125059995130372,0.00651684979383381,0.112286969534458,0.137833020726286,3.63744276835976e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.118374424328496,0.00616879956627922,0.106283577178589,0.130465271478404,5.40942817352158e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.216428669831428,0.0112793458650536,0.194321151935923,0.238536187726933,5.50590130263388e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.144911110957258,0.00755831523598395,0.13009681309473,0.159725408819787,7.41788959207161e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0444068135498443,0.00231883654494598,0.0398618939217501,0.0489517331779384,7.83480891932231e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNMBP,Dynamin-binding protein,39749,0.116777115774073,0.00610615408811586,0.104809053761366,0.12874517778678,1.26939923113715e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPD52L2,Tumor protein D54,37124,0.205320776162809,0.0107460426987923,0.184258532473176,0.226383019852442,2.65568331715017e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.212764705220477,0.0111585662225518,0.190893915424275,0.234635495016678,3.64254213786888e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.136216890345438,0.00714074515476431,0.1222210298421,0.150212750848776,4.46470002419616e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PENK,Proenkephalin-A,37124,0.0546886715274904,0.00286747944403748,0.049068411817177,0.0603089312378039,5.06002313945027e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0372993415665706,0.00195617961161645,0.0334652295278024,0.0411334536053389,5.25681571014975e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.115066685212574,0.00605074200061519,0.103207230891369,0.12692613953378,9.36945209248052e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.159887767574062,0.00840802273995473,0.143408043003751,0.176367492144374,9.95836291244208e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNST,Consortin,39868,0.202212230197923,0.0106469754791644,0.181344158258761,0.223080302137086,1.47408731934521e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.19171061263937,0.0100891693020086,0.171935840807433,0.211485384471307,1.78893599000449e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.134954830983299,0.00711945831889262,0.12100069267827,0.148908969288329,4.14630520820744e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.208930897243606,0.0110324313891557,0.187307331720861,0.230554462766351,4.14655485394447e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.145364276828021,0.00767269266878645,0.130325799197199,0.160402754458842,5.27858260689219e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLK1,Protein delta homolog 1,40052,0.103981647421316,0.00549544355585705,0.093210578051836,0.114752716790796,5.39991035316941e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EREG,Proepiregulin,39713,0.148667932771362,0.00786413349825336,0.133254231114785,0.164081634427938,7.69600562559219e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0939059962937648,0.00497996665360943,0.0841452616526903,0.103666730934839,1.91774152112254e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAG1,Dystroglycan,39931,0.0901472906506644,0.00478169833694311,0.0807751619102559,0.0995194193910729,1.96255826461909e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.117275535234897,0.00621592393122947,0.105092324329687,0.129458746140106,2.1576171371304e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT2,Omega-amidase NIT2,37377,0.140205733851602,0.0074318400996955,0.125639327256199,0.154772140447005,2.21828040769623e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.10166767266071,0.00539670777497252,0.0910901254217643,0.112245219899657,2.54971727348999e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTDH,Protein LYRIC,37056,0.171787334187289,0.00911684163115036,0.153918324590234,0.189656343784344,3.56029631312049e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.161100454574175,0.00856384568918802,0.144315317023366,0.177885592124983,4.18782579584535e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0567155556785221,0.00301840221473037,0.0507994873376506,0.0626316240193936,8.90127175176535e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMN,Protein amnionless,39587,0.0881871010857742,0.00469962156732967,0.0789758428138081,0.0973983593577404,1.03463202254695e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTBDN,Retbindin,39788,0.0541247941605164,0.00288527481626786,0.0484696555206314,0.0597799328004014,1.12255510401186e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOA,Elongin-A,39788,0.0941187345512925,0.00502993523610237,0.0842600614885318,0.103977407614053,2.67594756528008e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COCH,Cochlin,37437,0.0843741507372607,0.00450603047459493,0.0755423310070547,0.0932059704674668,2.91869369170439e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBPL,FK506-binding protein-like,37382,0.109838196865546,0.00586840053115094,0.0983361318244898,0.121340261906601,3.39862367018452e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.119525580690001,0.00640650867635389,0.106968823684347,0.132082337695655,7.12807165075086e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP2,Methionine aminopeptidase 2,40011,0.106151980197782,0.00569019689436123,0.0949991942848336,0.11730476611073,7.34641122601002e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0639173998017686,0.00342649953862754,-0.0706333388974786,-0.0572014607060586,7.66206570052142e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB3,Plexin-B3,39812,0.0876012500591049,0.00469812129319382,0.078392932324445,0.0968095677937648,8.89835245876954e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH2,Neutral ceramidase,39749,0.096061067529486,0.0051602554086772,0.0859469669284787,0.106175168130493,1.56429923882211e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSB,Arylsulfatase B,39788,0.10125612880274,0.00543993863246135,0.0905938490831156,0.111918408522364,1.61802091899551e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.10468243072176,0.00562314630863297,0.093661063956839,0.11570379748668,2.13379290945763e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.154923537697447,0.00833325438765153,0.13859035909765,0.171256716297244,2.43866877712214e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.133410441246496,0.00717300126572569,0.119351358765674,0.147469523727318,2.92711162003435e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0921832866469279,0.00496534933257655,0.0824512019550779,0.101915371338778,3.86412264320981e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0514028139957687,0.00276878699398412,0.0459759914875598,0.0568296365039776,3.87534429233188e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.190391818991199,0.0102572630430683,0.170287583426785,0.210496054555612,4.09711581554433e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL11,Eotaxin,40058,0.0698208868073876,0.00376265788999259,0.0624460773430021,0.0771956962717731,4.45658859503767e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP10,Stromelysin-2,39857,-0.107332731784517,0.00578471563706404,-0.118670774433163,-0.0959946891358717,4.70373816927365e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0820423790548887,0.00442299035598732,0.0733733179571536,0.0907114401526239,5.2368197456073e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSZ,Cathepsin Z,39865,0.0566625808476765,0.00305490674918632,0.0506749636192713,0.0626501980760817,5.28848704337551e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.157570239614178,0.00851198366121364,0.140886751638199,0.174253727590157,1.02685727364375e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0488355298637272,0.00264100967403313,0.0436591509026223,0.0540119088248322,1.49612940285734e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.119855519865872,0.00647987812204623,0.107154958746662,0.132556080985083,1.86307885459574e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2B3,SH2B adapter protein 3,39477,0.179544245018056,0.00972012886843633,0.160492792435921,0.198595697600191,2.22677254124374e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.165082302398984,0.00893377280909109,0.147572107693165,0.182592497104802,2.57505107881654e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.139242263550136,0.0075501566349383,0.124443956545657,0.154040570554616,4.96682934390463e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG2,Secretogranin-2,39949,0.0564715072116263,0.00306719413682475,0.0504598067034498,0.0624832077198028,6.2500152117315e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0389915246191198,0.00211820287584021,0.034839846982473,0.0431432022557666,6.59940274217142e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C19orf12,Protein C19orf12,39489,0.117847327050559,0.00640539228112527,0.105292758179554,0.130401895921565,8.3685325769466e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.137549184342472,0.00748533764556919,0.122877922557156,0.152220446127788,1.23867202056992e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA2,Apolipoprotein A-II,37445,-0.086251288077795,0.00469185925855555,-0.0954473322245639,-0.0770552439310261,1.43363341157768e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0309311798921062,0.00168300171715846,0.0276324965264756,0.0342298632577368,1.55542910208441e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.100281324676971,0.00546415692305956,0.089571577107774,0.110991072246167,2.49806589223584e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0590604262838403,0.00322168872494337,-0.0653749361847293,-0.0527459163829513,2.62077885423616e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0918894020718533,0.00501440501408649,0.0820611682442437,0.101717635899463,3.12755897666132e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.164398954183756,0.0089640817802203,0.146829353894524,0.181968554472988,3.15878242215885e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX2,Heme oxygenase 2,39489,0.0853841681290978,0.00466482537247887,0.0762411103990392,0.0945272258591564,4.5774659805319e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0929668643593219,0.00508830530949981,0.0829937859527023,0.102939942765942,7.9722316865268e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAMBP,STAM-binding protein,39713,0.115956561863695,0.00634817077491297,0.103514147144866,0.128398976582524,8.78719180446946e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR,GMP reductase 1,40058,0.0893181282591946,0.00489353345913139,0.079726802679297,0.0989094538390921,1.08636255936883e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.185513794742623,0.0101669010991323,0.165586668588323,0.205440920896922,1.20780890963168e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD36,Platelet glycoprotein 4,37056,0.0822998985599883,0.00450679044452776,0.0734665892887139,0.0911332078312628,1.35238375254982e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCG,Gamma-synuclein,39749,0.116787616007282,0.00640325174093486,0.10423724259505,0.129337989419515,1.42909781957412e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSNL1,Visinin-like protein 1,37388,0.0677653167422055,0.0037241915933452,0.0604659012192489,0.0750647322651621,4.12612916861145e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0583794613127645,0.00321298287301771,0.0520820148816498,0.0646769077438792,4.86876483679871e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0904879824103967,0.00498266609948573,0.0807219568554047,0.100254007965389,7.75790068430572e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0524397055326255,0.00289193093932266,0.0467715208915531,0.0581078901736979,9.31282013184655e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OCLN,Occludin,37411,0.076665185402022,0.00423125536481081,0.0683719248869928,0.0849584459170511,1.6225343802257e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TALDO1,Transaldolase,37415,0.0798461723586277,0.00441129523522688,0.071200033697583,0.0884923110196724,2.24687277743215e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0498818980394517,0.00275889634100569,0.0444744612110806,0.0552893348678229,2.40418471527189e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUS,RNA-binding protein FUS,39455,0.0700191342266764,0.00387370945279799,0.0624266636991924,0.0776116047541605,2.71673918535423e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.152523980287528,0.00843419087351519,0.135992966175438,0.169054994399617,3.18536908201518e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBKS,Ribokinase,39504,0.088211985007615,0.00488501182982938,0.0786373618211494,0.0977866081940805,3.7062983515472e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0463364423738663,0.00256561880709224,0.0413078295119656,0.0513650552357671,4.80342502017559e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0993496516108841,0.00551071293931751,0.0885486542498218,0.110150648971946,5.99400911167506e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASHC3,WASH complex subunit 3,37388,0.134578516943249,0.00747667909112997,0.119924225924634,0.149232807961864,1.3360312306029e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.113123727294393,0.00629325073351352,0.100788955856706,0.125458498732079,1.59508161994393e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS8,Galectin-8,40009,0.108339014081014,0.00603511774368174,0.0965101833033982,0.120167844858631,2.30818299644561e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.179509399291904,0.0100131952349318,0.159883536631438,0.19913526195237,3.58416049480596e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX15,Sorting nexin-15,37124,0.095240360168196,0.00531287996703012,0.084827115432817,0.105653604903575,5.05040996749968e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.172285310738265,0.00963202394539991,0.153406543805281,0.191164077671248,1.02122497109958e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYDGF,Myeloid-derived growth factor,37437,0.178700433444877,0.00999385246896556,0.159112482605704,0.198288384284049,1.0698933217789e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM2,Paralemmin-2,37388,0.0666782352896186,0.00373240233273186,0.0593627267174641,0.073993743861773,1.43388603098356e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.141425832530789,0.00792505323833173,0.125892728183659,0.156958936877919,2.00320887117476e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRAP,BRCA1-associated protein,37249,0.193952067837068,0.0108772933012047,0.172632572966707,0.215271562707429,2.63857764001593e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.131969826299619,0.00741597499855671,0.117434515302448,0.14650513729679,3.63900984917321e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0751558677754711,0.00421996620399702,0.066884734015637,0.0834270015353053,3.95234233526381e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0788815331397582,0.00443110579522399,-0.0875665004983972,-0.0701965657811192,4.29358820054491e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0814982831474806,0.00459339763924905,0.0724952237745525,0.0905013425204088,9.1748726628345e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.100916642058334,0.0056835383140896,0.0897769069627182,0.112056377153949,1.00539028445957e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.154858279298041,0.00872777029504613,0.13775184951975,0.171964709076331,1.25052903506962e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.164667751468792,0.00929058802856588,0.146458198932803,0.182877304004781,1.29697770167839e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.226121270968824,0.0127829387498463,0.201066711019125,0.251175830918523,2.30255042787158e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MITD1,MIT domain-containing protein 1,39749,0.169359837638445,0.009584376990447,0.150574458737169,0.188145216539722,3.25373225891521e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GLB2,Endophilin-B2,37388,0.115474786053832,0.0065295283058354,0.102676910574395,0.128272661533269,3.28246694113237e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLB1,Beta-galactosidase,39749,0.0733005800735127,0.00415813810487829,0.0651506293879513,0.0814505307590742,6.76898057313549e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0824538826627718,0.00468008258820809,0.0732809207898839,0.0916268445356596,1.04708197765124e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0481158210230524,0.00273517947675391,0.0427548692486148,0.0534767727974901,1.7132915689179e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES2,Cocaine esterase,39788,0.0935346492998063,0.00533509727963152,0.0830778586317285,0.103991439967884,3.56702765772389e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.118265083686022,0.00676528593336079,0.105005123256634,0.131525044115409,8.39064292664911e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C3,Complement C3,36816,0.0795668250432525,0.0045507301428593,0.0706473939632483,0.0884862561232568,1.12487532820144e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.128790497461493,0.00737655789251595,0.114332443992162,0.143248550930825,1.24697324218736e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.13489961411988,0.00772667986003022,0.119755321594221,0.150043906645539,1.29045629090351e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.183882392161398,0.0105251698606653,0.163253059234494,0.204511725088302,1.31644238500488e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS2,Trypsin-2,39931,0.0883795505530691,0.00506482672480523,0.0784524901724509,0.0983066109336874,1.45212799266144e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.130501886130752,0.00747405876463414,0.115852730952069,0.145151041309435,1.56477946734559e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD1,COMM domain-containing protein 1,37043,0.106883528797288,0.00612646721689269,0.0948756530521779,0.118891404542397,2.09980403559379e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL7,C-C motif chemokine 7,39866,0.100258876114837,0.00575465442179611,0.0889797534481162,0.111537998781557,2.33949027510717e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0591721636284542,0.00339629988292151,0.0525154158579281,0.0658289113989804,2.38638888207846e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.182516351152996,0.010480229484265,0.161975101363836,0.203057600942155,3.50353734812765e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.140761857101661,0.0080973057606679,0.124891137810752,0.15663257639257,5.80394026540896e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.165396252602669,0.00951800090527376,0.146740970828332,0.184051534377005,6.53732851695772e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0456984385585322,0.002629898603198,0.0405438372962642,0.0508530398208003,6.56579855762156e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.133182843360919,0.00766471847592941,0.118159995148097,0.14820569157374,6.63928821023554e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM13A,Protein FAM13A,37382,0.116202892042521,0.00669053447037396,0.103089444480588,0.129316339604454,7.61532341276292e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCC,Tubulin-specific chaperone C,39749,0.139083422671878,0.00802092860945929,0.123362402597338,0.154804442746418,9.64374894473623e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D23,TBC1 domain family member 23,39788,0.153855508765313,0.00887563254352415,0.136459268980005,0.17125174855062,1.0551302654172e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.152578681934877,0.00879875119319786,0.135333129596209,0.169824234273545,1.21245824603625e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0830797263104192,0.00480052877270571,0.073670689915916,0.0924887627049224,1.73839237026451e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOF,Apolipoprotein F,37445,-0.0441894765333959,0.00255424695395022,-0.0491958005631383,-0.0391831525036534,2.39790623603179e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS1,Galectin-1,39868,0.0572224270371109,0.0033104764749773,0.0507338931461554,0.0637109609280664,2.43004291489624e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.123117470380462,0.00711957472585681,0.109163103917782,0.137071836843141,2.83558971793823e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRKL,Crk-like protein,39881,0.182454340660001,0.0105641231285947,0.161748659327956,0.203160021992047,3.08692255765928e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.064641212899606,0.00374578275226553,0.0572994787051655,0.0719829470940464,3.90452034330429e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.187008431965154,0.0108642184911711,0.165714563722458,0.208302300207849,8.2167267972721e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGA,Protein O-GlcNAcase,37382,0.121041628024566,0.00702986880882682,0.107263085159265,0.134820170889866,9.72689801837573e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDHD2,Phospholipase DDHD2,37411,0.113400672073297,0.00658623248398044,0.100491656404695,0.126309687741899,9.75228780990697e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.208729583009773,0.0121423340120808,0.184930608346095,0.232528557673451,1.2730338753552e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0659588820365585,0.00383786416648982,0.0584366682702385,0.0734810958028786,1.71735500126859e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.146993788425356,0.00857031023030558,0.130195980373957,0.163791596476755,2.43820594102397e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0680414234387889,0.00397264956994447,0.0602550302816977,0.07582781659588,3.47259282361511e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.098703107088906,0.00575741054346921,0.0874185824237063,0.109987631754106,3.52549804972831e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0818514011474028,0.0047785214873849,0.0724854990321284,0.0912173032626772,4.38259384867345e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.154040612085899,0.00899609766121855,0.13640826066991,0.171672963501887,5.0274576672329e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.084322796319026,0.00492862343182839,0.0746626943926424,0.0939828982454097,6.38797997892969e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0586950954580308,0.00343834276787117,0.0519559436330033,0.0654342472830583,9.16626526534468e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL4,C-C motif chemokine 4,39882,0.104964265746581,0.00615326584799734,0.0929038646845066,0.117024666808656,1.12882370030095e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.248253696295127,0.0145695274145953,0.219697422562521,0.276809970027734,1.97381786862314e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.132534685043294,0.00777854647394801,0.117288733954356,0.147780636132232,2.07552829965582e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0404872777538896,0.00237869319614906,0.0358250390894374,0.0451495164183417,2.12288677256336e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0552902285090489,0.0032463192184374,0.0489274428409116,0.0616530141771862,2.38580856146905e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.100758888170494,0.00592288161010498,0.0891500402146881,0.1123677361263,2.44060116480102e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.15903092407859,0.0093519752722576,0.140701052544966,0.177360795612215,2.76405511449152e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.105300102541627,0.0061941699094785,0.0931595295190495,0.117440675564205,3.79985859894496e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.108582806539151,0.00639286461323276,0.0960527918972151,0.121112821181088,3.87833936825887e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.120429821616844,0.0070942222675057,0.106525145972533,0.134334497261156,4.44683053859699e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.129266053670387,0.00761612505524087,-0.144193658778659,-0.114338448562115,4.73536057935781e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPHN1,Oligophrenin-1,37388,0.180988846537276,0.0106641092785519,0.160087192351314,0.201890500723237,6.08889285916636e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.140349328794341,0.00827828621249085,0.124123887817858,0.156574769770823,8.21850623132857e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THPO,Thrombopoietin,39585,0.0637656809475145,0.00376479233662576,0.056386687967728,0.0711446739273009,8.76816986774586e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.195394618900382,0.011537392849971,0.172781328914439,0.218007908886326,8.85927163186659e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0947459794935989,0.00559628750282721,0.0837772559880576,0.10571470299914,9.68284175648556e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18,Interleukin-18,39795,0.0760923517319954,0.00449574410359422,0.0672806932889508,0.0849040101750401,1.05238066489021e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0523878465186605,0.00309311831800665,0.0463253346153674,0.0584503584219535,1.1317120926184e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.199775787073052,0.0118219200740996,0.176604823727817,0.222946750418287,2.04705847638206e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0914419221337838,0.00541052120759928,0.0808373005668892,0.102046543700678,2.06023744564842e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBNL,Drebrin-like protein,39931,0.155094322259469,0.00918748079923596,0.137086859892966,0.173101784625971,2.18098621079807e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.10423399576253,0.00617004158805668,0.0921407142499392,0.116327277275121,2.33092326758512e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.122080543848096,0.00723472836808514,0.107900476246649,0.136260611449543,2.4550345983168e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB1,Carboxypeptidase B,40052,0.0956852455721266,0.00567273713635182,0.0845666807848771,0.106803810359376,2.70455088938909e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.130401798272819,0.00776254584970377,0.1151872084074,0.145616388138238,8.6610666510771e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT1,Deaminated glutathione amidase,37043,0.0782833098195848,0.00466105997324588,0.0691476322720228,0.0874189873671467,1.18441643372848e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOD,Apolipoprotein D,36780,-0.071964681570834,0.00428640766455522,-0.0803660405933622,-0.0635633225483058,1.35041811297317e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.113594556763598,0.00677522474925703,0.100315116255055,0.126873997272142,1.91156721485412e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.119737839064426,0.00717601538920712,0.10567284890158,0.133802829227272,5.5275412201011e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.111725267411168,0.0066948410074974,0.0986033790364734,0.124847155785863,6.61220842713115e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0746472568105446,0.00447921715978356,0.0658679911773688,0.0834265224437204,8.01652551133584e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.153344897949484,0.00921843286796387,0.135276769528275,0.171413026370693,1.31504395387447e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOT,Angiomotin,37124,0.0679120985195588,0.00408005240891169,0.0599151957980919,0.0759090012410257,1.38673849624245e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0436400780835108,0.00262690818723529,0.0384913380365296,0.048788818130492,1.84458148030231e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTPBP2,GTP-binding protein 2,37039,0.132913066027348,0.00799444343050508,0.117243956903558,0.148582175151138,1.91649108082476e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.151884774683981,0.00915049596341183,0.133949802595694,0.169819746772269,2.39444140613747e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0613321647349487,0.00369622124954575,0.054087571085839,0.0685767583840583,2.53761560992727e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0873773900073484,0.00526234253749874,0.0770631986338509,0.0976915813808459,2.6227880047881e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT1,Angiopoietin-1,39794,0.138186391991193,0.00833104748499275,0.121857538920607,0.154515245061779,2.82765167749345e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0966244650392334,0.00582506247431623,0.0852073425895736,0.108041587488893,2.85982750228402e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMNL1,Formin-like protein 1,39489,0.0998996430454026,0.00602384940347182,0.0880928982145978,0.111706387876207,3.03324814092763e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0988384661326937,0.00596206378338272,0.0871528211172636,0.110524111148124,4.02216962633591e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.132184469966232,0.0079800408340821,0.116543589931431,0.147825350001033,4.06552701636529e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.150234316629739,0.00906180292101898,0.132473182904542,0.167995450354937,4.11361996478109e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0436005450296853,0.00263537999577649,0.0384352002379634,0.0487658898214073,5.63633189687885e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASC3,Protein CASC3,37039,0.0686059215108218,0.00414446685676121,0.0604827664715698,0.0767290765500738,6.20752983475952e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.118810201404958,0.00718220575927163,0.104733078116786,0.132887324693131,7.46263913778564e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0481472885847251,0.00291530835642511,0.0424332842061319,0.0538612929633183,9.05321765174924e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAX,Protein max,39489,0.171910813830176,0.0104240947172865,0.151479588184295,0.192342039476058,1.36804169143627e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0777611557380286,0.00471234852138241,0.068524952636119,0.0869973588399381,1.39251905606964e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RWDD1,RWD domain-containing protein 1,40009,0.104004867555207,0.00630802305938412,0.0916411423588137,0.116368592751599,1.40552222879671e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC4,Syndecan-4,39868,0.0738847278094821,0.00448402627816046,0.0650960363042876,0.0826734193146766,1.68103249214867e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.059673066975693,0.00362072807721908,0.0525764399443436,0.0667696940070424,1.95005215092735e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.135616569013706,0.00824765015503661,0.119451174709835,0.151781963317578,2.93299621258623e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0711590003020912,0.00432402185769426,0.0626839174610104,0.0796340831431719,2.9556185551237e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPBP,Platelet basic protein,37371,0.137967639846182,0.00839558866139425,0.121512286069849,0.154422993622514,4.22264237817297e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IST1,IST1 homolog,37287,0.161946715483811,0.00987137262732611,0.142598825134252,0.18129460583337,6.65610332810431e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.134067286629914,0.00817787920991856,0.118038643378474,0.150095929881354,8.18380202166755e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RFC4,Replication factor C subunit 4,37368,0.034592847067007,0.00211276836045436,0.0304518210805165,0.0387338730534975,1.11470818964489e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YJU2,Splicing factor YJU2,37368,0.052530092123188,0.00321077801402119,0.0462369672157065,0.0588232170306695,1.36737144553733e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.127479760448869,0.0077973520422265,0.112196950446105,0.142762570451633,1.37626937595376e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.109778282579688,0.00672359585001723,0.0966000347136541,0.122956530445722,2.3898334511178e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST13,Hsc70-interacting protein,37124,0.089147387912036,0.00546097137814577,0.0784438840108703,0.0998508918132017,2.50223391355914e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINC1,Antithrombin-III,37424,0.0234689641809361,0.00143820910163694,0.0206500743417277,0.0262878540201445,2.68817744559088e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0959902348574308,0.00588988747503555,0.0844460554063612,0.107534414308501,3.14442950944826e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.137113397257962,0.00841389291065612,0.120622167153076,0.153604627362848,3.2408437213184e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.114155090587877,0.00702322852454046,0.100389562679778,0.127920618495976,6.20867498892616e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICA1,Islet cell autoantigen 1,39587,0.128762120869059,0.00793200483560374,0.113215391391275,0.144308850346842,8.81875666283532e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.138629833617145,0.00853725643408717,0.121896811006334,0.155362856227956,9.99809989862634e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD69,Early activation antigen CD69,39785,0.140952735324791,0.00868852765394788,0.123923221123053,0.157982249526528,1.02749535029871e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0372514344962552,0.00229651672343967,0.0327502617183135,0.041752607274197,1.043828326491e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESYT2,Extended synaptotagmin-2,37388,0.13206151633477,0.00814060424827931,0.116105932008142,0.148017100661397,1.24767279879667e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.124722810697334,0.00769888087395143,0.109633004184389,0.139812617210279,1.47040192978274e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.089382704410627,0.00553183800063989,0.0785403019293728,0.100225106891881,2.86211674220251e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA11,Annexin A11,39829,0.106730715885105,0.00660745996033827,0.0937800943628424,0.119681337407368,3.12661990327032e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNMT,Histamine N-methyltransferase,39669,0.0737627775009732,0.00456857745644843,0.0648083656863342,0.0827171893156121,3.55505508165393e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MENT,Protein MENT,37124,-0.0354765847485351,0.00219575575685925,-0.0397802660319793,-0.031172903465091,3.64355654264185e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN3,Ataxin-3,37388,0.0979072210173149,0.00606076253668861,0.0860281264454053,0.109786315589225,3.70603620486341e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARC,SPARC,39913,0.112383013888213,0.00696653710573756,0.0987286011609675,0.126037426615459,4.36213889508791e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMA,Granzyme A,40058,0.0538816407929457,0.00334144734765539,0.0473324039915412,0.0604308775943503,4.8004203179373e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.113750283192053,0.00705857237473615,0.0999154813375706,0.127585085046536,5.68887024308858e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1S,Complement C1s subcomponent,37453,0.0333390990491749,0.00206821610130941,0.0292853954906085,0.0373928026077413,6.37888251002875e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA1,Carboxypeptidase A1,40052,0.0941333633998479,0.00584627512360285,0.0826746641575863,0.105592062642109,7.01608196300559e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PF4,Platelet factor 4,37385,0.153677700127177,0.00953905470181712,0.134981152911615,0.172374247342738,7.44688461362433e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0868727807184391,0.00540008453140317,0.0762886150368889,0.0974569463999893,8.93279796525314e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDT,D-dopachrome decarboxylase,37437,0.0638847253062901,0.00396966274287668,0.0561041863302518,0.0716652642823284,9.72636336954558e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEFTY2,Left-right determination factor 2,40011,0.0847603926078159,0.00527172502041779,0.074427811567797,0.0950929736478348,1.01591524031401e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TWF2,Twinfilin-2,37437,0.134425762990066,0.00836064115779017,0.118038906320798,0.150812619659335,1.23035850597872e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0977487223607943,0.00608610324370294,0.0858199600031366,0.109677484718452,1.3501287803419e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0356873224208188,0.00222045021934169,0.0313352399909091,0.0400394048507285,1.39855187883753e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0539331962007272,0.00335976572116438,0.047348055387245,0.0605183370142094,1.53562404060443e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPART,Spartin,37124,0.123810140908962,0.00771331126554683,0.10869205082849,0.138928230989434,1.93783970930069e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.0987184089483388,0.00615497245213577,0.0866546629421527,0.110782154954525,1.9664649182093e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.140454746651104,0.0087582546943443,0.12328856745019,0.157620925852019,1.98924784306093e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRY2,Protein sprouty homolog 2,39587,0.146920835177142,0.00916175234503849,0.128963800580866,0.164877869773417,2.03203475915291e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY4,Protein canopy homolog 4,39788,0.119663140401058,0.00746786795676369,0.105026119205801,0.134300161596315,2.44812166526709e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.152783246256795,0.00953579381978822,0.13409309037001,0.17147340214358,2.50067782753346e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0410684843186876,0.00256778136819354,0.0360356328370283,0.0461013358003469,3.86705480298326e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0442583539600476,0.0027697445983408,0.0388296545472996,0.0496870533727955,4.90434003713556e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0775563245308298,0.00485204631234711,0.0680463137586294,0.0870663353030301,5.64095376249881e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGF,Pro-epidermal growth factor,39808,0.163536255970784,0.010246924858691,0.143452283247749,0.183620228693818,6.74144308742091e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0906224686660144,0.00567830190854713,0.0794929969252621,0.101751940406767,6.77873864221393e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.125568874694996,0.00786910489055494,0.110145429109508,0.140992320280483,7.02154931957856e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLG,Plasminogen,37162,0.0357037481875739,0.00223757580548511,0.0313180996088231,0.0400893967663247,8.63876929141419e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.122991834908163,0.00771629258621208,0.107867901439188,0.138115768377139,1.10739216965016e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0888593243376768,0.00558751135944632,0.077907802073162,0.0998108466021916,1.67140205484519e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPSE,Heparanase,37306,0.148041673195759,0.00930522196563665,0.129803438143111,0.166279908248406,1.7813510668773e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTNB,Dystrobrevin beta,37348,0.0690614399447504,0.00434890215281915,0.0605375917252249,0.0775852881642759,2.80968890948731e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2,Microtubule-associated protein 2,37388,0.0722901144205764,0.0045530575536061,0.0633661216155084,0.0812141072256443,2.93159627295283e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR2,GMP reductase 2,37124,0.105145960097159,0.00662554546103747,0.0921598909935252,0.118132029200792,3.37233212292298e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.13401919661072,0.008450877660576,0.117455476395991,0.150582916825449,3.93142835668613e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.125295030347192,0.00790322507924191,0.109804709191878,0.140785351502506,4.37667315092845e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.120745184939766,0.00761655930940968,0.105816728693323,0.135673641186209,4.41636532744061e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF19,Fibroblast growth factor 19,39931,0.119697882975953,0.00756281087005668,0.104874773670642,0.134520992281264,5.35208840759818e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSS,Cathepsin S,36543,0.0381675992696022,0.00241527062297594,0.0334336688485694,0.042901529690635,1.01403836551929e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0777627633819176,0.00492965041858004,0.0681006485615008,0.0874248782023345,1.23189427433599e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0548400722009874,0.00348186354123915,0.0480156196601587,0.0616645247418162,1.78340276973058e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.163255448604739,0.0103652736808807,0.142939512190212,0.183571385019265,1.78550523703754e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC5,Glypican-5,39749,0.086906277316254,0.00552554474474649,0.0760762096165509,0.0977363450159571,2.53743097858652e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0869154751702094,0.00552664667654353,0.0760832476841841,0.0977477026562348,2.62170264941879e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX8,Syntaxin-8,39866,0.0758237174476685,0.00482470866992523,0.066367288454615,0.0852801464407219,3.05474982550699e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.151317860357117,0.0096288016747292,0.132445409074647,0.170190311639586,3.76885400251607e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.130127841669123,0.00828597762382619,0.113887325526424,0.146368357811822,4.31272641995185e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK1,Docking protein 1,37388,0.21316123390465,0.0135742138744712,0.186555774710687,0.239766693098614,4.39083431957135e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.132403693982482,0.0084394694722415,0.115862333816889,0.148945054148075,4.76093646882361e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN2,Centrin-2,39489,0.105130742370613,0.00670227826235519,0.0919942769763973,0.11826720776483,4.96899470351686e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPACT,Protein IMPACT,37388,0.0859238590743396,0.00547713936250523,0.0751886659238294,0.0966590522248499,5.59584618578524e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD226,CD226 antigen,37056,0.0648968656342556,0.00414629306683234,0.0567701312232642,0.0730236000452469,1.00235647061438e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.143408498573614,0.0091702517565199,-0.161382192016393,-0.125434805130835,1.01180164837629e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP10,Caspase-10,39489,0.110569336271176,0.00707054770854402,0.0967110627624293,0.124427609779922,1.04162092494327e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0580011890622611,0.00371293250175948,0.0507238413588125,0.0652785367657096,1.34602875333304e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0512801429445768,0.00328307922184862,0.0448453076697534,0.0577149782194001,1.35567287769394e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0798247393325366,0.00511334919712188,0.0698025749061777,0.0898469037588955,1.87763224121397e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADD1,Alpha-adducin,37124,0.106473413136859,0.0068205748983283,0.0931050863361356,0.119841739937583,1.87929882643107e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APP,Amyloid-beta precursor protein,39829,0.102710212064278,0.00658509324870037,0.0898034292968256,0.115616994831731,1.91222331145898e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.129958991751464,0.00833533269560576,0.113621739668077,0.146296243834851,2.09459361541802e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0947589563491346,0.00607887546793849,0.0828443604319752,0.106673552266294,2.19130753935409e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0457970874084214,0.00294166354104366,0.0400314268679758,0.051562747948867,3.00990688056201e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0407475809070349,0.00261617781151624,0.0356198723964631,0.0458752894176068,3.15756665090321e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.082293639218069,0.00529129472748386,0.0719227015522006,0.0926645768839373,4.67611740211357e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN3,Centrin-3,37382,0.121489402620462,0.00781561457546206,0.106170798052556,0.136808007188368,5.08699702465372e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM3,Junctional adhesion molecule C,37124,0.0777689851420623,0.00500344364613981,0.0679622355956283,0.0875757346884964,5.30219522579321e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0765154689826001,0.00492288832511705,0.0668666078653707,0.0861643300998295,5.3065147705638e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRAS,Ras-related protein R-Ras,37039,0.202435388263155,0.0130319969660102,0.176892674209775,0.227978102316535,6.1638559930683e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0999999171285992,0.0064442397472584,0.0873692072239727,0.112630627033226,7.81308552537424e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL3,C-C motif chemokine 3,39866,0.096221655806119,0.00621112535198847,0.0840478501162216,0.108395461496016,9.67209137339204e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0897327050142522,0.00579565868638218,0.0783732139889431,0.101092196039561,1.34218325987106e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPP,Lipoma-preferred partner,37021,0.102756247456187,0.00663977302732877,0.0897422923226223,0.115770202589751,1.49501260005422e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL18,C-C motif chemokine 18,39715,0.108011684329672,0.00698490808058854,0.094321264491718,0.121702104167625,1.50312382009904e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0605749526500299,0.00391853556904129,0.052894622934709,0.0682552823653509,1.63483583955298e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBXN1,UBX domain-containing protein 1,37124,0.106186519389086,0.00686431797424532,0.0927324561595647,0.119640582618606,1.63772672487658e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0455189630351708,0.002943937308352,0.0397488459108008,0.0512890801595407,1.81305190688161e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0678483981489925,0.00439171321775297,0.0592406402421967,0.0764561560557883,1.8695868756831e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0935008632265544,0.0060579423581589,0.081627296204563,0.105374430248546,2.33743416793326e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0606082133147762,0.00393181677004874,0.0529018524454807,0.0683145741840718,3.18862958935729e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0497539584271095,0.00323123986723426,0.0434207282873303,0.0560871885668886,4.06930296811081e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0431143938828214,0.00280319074002515,0.0376201400323721,0.0486086477332707,5.32811184295122e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KITLG,Kit ligand,39868,-0.0563505660965064,0.0036666558927166,-0.0635372116462309,-0.0491639205467818,6.36727236875339e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEXN,Nexilin,37445,0.104665346548761,0.0068064090292021,0.0913247848515251,0.118005908245997,6.46680047352297e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA2,Carboxypeptidase A2,39933,0.097905130910595,0.00637584397099365,0.0854084767274474,0.110401785093743,7.70198862062306e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD2,Polycystin-2,37021,0.0905615336561854,0.00589405843528118,0.0790091791230343,0.102113888189337,8.08616555344929e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0418772974532511,0.00272938648933012,0.0365276999341641,0.0472268949723381,9.43363108707946e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53,Cellular tumor antigen p53,39477,0.0670598949075225,0.00437071324474647,0.0584932969478195,0.0756264928672256,9.56546108616874e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLG4,Disks large homolog 4,37388,0.108878236817365,0.00709390371237235,0.094974185541115,0.122782288093615,1.01315067688613e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.194906559041766,0.012709984811467,0.16999498881129,0.219818129272241,1.05865534050069e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.102757101996917,0.00670474904843877,0.0896157938619766,0.115898410131857,1.19964156302249e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0512782051736441,0.00334974551319772,0.0447127039677765,0.0578437063795116,1.57836834724564e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM17,Splicing factor 45,37411,0.116043452111194,0.00757740443221453,0.101191739424053,0.130895164798334,1.6851813500765e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE2,Glia-derived nexin,37437,0.0978507904472221,0.00639058640462361,0.0853252410941598,0.110376339800284,1.75199805081615e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX4,Syntaxin-4,39788,0.0895774083940763,0.0058546428292404,0.0781023084487651,0.101052508339388,1.79865247401325e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.114509837167168,0.00748915865385041,0.0998310862056213,0.129188588128715,2.42890906317673e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXJ3,Forkhead box protein J3,37056,0.0678489796255143,0.00443969151980323,0.0591471842466999,0.0765507750043286,2.80802060480047e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.14835801430306,0.00973599525913116,0.129275463595163,0.167440565010957,4.67778555388769e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.104619291600437,0.006862980288233,0.0911678502355007,0.118070732965374,4.9783917103638e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDC,Nuclear migration protein nudC,40058,0.0969793391194013,0.00636707209179365,0.0844998778194858,0.109458800419317,5.01969150385454e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.120418812414583,0.00790242324225481,0.104930062859764,0.135907561969402,5.46659068987412e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILPL2,RILP-like protein 2,37437,0.148839422525064,0.00977330078431479,0.129683752987807,0.167995092062321,6.07922617624597e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD22,B-cell receptor CD22,40058,0.0603527236231181,0.00396774889455046,0.0525759357897992,0.068129511456437,6.84344752989516e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.05395698853982,0.0035474626346719,0.047003961775863,0.0609100153037769,8.14854599360795e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.05377170802148,0.00354057921456069,0.0468321727609411,0.060711243282019,9.86851170250864e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0890780642018196,0.00587121145030829,0.0775704897592153,0.100585638644424,1.23156881671904e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.115416480269137,0.00761037100997925,0.100500153089577,0.130332807448696,1.39043792131712e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0615838472968505,0.00406374300553376,0.0536189110060043,0.0695487835876967,1.60699301276061e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0622079621208904,0.00410666635413156,0.0541588960667926,0.0702570281749883,2.09996082395125e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2,Prothrombin,37453,0.0219811124647604,0.00145235760128798,0.019134491566236,0.0248277333632849,2.50074889983638e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UMOD,Uromodulin,40012,-0.0787187659756076,0.00521502846706608,-0.0889402217710571,-0.0684973101801581,3.92332930503774e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3C,Protein FAM3C,39846,0.0432382724350692,0.00286488514291413,0.0376230975549575,0.0488534473151809,4.08211364397199e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0697972441118787,0.00462307029023724,0.0607360263430137,0.0788584618807437,4.36184510920257e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMT,Catechol O-methyltransferase,39403,0.126982887214138,0.00842025556968858,0.110479186297549,0.143486588130728,4.98534430430682e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6AP2,Renin receptor,39477,0.060804684393067,0.00403289459586217,0.0529002109851771,0.0687091578009568,5.22944007201099e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.128402230411562,0.00851659121492044,0.111709711630318,0.145094749192806,6.08727241373619e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.139417917028451,0.00926844447314939,0.121251765861078,0.157584068195824,9.96556744378073e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGLL,Monoglyceride lipase,39908,0.12961997551825,0.00863977603591983,0.112686014487847,0.146553936548653,1.55144356958518e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK10,Kallikrein-10,39856,0.0583397715129296,0.00389469091566167,0.0507061773182328,0.0659733657076265,2.20138893256746e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0735033483485302,0.0049044304905233,0.0638906645871045,0.0831160321099558,2.36234263365645e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0853063798243154,0.00570322077353359,0.0741280671081896,0.0964846925404412,3.03782789597664e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0815357690653009,0.00545369492018691,0.0708465270217346,0.0922250111088673,3.43513319765318e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0471921543241002,0.00315785502596514,0.0410027584732085,0.0533815501749918,3.6689099047423e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0681391053281385,0.00455724151279793,0.0592069119630546,0.0770712986932225,3.80876688592169e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0377486173505249,0.0025264947078234,-0.0427005469778588,-0.0327966877231911,3.86081363770411e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0552084765468798,0.00369605545415315,0.0479642078567396,0.06245274523702,4.16723482032052e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0480403703459868,0.00321998920849859,0.0417291914973296,0.0543515491946441,5.36138724883396e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4D,Semaphorin-4D,40009,0.044207853739287,0.00296350279593628,0.0383993882592518,0.0500163192193221,5.46327789000098e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK13,Kallikrein-13,39490,0.0621881122729231,0.00417184564495831,0.0540112948088048,0.0703649297370414,6.57298338255169e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATOX1,Copper transport protein ATOX1,39913,0.107148396048468,0.00720023769804921,0.0930359301602912,0.121260861936644,9.36519414807286e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0568629731895529,0.0038202039105479,0.049375373524879,0.0643505728542268,1.04437297147884e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0918221095215158,0.00617222196770969,0.0797245544648049,0.103919664578227,1.15137215159588e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRADD,Death domain-containing protein CRADD,39713,0.112292813552795,0.00755282531334473,0.0974892759386392,0.127096351166951,1.15485498157754e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0428636546658872,0.00288869809109104,0.0372018064073487,0.0485255029244256,1.75175234568811e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POSTN,Periostin,37437,-0.0545920540907756,0.00367993557888806,-0.0618047278253962,-0.047379380356155,2.1176058963621e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0653785075977473,0.00441066808372273,0.0567335981536508,0.0740234170418439,2.59895093305951e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIN2,Bridging integrator 2,39858,0.131392879694495,0.00887616634463403,0.113995593659013,0.148790165729978,2.97181388801798e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0691708140201495,0.00467351377366859,0.0600107270237591,0.07833090101654,3.05181603104643e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL8,C-C motif chemokine 8,40003,0.0882933549912639,0.00597225962731061,0.0765877261217351,0.0999989838607927,3.89891625810118e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFB,Complement factor B,37220,0.0483238755294865,0.00326774166021787,0.0419191018754595,0.0547286491835136,4.2679149196898e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFASC,Neurofascin,40058,0.0404591761739568,0.00274078034609522,0.0350872466956102,0.0458311056523035,5.36683535210416e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0911577821758935,0.00617136380878964,0.0790619091106658,0.103253655241121,5.39968121498161e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.11340086665994,0.00768501988682396,0.0983382276817652,0.128463505638115,5.8975296899907e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP7,Caspase-7,37388,0.123308656560039,0.00835303964864639,0.106936698848692,0.139680614271386,6.17375755189875e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.11416441065473,0.00774096723353714,0.0989921148769969,0.129336706432462,6.63135200924603e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.11198911489145,0.00759377732194551,0.097105311340437,0.126872918442463,6.67321650446782e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.184801224455654,0.0125266563717464,0.160248977967031,0.209353470944277,7.21385513567839e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMMT,MICOS complex subunit MIC60,37368,0.06409293863059,0.00434601774085173,0.0555747438585206,0.0726111334026594,7.65114546483005e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL2,C-C motif chemokine 2,39720,0.0753262453280089,0.00511133711498807,0.0653080245826323,0.0853444660733855,7.83491034397235e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0823552551793457,0.00559184134945768,0.0713952461344086,0.0933152642242827,8.9513785800518e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.142958694410881,0.00970433383639235,0.123938200091552,0.16197918873021,9.65939068738781e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.0466893253889829,0.00316941801959962,0.0404772660705676,0.0529013847073981,9.90364284410746e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM3,Dynamin-3,37411,0.0799826762943714,0.00543324849121185,0.0693335092515962,0.0906318433371466,1.12320877219572e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0559899419904216,0.00380439810097749,0.0485333217125057,0.0634465622683374,1.18891019372996e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TADA3,Transcriptional adapter 3,37368,0.0577394503817539,0.00392408013920108,0.0500482533089198,0.065430647454588,1.24398844911336e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED8,Protein TMED8,37382,0.150811591568528,0.0102519468778002,0.13071777568804,0.170905407449017,1.3097930283309e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0699218891539472,0.00475551748464577,0.0606010748840415,0.0792427034238529,1.45198840072055e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0417230095185713,0.00284615804528908,0.0361445397498047,0.0473014792873379,2.45557612872455e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0721128403398238,0.00492010991995339,0.0624694248967152,0.0817562557829324,2.50835554418768e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0651805569043162,0.00444495915073549,0.0564684369688746,0.0738926768397578,2.58433714524955e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F12,Coagulation factor XII,37453,0.0600900937576595,0.0041027063879684,0.0520487892372414,0.0681313982780776,3.30544930065032e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSTN,Growth/differentiation factor 8,39585,0.0750213984844959,0.00513223541876529,0.064962217063716,0.0850805799052759,4.47803968323509e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D5,TBC1 domain family member 5,39866,0.11276170713729,0.00771572366018703,0.0976388887633229,0.127884525511256,4.62835099689227e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0666528313193972,0.00456086241722013,0.0577135409816457,0.0755921216571487,5.41794623563159e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.0979570088571548,0.00670529353684725,0.0848146335249342,0.111099384189375,5.847089971078e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0980100946852127,0.00670997395248102,0.0848585457383499,0.111161643632076,5.89590433783372e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL32,Interleukin-32,39866,-0.0618791136483693,0.00423960208583682,-0.0701887337366094,-0.0535694935601291,6.09707110780395e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCB,Tubulin-folding cofactor B,39749,0.146139002811299,0.0100258762031246,0.126488285453174,0.165789720169423,8.10370243023122e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0434772010560052,0.00298551039260624,0.0376256006864969,0.0493288014255134,9.73487103688282e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0980655753819188,0.00674205795901797,0.0848511417822435,0.111280008981594,1.25820449605836e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.123157605247294,0.00846312668510141,0.106569876944495,0.139745333550093,1.29143166237169e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0542897904255563,0.0037331079263724,0.0469728988898664,0.0616066819612462,1.48387983619328e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIFBP,KIF-binding protein,39788,0.119114956907951,0.00820661339302156,0.103029994657628,0.135199919158273,1.96889859136393e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WDR46,WD repeat-containing protein 46,37368,0.0518893602065861,0.00357352565306741,0.044885249926574,0.0588934704865982,2.04439672785579e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0964808555088948,0.0066444930634815,0.0834576491044711,0.109504061913319,2.07152132271382e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTF1,Cardiotrophin-1,39585,0.121870914614191,0.00839858150810437,0.105409694858306,0.138332134370075,2.09261513473463e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YWHAQ,14-3-3 protein theta,37124,0.106379479539057,0.00735074243507329,0.0919720243663138,0.120786934711801,4.16310492237879e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0680003610373264,0.00469968730185823,0.0587889739256842,0.0772117481489685,4.25122658847503e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSL,Cathepsin L1,39868,0.0341820089853909,0.00236533684627066,0.0295459487667005,0.0388180692040814,4.86952649222769e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHD3,EH domain-containing protein 3,37043,0.168502581347266,0.0116586556736763,0.145651616226861,0.191353546467672,5.4855459263327e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0825960681777507,0.00571895030436105,0.0713869255812031,0.0938052107742984,5.60990423690436e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0908527668001874,0.00629327620057145,0.0785179454470673,0.103187588153307,6.01447322203097e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.083409912602377,0.00577861988101016,0.0720838176355971,0.0947360075691569,7.02822288122445e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0936556714576731,0.0064930027194939,0.080929386127465,0.106381956787881,7.13944719284944e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0640248355446111,0.00443640669094679,0.0553294784303554,0.0727201926588668,7.43202660333998e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0553784953602045,0.0038437975766899,-0.0629123386105167,-0.0478446521098923,9.13959127113325e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGLAP,Osteocalcin,37437,0.123390419088238,0.00856464012579354,0.106603724441683,0.140177113734794,1.03382933823575e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0906982848311999,0.00629984819074679,0.0783505823773362,0.103045987285064,1.05223749266196e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0607883836704113,0.00423567535925318,0.0524864599662751,0.0690903073745475,2.00808313160532e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0409353374245019,0.00285530110988244,0.0353389472491323,0.0465317275998715,2.48224245869015e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0953823661741889,0.00665108152941975,0.0823462463765262,0.108418485971852,2.71197957830383e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0945073197660046,0.0065977085594477,0.0815758109894872,0.107438828542522,2.98131470572e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0756274643136869,0.00527701887603107,0.065284507316666,0.0859704213107078,3.08000064034382e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0635211470464896,0.00443598852975606,0.0548266095281677,0.0722156845648114,3.24250043804138e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0340462874651401,0.00237710280778526,0.029387165961881,0.0387054089683992,3.4304333852126e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0834131674733209,0.00583085160747327,0.0719846983226733,0.0948416366239685,3.95628944119633e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.136311400454028,0.00953137199295924,0.117629911347827,0.154992889560228,4.13355516623509e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0523151417820576,0.00365946663177632,0.045142587183776,0.0594876963803392,4.51589134764249e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.104332490565913,0.00729378469437451,0.0900366725649394,0.118628308566887,4.54820514628422e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADM,Pro-adrenomedullin,40030,0.0372146160349697,0.00260533107251473,0.0321081671328408,0.0423210649370985,5.24334084628034e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.109523087203642,0.00766347210400496,0.0945026818797924,0.124543492527492,5.33777246940025e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.105257201642647,0.00737284865385095,0.0908064182810994,0.119707985004195,5.97820798104655e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.091855747541418,0.00643692896894516,0.0792393667622855,0.10447212832055,7.23159914457232e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEPR,Leptin receptor,39868,-0.0436409697901695,0.0030608881029704,-0.0496403104719914,-0.0376416291083475,7.67047024785416e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0962331830209781,0.00675076079915275,0.0830016918546387,0.109464674187317,7.95500686456749e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0284276906869317,0.00199461030837608,-0.0323371268913488,-0.0245182544825146,8.25435360676766e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12A_IL12B,Interleukin-12,39788,0.103757639652399,0.00728226053515074,0.0894844090035032,0.118030870301294,8.81639939844076e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM106A,Transmembrane protein 106A,37368,0.100635292623961,0.00705969679904437,0.0867982868978339,0.114472298350088,8.97190941475449e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO9B,Unconventional myosin-IXb,39587,0.093160498695326,0.00654800792375639,0.0803264031647635,0.105994594225888,1.19071632732944e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB6,Serpin B6,39970,0.0847706477357295,0.00595989596786156,0.0730892516387208,0.0964520438327382,1.23704023947487e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB1,Heat shock protein beta-1,39617,0.0980996874185947,0.00690085564787966,0.0845740103487506,0.111625364488439,1.40312661379618e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.123581910662792,0.0087051088688053,0.106519897279934,0.14064392404565,2.03514119786948e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBN,Nibrin,39587,0.0724120098023073,0.00510383178896255,0.0624084994959407,0.0824155201086739,2.07879167353636e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0717624569470665,0.00505672241731809,0.0618512810091231,0.08167363288501,2.19109685237451e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP7,Matrilysin,39563,0.0693742304897434,0.00489469623210953,0.0597806258748087,0.0789678351046781,2.54910550213375e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LARP1,La-related protein 1,37368,0.0900845806255208,0.00635303566617269,0.0776326307198223,0.102536530531219,2.58343323521988e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164,Sialomucin core protein 24,39858,0.0367372660201749,0.00259505814717947,0.0316509520517031,0.0418235799886467,3.18695394284145e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.167511716360312,0.0118279398474095,0.144328954259389,0.190694478461235,3.34266478555606e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACYBP,Calcyclin-binding protein,37088,0.14557436130328,0.0102792299296646,0.125427070641138,0.165721651965423,3.36757002435786e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0861970028464885,0.00608785903538725,0.0742647991371295,0.0981292065558475,3.45839260498588e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.102896934744869,0.0072694144771463,0.0886488823696623,0.117144987120076,3.70892508995077e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.125314779938567,0.00886211047548971,0.107945043406608,0.142684516470527,4.0035088158163e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.146570670653692,0.0103627049461774,0.126259768959184,0.166881572348199,4.32085712993953e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.139467120598011,0.00986185409485585,0.120137886572094,0.158796354623929,4.47578777735422e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.158317725062614,0.0111955976544101,0.13637435365997,0.180261096465258,4.50531154533188e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2,Complement C2,39908,0.0328864870393919,0.00233917122931957,0.0283017114299255,0.0374712626488582,1.24762756270787e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.124105518090896,0.00882951417248195,0.106799670312831,0.14141136586896,1.4575649983286e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.142587289555107,0.0101535927554402,0.122686247754444,0.162488331355769,1.74488587443114e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.155916408590361,0.0111245409948707,0.134112308240414,0.177720508940307,2.28544350110017e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0732288954570813,0.00522740361781254,0.0629831843661687,0.0834746065479939,2.55905563824758e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRB1,Chymotrypsinogen B,39858,0.0739274813670054,0.00529200639794977,0.0635551488270238,0.0842998139069869,4.33543301223269e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.151959813976423,0.0108869340573051,0.130621423224105,0.173298204728741,5.10316425302625e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.131034848149547,0.00938661537886484,0.112637082006972,0.149432614292122,5.54354222564994e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSA,Arylsulfatase A,39858,0.0621301564547627,0.00445350042208309,0.0534012956274798,0.0708590172820455,5.62555002580168e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0922149737900088,0.00660972685447159,0.0792599091552445,0.105170038424773,6.33703465509891e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARK7,Parkinson disease protein 7,39858,0.0723935655337919,0.00519555420251071,0.0622102792968709,0.0825768517707129,7.12893389019817e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0833573794858408,0.00598259896087643,0.071631485522523,0.0950832734491586,7.276324488738e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7,Interleukin-7,39866,0.0899956025136652,0.00646084316194441,0.0773323499162542,0.102658855111076,7.57024051861505e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIAPIN1,Anamorsin,39913,0.0869858946148355,0.0062505008884637,0.0747349128734466,0.0992368763562243,9.01575769160253e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH9,Protocadherin-9,37382,0.0458476438226229,0.00329478648118294,0.0393898623195044,0.0523054253257415,1.02480533218776e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0580419460807402,0.0041752331185749,0.0498584891683334,0.066225402993147,1.25476930979415e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0710176878430919,0.005112536673764,0.0609971159625144,0.0810382597236693,1.28868521216766e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.138482910160308,0.00997962710702949,0.11892284103053,0.158042979290086,1.56997655115233e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP1,Guanylate-binding protein 1,37376,0.0874328277185398,0.00629951543199511,0.0750857774718294,0.0997798779652502,1.68105434013894e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.130311754688189,0.00939527537600562,0.111897014951218,0.148726494425161,1.72763403851807e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THTPA,Thiamine-triphosphatase,37345,0.121454038357913,0.00875617237542817,0.104291940502074,0.138616136213753,1.8954804205487e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0845086825031399,0.00609308687434647,0.0725662322294208,0.0964511327768589,1.91488043289748e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0894839121444382,0.00645235999139625,0.0768372865613016,0.102130537727575,1.95209264365646e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3B,Protein FAM3B,39788,0.0491415600996111,0.00355093424190648,0.0421817289854744,0.0561013912137478,2.63833923405301e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.083443590494043,0.00603313086527866,0.0716186539980968,0.0952685269899892,2.94309376853038e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.117918525231016,0.00854001242790836,0.101180100872315,0.134656949589716,4.05378186502649e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.0753466121588001,0.00545454925866209,0.0646556956118224,0.0860375287057778,4.14636421553418e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.124759430012459,0.00903458082578702,0.107051651593917,0.142467208431002,4.47602818054254e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMVK,Phosphomevalonate kinase,39480,0.15188710899108,0.0110093360903924,0.130308810253911,0.173465407728249,4.80321759089558e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CERT,Ceramide transfer protein,39489,0.0842459058228553,0.00610757272334401,0.0722750632851011,0.0962167483606096,4.97092241238003e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.084684628910761,0.006138199130537,0.0726537586149084,0.0967154992066135,5.33369185036145e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2R,Proteinase-activated receptor 1,39908,0.0796760542981436,0.00578439662829501,0.0683386369066854,0.0910134716896018,6.38443129236577e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0466365996534201,0.00338875218259285,0.0399946453755381,0.0532785539313021,7.6534196471901e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.147278244385328,0.0107097665131316,0.12628710201959,0.168269386751066,9.64172104774982e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREH,Trehalase,37437,0.102698219632101,0.00746980574621112,0.0880574003695269,0.117339038894675,1.00550659963812e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.0993916691879424,0.00722972936426395,0.0852213996339851,0.1135619387419,1.01631182255579e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0425452275546015,0.00309684236450445,0.0364754165201728,0.0486150385890302,1.03978380476835e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0547671606081942,0.00398739785836927,0.0469518608057905,0.062582460410598,1.20894077775527e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.064292116570117,0.00468266593981887,0.055114091328072,0.0734701418121619,1.32145584389038e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA14,Carbonic anhydrase 14,40030,-0.0476375412610862,0.00347631168729087,-0.0544511121681763,-0.0408239703539961,1.67208075550166e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGR1,Prostaglandin reductase 1,37437,0.108140678404424,0.00789408668575797,0.0926682685003384,0.12361308830851,1.97194118275349e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0412639250728944,0.00301268698641824,0.0353590585795147,0.0471687915662742,2.04533061945377e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.125663142099617,0.00918024432466642,0.107669863223271,0.143656420975963,2.31864223187721e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.152884453703931,0.0111755620527434,0.130980352080554,0.174788555327308,2.3366739410734e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0603715568690287,0.00441632877992324,-0.0690275612776782,-0.0517155524603791,2.63527542010923e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0488416951814555,0.00357557980496045,0.0418335587637331,0.055849831599178,3.02519153769782e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0541195510599376,0.00396115397947638,0.0463556892601639,0.0618834128597113,3.23002935419807e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID1,Nidogen-1,39892,0.0507798263287013,0.00371999408458284,0.043488637922919,0.0580710147344837,3.45044162514126e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0652264351677136,0.00477604912758259,0.0558653788776517,0.0745874914577754,3.48507174740741e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MESD,LRP chaperone MESD,39858,0.164895648451573,0.0120950747408571,0.141189301959493,0.188601994943653,4.36293472321919e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3,Galectin-3,39901,0.0398281243965229,0.00292155776764046,0.0341018711719476,0.0455543776210982,4.40371389691476e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0386009090763359,0.00283071569386895,0.0330527063163528,0.044149111836319,4.60021298400623e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0921752208304684,0.00676330292358926,0.0789191471002335,0.105431294560703,4.70209283018205e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.13494518403353,0.00992191570786085,0.115498229246122,0.154392138820937,7.4705063922316e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0724547411672165,0.00532842065088145,0.0620110366914889,0.0828984456429441,7.77157719320233e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.13308077579482,0.00979039758830213,0.113891596521747,0.152269955067892,8.27241672295884e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0423697980112751,0.00312258344500776,0.0362495344590599,0.0484900615634903,1.04521852632552e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP2,Caspase-2,39866,0.0918586897869569,0.00677258919036441,0.0785844149738427,0.105132964600071,1.12313531172845e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICALL2,MICAL-like protein 2,37039,0.0914830036584994,0.00674488970852641,0.0782630198297876,0.104702987487211,1.25710014632748e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO3,Forkhead box protein O3,39477,0.131194421727353,0.00968013671932068,0.112221353757484,0.150167489697221,1.30828119123457e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN2,Nectin-2,39846,0.0378633518886029,0.00279504019858495,0.0323850730993764,0.0433416306778294,1.40713209628218e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAP3,Cytosol aminopeptidase,39587,0.0652595401618679,0.00482168279316668,0.0558090418872612,0.0747100384364746,1.66859426834536e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0556057225893088,0.00411188358550497,0.0475464307617191,0.0636650144168985,1.93513008668805e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA4,Ephrin-A4,39720,0.0370644042356243,0.00274105409172491,0.0316919382158435,0.0424368702554051,1.9690734114487e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD83,CD83 antigen,39866,0.0439671283377631,0.00325168211691094,0.0375938313886176,0.0503404252869085,1.97564586744984e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA3,Annexin A3,39985,0.0935197363893021,0.00691815892797536,0.0799601448904704,0.107079327888134,2.05843271454912e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF6,SLAM family member 6,39477,0.0505517776760463,0.00374165629859257,0.0432181313308049,0.0578854240212878,2.31427546147485e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPPK1,Epiplakin,37043,0.100017717420537,0.00740478278156697,0.0855043431686657,0.114531091672408,2.66967721716661e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0629909052292705,0.00466475017138155,0.0538479948933626,0.0721338155651783,2.75362355008994e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBI,Acyl-CoA-binding protein,39793,0.106903486005219,0.00792085947058468,0.0913786014428734,0.122428370567565,2.76661222624158e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFA,Protransforming growth factor alpha,39866,0.0612677694949955,0.00454786937671548,0.0523539455166332,0.0701815934733579,3.8433357484532e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.10946513781031,0.00812565674402258,0.0935388505920255,0.125391425028594,3.8540990233003e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMSB10,Thymosin beta-10,39858,0.103052851155608,0.00765480712019145,0.0880494292000331,0.118056273111184,4.35121573239453e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.136863125596462,0.0101653646451823,0.116939010891905,0.156787240301019,4.77707643462181e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL1,Growth-regulated alpha protein,39839,0.126405712944186,0.009397503095863,0.107986606876295,0.144824819012078,5.07882298807428e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF23,Fibroblast growth factor 23,40008,0.0777464504250915,0.00578394884692536,0.0664099106851178,0.0890829901650652,5.71527062535663e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCA,Calcitonin,39713,0.081004808234285,0.0060371593865993,0.0691719758365504,0.0928376406320196,7.95427303944907e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPH,Hephaestin,37437,0.0350413662209935,0.00261057912927504,0.0299246311276144,0.0401581013143725,8.08999637092449e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.085427932329809,0.00636734346921947,0.0729479391301388,0.0979079255294791,8.91700922004173e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.037738403887285,0.00281559163042454,0.0322198442916529,0.0432569634829171,9.59652767648233e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.132118023755816,0.0098674546587135,0.112777812624738,0.151458234886895,1.26574949238431e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0407933899105695,0.00305481925012922,-0.0467808356408227,-0.0348059441803162,1.84300006442988e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP3,Caspase-3,40052,0.117457680140589,0.00881653864976673,0.100177264387046,0.134738095894132,2.79374307752871e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0520151634527655,0.00390837619543119,0.0443547461097203,0.0596755807958106,3.41360276667102e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0442063578516676,0.0033228937177304,0.037693486164916,0.0507192295384192,3.61912109058528e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0397357840530428,0.00298576882746399,0.0338836771512134,0.0455878909548722,3.689232073194e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRD2,Protein ZNRD2,37382,0.0896380486438237,0.00673601088266979,0.0764354673137909,0.102840629973856,3.75466153930479e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RP2,Protein XRP2,39788,0.054941296480905,0.00413243041516228,0.0468417328671869,0.063040860094623,4.04057740526811e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.0478687496384001,0.00360151713818437,0.0408097760475587,0.0549277232292414,4.26784223543434e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0260306791623785,0.00195915063966055,-0.0298706144161132,-0.0221907439086438,4.51729405773091e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.108726181122071,0.00818385288880255,0.0926858294600178,0.124766532784124,4.99732778358366e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ING1,Inhibitor of growth protein 1,39453,0.0592791290567537,0.00446428003709558,0.0505291401840463,0.068029117929461,5.08529676820538e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0863735260312791,0.00650739293711178,0.07361903587454,0.0991280161880182,5.45713752337874e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.040978462686084,0.00308836984538277,0.0349252577891337,0.0470316675830342,6.24988224220816e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XCL1,Lymphotactin,40030,0.0719711705534949,0.0054330611650905,0.0613223706699175,0.0826199704370723,7.58534087413722e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTF2,Transcription termination factor 2,37039,0.0646572926910507,0.00487953467174919,0.0550934047344223,0.0742211806476791,8.03308978609031e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.123974484218827,0.00939486182040544,0.105560555050833,0.142388413386822,1.49229683490687e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0662875920994033,0.00502396819981961,0.0564406144277568,0.0761345697710497,1.5228132046532e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.052956618842959,0.00401168593284687,0.0450937144145791,0.0608195232713388,1.52819416839473e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON2,Spondin-2,39775,-0.0438701525026907,0.00332567502745284,-0.0503884755564983,-0.0373518294488831,1.58651864569469e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0349012146877157,0.00264661238818648,0.0297138544068702,0.0400885749685612,1.66313972218994e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0391905936830237,0.00297491455604583,0.0333597611531739,0.0450214262128736,1.99524603925083e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0800845043580528,0.0060756939445263,0.0681761442267813,0.0919928644893244,2.00101958875404e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVR,Poliovirus receptor,40009,0.0485030170804551,0.00368725870878523,0.0412759900112361,0.0557300441496742,2.56344626465414e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.120616572588284,0.00918207996959067,0.102619695847886,0.138613449328681,3.26318791294761e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0646551160858519,0.00492778550232081,-0.0743135756704006,-0.0549966565013031,3.9987978373861e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMFG,Glia maturation factor gamma,37437,0.0937899016978617,0.00714572989408955,0.0797842711054462,0.107795532290277,4.08002080954032e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0847306519062385,0.00645608819289605,0.0720767190481622,0.0973845847643148,4.15035294390211e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.101004157962353,0.00771419996272968,0.0858843260354028,0.116123989889303,5.68181542124027e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0843219567948001,0.00643821604688161,0.0717030533429121,0.096940860246688,5.99214819879285e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMTN,Smoothelin,37342,0.125133570867078,0.00955590868295765,0.106403989848481,0.143863151885675,6.08578572385951e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGT1,Protein SGT1 homolog,39477,0.105137355699049,0.00803960003090052,0.0893797396384837,0.120894971759614,7.09186854992472e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL15,C-C motif chemokine 15,40052,0.0561688089599847,0.00429690099659355,0.0477468830066614,0.0645907349133081,7.49290253179908e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.114495981589221,0.00875904511038685,0.0973282531728624,0.131663710005579,8.20822441835371e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NADK,NAD kinase,39868,0.0690581817269993,0.00529286930504546,0.0586841578891102,0.0794322055648884,1.03605182002323e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB1,Beta-crystallin B1,37437,0.0860889141842041,0.00660334787557081,0.0731463523480853,0.0990314760203228,1.2824826180149e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.043828226389083,0.003363966738593,0.0372348515814407,0.0504216011967253,1.33117059523526e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.145008307533321,0.0111371546752584,0.123179484369815,0.166837130696828,1.48576528818159e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0991551831751417,0.00761456985052894,0.084230626268105,0.114079740082178,1.56855247750556e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0562577084058148,0.00432041408426364,0.0477896968006581,0.0647257200109715,1.59856530471621e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0686231005552818,0.0052762812788944,0.0582815892486488,0.0789646118619149,1.76615031759876e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.078186165150417,0.00601456176004881,0.0663976241007213,0.0899747062001127,2.11382159305468e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0873772804498786,0.00672606457668064,0.0741941938795846,0.100560367020173,2.1532232816131e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0541421786392391,0.00416995801565012,0.0459690609285649,0.0623152963499134,2.56078896755004e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0741954665834501,0.00571731802958679,0.06298952324546,0.0854014099214402,2.57629171829998e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0738838641766468,0.00569321007759015,0.0627251724245701,0.0850425559287235,2.81299047735396e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA1,Apolipoprotein A-I,37453,-0.0351281685783894,0.00270716070777716,-0.0404342035656326,-0.0298221335911461,2.82426277136957e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0622143917204357,0.00479878993331182,0.0528087634511445,0.0716200199897269,3.05876163072488e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL14,C-C motif chemokine 14,39843,0.0499030533136148,0.00385333564856479,0.0423505154424278,0.0574555911848018,3.6269547246208e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0615830874500122,0.00475650002980763,0.0522603473915892,0.0709058275084351,4.16035867799809e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.113341773257231,0.00875906542439235,0.0961740050254222,0.13050954148904,4.50906159547955e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSNAX,Translin-associated protein X,37021,0.0503258990777783,0.00388934868830001,0.0427027756487103,0.0579490225068463,4.60138383474979e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASS1,Argininosuccinate synthase,37021,0.10242119416445,0.00792720221127341,0.0868838778303544,0.117958510498546,5.88785671783343e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0582679160225832,0.00451112059023568,0.0494261196657213,0.0671097123794452,6.08769729322274e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0587924988130761,0.00455536017609309,0.0498639928679337,0.0677210047582186,7.03953962825427e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRL,Appetite-regulating hormone,39868,0.0980184470064341,0.00760774604675862,0.0831072647547872,0.112929629258081,8.53265780776548e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0729726922722161,0.00566337892210124,0.0618724695848976,0.0840729149595345,9.2378739057691e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB9,Serpin B9,39749,0.0426558697154227,0.00331247941893072,0.0361634100543185,0.0491483293765269,9.32918613833899e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.0405864683174699,0.0031510224932669,0.0344104642306667,0.046762472404273,9.65110653385372e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0582657107525296,0.00452866261392207,0.0493895320292423,0.0671418894758168,1.07135127106907e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0697166301453926,0.00542545061399862,0.0590827469419553,0.0803505133488299,1.33499182595485e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0984164947754416,0.00766442771497425,0.0833942164540921,0.113438773096791,1.62771352779045e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLMH,Bleomycin hydrolase,40052,0.0406906788150386,0.00317205218784612,0.0344734565268602,0.046907901103217,1.74265609277298e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11,Coagulation factor XI,37249,0.0397588912030593,0.00310078523235588,0.0336813521476418,0.0458364302584768,2.04412376428918e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB2,Calretinin,39489,0.0370659308041736,0.00289356859254882,0.0313945363627779,0.0427373252455693,2.2289546858816e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.102115231895589,0.00796894270932039,0.0864961041853208,0.117734359605857,2.28154652219431e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRGN,Neurogranin,37445,0.116407057680193,0.00909330918342572,0.0985841716806783,0.134229943679707,2.64497089025041e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GET3,ATPase GET3,37437,0.0711207827637164,0.00555633658841592,0.0602303630504212,0.0820112024770116,2.69518549512747e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.106015142627225,0.00829521212720057,0.0897565268579123,0.122273758396538,3.20866647850397e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0635064043858068,0.00497345953579279,0.0537584236956529,0.0732543850759607,3.68904972753629e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0938693423983893,0.00735217314925985,0.07945908302584,0.108279601770939,4.06705595262519e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.160673282237517,0.0126075927354964,0.135962400475944,0.18538416399909,5.47690507614432e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.076615001371874,0.00601224925087662,-0.0883990099035922,-0.0648309928401558,5.62349015097546e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL25,C-C motif chemokine 25,40058,0.0628889969255296,0.00494112150253532,0.0532043987805604,0.0725735950704988,6.23650638296345e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0964597467416936,0.00758427891552733,0.08159456006726,0.111324933416127,7.12659222008168e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0659636091642501,0.0051880659559359,0.0557949998906158,0.0761322184378845,7.37084452201415e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0747183735084995,0.00587773066826982,0.0631980213986907,0.0862387256183084,7.71071120001965e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.15194030761935,0.011957141907679,0.128504309480299,0.1753763057584,8.1220422371153e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0459373245092881,0.00361457225455895,0.0388527628903526,0.0530218861282237,8.67517279489753e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.057070699916599,0.00449218294105206,0.048266021352137,0.065875378481061,9.16990571868333e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0956317304886471,0.0075308316950309,0.0808713003663866,0.110392160610908,9.74465665442111e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCA,Tubulin-specific chaperone A,37124,0.108810204556345,0.00857413123254163,0.0920049073405637,0.125615501772127,1.09043332942299e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0398313652098118,0.00314098452324664,0.0336750355442483,0.0459876948753752,1.13219193627413e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.109188492764343,0.00863561388533106,0.0922626895490943,0.126114295979592,1.94130896264346e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAST,Gastrin,37388,0.145563366204197,0.011520729375937,0.12298273662736,0.168143995781033,2.17564536266817e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0706579111652509,0.00559481946645008,0.0596920650110087,0.0816237573194931,2.19545165234053e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN4,CCN family member 4,40030,0.0500302388054995,0.00397073150865348,0.0422476050485387,0.0578128725624604,3.13455624399299e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0615511029003884,0.00489137340193434,0.0519640110325971,0.0711381947681797,4.13680053063609e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSTB,Cystatin-B,39619,0.0529002067860013,0.00420829726373904,0.0446519441490728,0.0611484694229299,4.57218214162849e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL26,C-C motif chemokine 26,39866,0.106547054922873,0.00848678039147761,0.0899129653555773,0.12318114449017,5.55070978613307e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0628642320659025,0.00501701768895625,0.0530308773955483,0.0726975867362568,7.58812985622483e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0448738192268247,0.00358289027506012,0.0378513542877069,0.0518962841659425,8.06586779815244e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTD,Deoxycytidylate deaminase,37124,0.118992660374477,0.00949823395761069,0.10037612181756,0.137609198931394,8.3792707977968e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP6,Platelet glycoprotein VI,39836,0.110019018488614,0.00879604365506087,0.0927787729246943,0.127259264052533,9.950890738635e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.083874656892402,0.00671368113132497,0.0707158418750051,0.097033471909799,1.2050628150725e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB6,Heat shock protein beta-6,40030,0.0463365104925683,0.00371554236587814,0.0390540474554472,0.0536189735296895,1.56588550559679e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0539237588916983,0.00432295503112581,0.0454507670306918,0.0623967507527049,1.64548006049613e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDHB,Succinate dehydrogenase,37382,0.086798235262747,0.00696414142600169,0.0731485180677837,0.10044795245771,1.8466817033673e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDK,Midkine,39843,0.0624257278503758,0.00501520903021657,0.0525959181511513,0.0722555375496003,2.11123601033489e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA2,Annexin A2,36879,0.0862197246289596,0.0069230662331527,0.0726505148119803,0.0997889344459389,2.11639618277185e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0515817985984949,0.00414448450288044,0.0434586089728492,0.0597049882241405,2.16220255265187e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.108796564346443,0.00875174756942386,0.0916431391103719,0.125949989582513,2.77474323997494e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0370112209468348,0.0029790743861533,-0.0428502067436953,-0.0311722351499744,2.82228636383655e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APLP1,Amyloid-like protein 1,39868,-0.0630832299738174,0.00507912211844526,-0.0730383093259701,-0.0531281506216647,2.95506255909907e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FEN1,Flap endonuclease 1,39477,0.0768563317764174,0.00618825817756074,0.0647273457483984,0.0889853178044365,2.99754233471954e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.0963806054575166,0.0077576354463595,0.081175639982652,0.111585570932381,3.01347616140115e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0719035789461615,0.00578983205763111,0.0605555081132045,0.0832516497791184,3.03237455942391e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0790008630146044,0.00639019686651849,0.0664760771562282,0.0915256488729807,6.04947383581444e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB10,Ras-related protein Rab-10,37437,0.0656971319075579,0.00531417866356896,0.0552813417269628,0.0761129220881531,6.41707576619028e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSE,Cathepsin E,37124,0.0647394851355561,0.00523972849873099,0.0544696172780434,0.0750093529930689,7.07459427541574e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0851260894578683,0.00688974369985417,0.0716221918061541,0.0986299871095825,7.10098596534391e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0323784584196951,0.00262207384967014,0.0272391936743417,0.0375177231650486,7.15315261579364e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0683011057164622,0.0055338776464587,0.0574547055294032,0.0791475059035213,8.28866450546179e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.105722973195561,0.00857145950038604,0.0889229125748039,0.122523033816317,9.19983313002162e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0443397576579733,0.00359821434046061,0.0372872575506705,0.0513922577652761,9.78131501417283e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN1,Ficolin-1,37430,0.0687066881260236,0.00558088470311832,0.0577681541079117,0.0796452221441355,1.20857282051412e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0585877323551643,0.00476091346642007,0.0492563419609809,0.0679191227493476,1.28825490340906e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0645539944097467,0.00525442548822143,0.0542553204528327,0.0748526683666607,1.55783410438725e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.085773069840676,0.00697989507042234,0.0720924755026483,0.0994536641787038,1.61246295194483e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0670114956592761,0.00545465424560952,0.0563203733378815,0.0777026179806708,1.67958094571558e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACYP1,Acylphosphatase-1,37073,0.0798742852153743,0.00651634372112884,0.0671022515219618,0.0926463189087868,2.35237464918008e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0729428349080803,0.00595135505481094,0.0612781790006508,0.0846074908155097,2.38420638292112e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASET2,Ribonuclease T2,39974,0.0309433675558704,0.00252726761561715,0.0259899230292608,0.03589681208248,2.5761273092276e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGMN,Legumain,39931,0.0435758759934873,0.00356037499605295,0.0365975410012235,0.0505542109857511,2.73007759589252e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLB,Beta-klotho,39489,-0.089333446410454,0.00730584191338413,-0.103652896560687,-0.0750139962602211,3.17052065678574e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPLAH,5-oxoprolinase,37043,0.0842960395251542,0.00689380772395898,0.0707841763861946,0.0978079026641138,3.38302644212038e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0856176194652841,0.00700538057638348,0.0718870735355725,0.0993481653949957,3.64201173831911e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100P,Protein S100-P,39585,0.0637721905143395,0.00522355570733506,0.0535340213279628,0.0740103597007162,3.99220493790912e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMD,Dystrophin,37043,0.0628655233848709,0.00514813724577626,0.0527751743831494,0.0729558723865924,4.13366836581475e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP5,Platelet glycoprotein V,37124,0.0438135902721468,0.00358971558094244,0.0367777477334996,0.0508494328107939,4.43518627456883e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX,Glutaredoxin-1,39771,0.0677131627378614,0.00556389170112482,0.0568079350036568,0.078618390472066,6.34641904223487e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF2,Fibroblast growth factor 2,39866,0.0804472321527326,0.00661385028792587,0.0674840855883979,0.0934103787170673,6.86647527965536e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAP,Prosaposin,37347,0.0337954468226221,0.0027776174737539,0.0283513165740645,0.0392395770711798,7.00575409234345e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1R,Complement C1r subcomponent,37453,0.0233274857901643,0.00191826483647323,0.0195676867106768,0.0270872848696519,7.54114986140637e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0465277656091939,0.00382604516104215,0.0390287170935513,0.0540268141248365,7.54354198733432e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.086122281997668,0.00708822277409314,0.0722293653604455,0.100015198634891,8.5848394616422e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLF4,Krueppel-like factor 4,36991,0.0475309348002216,0.00391660443019148,0.0398543901170463,0.0552074794833969,1.03449974028285e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP1,Interstitial collagenase,39314,0.110137797319296,0.00910547616671325,0.092291064032538,0.127984530606054,1.57594459485533e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.118950902094882,0.009831574905125,0.0996810152808372,0.138220788908927,1.59537719766186e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.105049787581009,0.00868435430760845,0.0880284531380962,0.122071122023921,1.65944027820173e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLNK,B-cell linker protein,37056,0.0469467177797759,0.00388277764906767,0.0393364735876033,0.0545569619719485,1.77082691143161e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0645706089735266,0.00534551245865827,0.0540934045545564,0.0750478133924968,1.90017742440952e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0866872499605451,0.00717903496240438,0.0726163414342326,0.100758158486858,2.01096308855561e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNF,Tumor necrosis factor,39555,0.0454558244235324,0.00376889701749895,0.0380687862692344,0.0528428625778303,2.38978078299682e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0556242602608908,0.0046125013646757,0.0465837575861264,0.0646647629356551,2.4171354606096e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0884874168418939,0.00733823971627728,0.0741044669979904,0.102870366685797,2.61222706421858e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAL,Integrin alpha-L,37056,0.0511673124695565,0.00424346730297817,0.0428501165557193,0.0594845083833938,2.63678600850862e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.107851356979247,0.00895106976498378,0.0903072602398789,0.125395453718615,2.93445676228872e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.10532509317926,0.0087472523810088,0.0881804785124823,0.122469707846037,3.00983495138986e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0441765527833813,0.00367122043701149,0.0369809607268387,0.0513721448399238,3.53871577008454e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0455029005085935,0.00378349417151477,0.0380872519324245,0.0529185490847624,3.58188603805492e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0542890793017303,0.00451547380626578,0.0454387506414494,0.0631394079620113,3.73755600928363e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.033802482100783,0.00281250211644706,0.0282899779525468,0.0393149862490192,4.21603942106938e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0804206342685694,0.00669197298268833,0.0673043672225003,0.0935369013146385,4.28310697806828e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.145981169522642,0.0121609067147422,0.122145792361747,0.169816546683537,4.68641739136181e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGN,Biglycan,39448,-0.14208677825799,0.0118409870327897,-0.165295112842257,-0.118878443673722,4.99289648252715e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD46,Membrane cofactor protein,39777,0.0337126096726594,0.00281061596193638,0.0282038023872641,0.0392214169580547,5.2538952407334e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0492131277083049,0.00411185691783392,0.0411538881493504,0.0572723672672594,7.16023367088923e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0776610913172019,0.00649249340128888,0.0649358042506757,0.0903863783837281,7.83106460895256e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGRN,Neugrin,37388,0.0253339277375335,0.00211726073019082,0.0211840967063595,0.0294837587687075,7.89567554260013e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0477407040640238,0.00399255308471602,0.0399153000179804,0.0555661081100672,8.21823601301915e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLO1,Lactoylglutathione lyase,39585,0.068590148901566,0.00573946976164555,0.0573407881687407,0.0798395096343913,8.9367476236723e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0519138891373715,0.00434445637784533,0.0433987546367947,0.0604290236379484,9.55581093885275e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0827649878696147,0.00692974901338297,0.069182679803384,0.0963472959358453,9.69467258184652e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL19,C-C motif chemokine 19,40009,0.137027788399006,0.0114751312731999,0.114536531103535,0.159519045694478,9.90279213086735e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0803499672012365,0.00672807895099302,0.0671629324572902,0.0935370019451828,1.04863017361466e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC79,Protein unc-79 homolog,36962,0.0668839697987412,0.00560290532725304,0.0559022753573253,0.0778656642401572,1.11627528980685e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.112229355107242,0.00940900390353685,0.0937877074563094,0.130671002758174,1.16830532703534e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID2,Nidogen-2,39858,0.0859354235534341,0.00720787992187907,0.0718079789065511,0.100062868200317,1.24327944274773e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40LG,CD40 ligand,40058,0.0917759905634997,0.00771693958183429,0.0766507889831045,0.106901192143895,1.76129523610004e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBN1,Drebrin,37056,0.0618636093607563,0.00520371021618592,0.0516643373370319,0.0720628813844807,1.99143963673652e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.104136559990964,0.00879565419045227,0.0868970777776774,0.12137604220425,3.34010798181555e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0836192412951916,0.00706138339159384,0.0697789298476676,0.0974595527427155,3.42578263347373e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0703594654118143,0.00595395684489297,0.0586897099958241,0.0820292208278046,4.61632094768166e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABHD14B,Protein ABHD14B,39687,0.0673110385830117,0.00570271208217542,0.0561337229019479,0.0784883542640755,5.11037548196011e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0374141266556514,0.00317602081013735,0.0311891258677822,0.0436391274435206,6.66521241313152e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0622117303045845,0.00528294169872664,0.0518571645750803,0.0725662960340887,7.49682859991857e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0971339645162712,0.00825336066768951,0.0809573776075998,0.113310551424943,7.6269129687726e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.127712620988669,0.0108468814650768,0.106452733317118,0.14897250866022,7.73260045736004e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FADD,FAS-associated death domain protein,39868,0.0897906979822778,0.00763115724944804,0.0748336297733597,0.104747766191196,7.87170612571977e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0429227046814958,0.00364793341806057,0.0357727551820971,0.0500726541808945,8.40122228155121e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH1,Acid ceramidase,37340,0.0552296637398461,0.00469523393305614,0.0460270052310561,0.0644323222486361,8.66657014908147e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0817158744986453,0.00699946140112279,0.0679969301524446,0.095434818844846,2.30833701105992e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA9,Serpin A9,39715,0.0837787444912203,0.00719799834366394,0.0696706677376389,0.0978868212448016,3.48869808669482e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN2,Dynactin subunit 2,39788,0.109207231745688,0.00939691087837543,0.090789286424072,0.127625177067304,4.27256670314814e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPT,Dermatopontin,40052,0.0308239197294947,0.00265946634088739,0.0256113657013554,0.036036473757634,6.11628136278984e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.054443808140803,0.0046956523930782,0.0452403294503698,0.0636472868312363,6.21489561413782e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0613739950307752,0.00529838782438849,0.0509891548949738,0.0717588351665767,6.68105488899318e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0712095449209644,0.00614795752714862,-0.0832595416741757,-0.0591595481677531,7.0480795292289e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0835225960956037,0.00721793328222679,0.0693754468624392,0.0976697453287682,7.62027173770157e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0507023017285877,0.00438759156512861,0.0421026222609356,0.0593019811962397,9.19980343601546e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX9,Sorting nexin-9,39868,0.0794660390661076,0.00688296912084156,0.0659754195892582,0.0929566585429571,1.0315430516569e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENAH,Protein enabled homolog,39587,0.0549879891752173,0.00476388051776371,0.0456507833604004,0.0643251949900342,1.06855417611736e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0379261131959543,0.00328753958062387,0.0314825356179315,0.0443696907739771,1.14443992105206e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.0452220474909536,0.00392184888127192,0.0375352236836606,0.0529088712982466,1.22259377534552e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLTA,Clathrin light chain A,39585,0.0532399897970392,0.00461830326166664,0.0441881154041726,0.0622918641899058,1.26507240970587e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCOF1,Treacle protein,37437,0.0348715121101874,0.00302493997319315,0.0289426297627288,0.040800394457646,1.32330747025455e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0718312523019597,0.0062315373114877,0.0596174391714439,0.0840450654324756,1.34006798598347e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0512703916274024,0.0044499819640563,0.042548426977852,0.0599923562769527,1.35940708068572e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOC1,Apolipoprotein C-I,37424,0.0428302215674188,0.00371678285690586,0.0355453271678834,0.0501151159669543,1.39458195892064e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH7,Protocadherin-7,37382,0.0383919531599662,0.00333656944505616,0.0318522770476561,0.0449316292722763,1.69805965565347e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.059363320520268,0.00516296068646001,0.0492439175748063,0.0694827234657296,1.78365692075032e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.137910853134844,0.0119951189215837,0.11440042004854,0.161421286221148,1.79390938155066e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0441646549852356,0.00384836948335268,0.0366218507978643,0.0517074591726068,2.28871767313473e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA6,Integrin alpha-6,39866,0.0603427031346787,0.00526671103740545,0.050019949501364,0.0706654567679934,2.83387402693366e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0544275004703349,0.00475713728046727,0.045103511400619,0.0637514895400507,3.58136393648891e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0313493394207448,0.00274397422904051,0.0259711499318254,0.0367275289096642,4.35759308955001e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.055127197486979,0.00483477071695359,0.0456510468817499,0.064603348092208,5.58742025188411e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRBP,Acrosin-binding protein,37368,0.0434173145464289,0.00381485155552073,0.0359402054976082,0.0508944235952495,7.10282634226214e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0532637726800706,0.00468319982343372,0.0440847010261405,0.0624428443340007,7.40381630143332e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0345471112776986,0.00304429492898329,-0.0405139293385059,-0.0285802932168914,1.01793150241476e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0307068556433049,0.00270782816087119,0.0253995124479974,0.0360141988386125,1.07570625726723e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN2,Matrilin-2,39885,0.0334276571384139,0.00295176020150848,0.0276422071434573,0.0392131071333705,1.28386207468984e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0369600317106062,0.00326421928464074,0.0305621619127103,0.043357901508502,1.31174154561335e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL24,C-C motif chemokine 24,39908,0.0925948131197652,0.00817814429467987,0.0765656503021926,0.108623975937338,1.31909354096264e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0984973406531758,0.00870144118714426,0.081442515926373,0.115552165379979,1.42474366997158e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0216034302395944,0.00191021008987743,0.0178594184634346,0.0253474420157541,1.59702931316518e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN4,Cerebellin-4,40030,0.0347586780942381,0.00307616998403563,0.0287293849255283,0.0407879712629479,1.7055270334557e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0487754273558566,0.00431768769237309,0.0403127594788054,0.0572380952329079,1.77379221656356e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF22,Kinesin-like protein KIF22,37021,0.136072418400388,0.01204194980199,0.112470196788488,0.159674640012289,1.79631916758676e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0773551146745229,0.00686785450707784,0.0638941198406503,0.0908161095083954,2.55806331085361e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.041993812769405,0.00373191859069724,0.0346792523316384,0.0493083732071716,2.89622170168879e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO1A,Coronin-1A,39520,0.0998084741440868,0.0088734479655713,0.082416516131567,0.117200432156606,3.06712911398547e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.133841319362962,0.0119066529554565,0.110504279570267,0.157178359155656,3.30278988540513e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA13,Carbonic anhydrase 13,39657,0.117717598023886,0.0104781757795297,0.0971803734960083,0.138254822551765,3.55936802530137e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0509128934878941,0.00453350996537483,0.0420272139557594,0.0597985730200287,3.70810199833272e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSB,Cathepsin B,39847,-0.0571201548871182,0.00509617846583023,-0.0671086646801454,-0.0471316450940909,4.75729489813887e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA,Adenosine deaminase,40058,0.0386319151051889,0.00345040826920875,0.0318691148975398,0.045394715312838,5.43022536944573e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COLEC12,Collectin-12,39862,0.0275751165465752,0.00246398411441927,0.0227457076823135,0.032404525410837,5.76384436011095e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FST,Follistatin,39908,0.0570992293068618,0.00510298099058867,0.047097386565308,0.0671010720484156,5.88256917752815e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0262239100364868,0.00234431190346174,0.0216290587057018,0.0308187613672718,6.09899965306331e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TF,Serotransferrin,37453,0.02424421742606,0.00216768436551485,0.0199955560696509,0.0284928787824692,6.50243292371731e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN9,Septin-9,39788,0.0313823615199844,0.00280746857163686,0.0258797231195762,0.0368849999203927,6.68116408722292e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.0236229443459317,0.00211614544283186,-0.0277705894138821,-0.0194752992779812,7.87135032506072e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0522228984021878,0.00468266473860528,0.0430448755145215,0.0614009212898542,8.95336066398777e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0424026919245492,0.00380640584207204,0.034942136474088,0.0498632473750104,1.02973035535181e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0295310879987716,0.00265142824845932,-0.0347278873657519,-0.0243342886317914,1.04716962347082e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.03051581493396,0.00274091840578404,0.0251436148586233,0.0358880150092967,1.14781352694676e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS27,Serine protease 27,39818,0.0443869447560197,0.00398844238383048,0.036569597683712,0.0522042918283274,1.15711913889731e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0446906732515332,0.00402461665082777,0.0368024246159108,0.0525789218871556,1.5259004279067e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.121600589582324,0.010963515226452,-0.14308907942617,-0.100112099738478,1.75725862829085e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.106052648435554,0.0095837393943173,0.0872685192226922,0.124836777648416,2.33216895550884e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0255369997970198,0.00231192812103657,0.0210056206797881,0.0300683789142515,2.9106631740549e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRN1,Secernin-1,39866,0.0615272581074593,0.00558593807740718,0.0505788194757412,0.0724756967391774,4.09729592919552e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0601293774483456,0.00546194837527293,0.0494239586328106,0.0708347962638805,4.39724964393735e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTC,Probetacellulin,39477,0.0809279294051585,0.0073520831306653,0.0665178464690545,0.0953380123412625,4.46041398550384e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0553593152461406,0.00503701925544114,0.045486757505476,0.0652318729868053,5.34387436607268e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0829781522585897,0.00754935586733504,0.068181414758613,0.0977748897585664,5.54394755642013e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0645119953377521,0.00589195591533251,0.0529637617437004,0.0760602289318038,8.7673496124721e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0649528202586102,0.00593458110254185,0.0533210412976282,0.0765845992195923,8.86329639411152e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX16,Syntaxin-16,39477,0.0633027554413005,0.00578789398572312,0.0519584832292832,0.0746470276533178,9.65905915262705e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_E,,39866,0.0296991103169091,0.0027190423751653,0.0243697872615851,0.0350284333722331,1.12510938716634e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.115589979379695,0.0105969657755487,0.0948199264596197,0.136360032299771,1.37751700148353e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0378581073541988,0.00348408912147477,-0.0446869220322894,-0.0310292926761083,2.18659548504041e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0457050318644043,0.00421677879866541,0.0374401454190201,0.0539699183097885,2.8088927076216e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN6,Dynactin subunit 6,39489,0.0764106044425515,0.00705454246414917,0.0625837012128192,0.0902375076722839,3.05364702462714e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0644191856455991,0.00595266723859373,0.0527519578579554,0.0760864134332428,3.50137142436001e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0562706168939232,0.00520563061519585,0.0460675808881393,0.0664736528997071,4.00096768168753e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.041281840682147,0.00382103994761542,0.0337926023848207,0.0487710789794732,4.25898872661382e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0577891439746158,0.00536485140234145,0.0472740352260266,0.0683042527232051,5.77445877803115e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0976795876604535,0.00906684615450518,0.0799085691976233,0.115450606123284,5.91904700441194e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0597375978550944,0.00554730639333708,0.0488648773241537,0.0706103183860351,6.24211021969631e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOE,Apolipoprotein E,37453,0.0773871601185605,0.00720043426101402,0.063274308966973,0.091500011270148,7.7987434053103e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2,Brorin,39684,0.0410160896591143,0.00382328180265997,0.0335224573259007,0.0485097219923278,9.29737945212289e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF2,Growth/differentiation factor 2,39868,0.037595226691375,0.00350452715279056,0.0307263534719055,0.0444640999108445,9.31103619931581e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSF,Cathepsin F,39913,0.0429990223453467,0.00401275096510082,0.0351340304537491,0.0508640142369443,1.05874846473498e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD302,CD302 antigen,39788,0.0308438640962609,0.00287998178733118,0.0251990997930918,0.03648862839943,1.12920187075612e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0230451542816543,0.0021523248053408,0.0188265976631863,0.0272637109001223,1.16167466616889e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0588199674666744,0.00549235043803246,0.0480549606081308,0.069584974325218,1.17814459861908e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX7,Syntaxin-7,37056,0.0524807531863312,0.00490645313120355,0.0428641050491723,0.0620974013234902,1.36168206441568e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.044044015223327,0.00412328649437453,0.0359623736943529,0.0521256567523011,1.58787895901344e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1F,Protein phosphatase 1F,37437,0.0565367092845387,0.00529407263214214,0.0461603269255401,0.0669130916435373,1.62207337496704e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0257290813080621,0.00241094019722212,0.0210036385215068,0.0304545240946175,1.69375516184717e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0589469000676915,0.0055228490502765,0.0481221159291495,0.0697716842062334,1.74401032881214e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO2,Gamma-enolase,40009,0.0700946349109198,0.0065723423568714,0.0572128438914518,0.0829764259303877,1.8159215295067e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0624292763439935,0.00585615068845868,0.0509512209946145,0.0739073316933725,1.98214557950195e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0708259005757268,0.0066477045056098,0.0577963997447316,0.083855401406722,2.12945785707828e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0617110116410259,0.0057943929111105,0.0503540015352493,0.0730680217468025,2.21403416018008e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK4,Dickkopf-related protein 4,39718,0.0478564907354132,0.00449769922735187,0.0390410002498035,0.0566719812210229,2.37664352341253e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0442936816901507,0.00416385343052349,0.0361325289663246,0.0524548344139767,2.53016894254456e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0774384491402269,0.00728415808865512,0.0631614992864628,0.0917153989939909,2.61979489880655e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD84,SLAM family member 5,39866,0.0328712678416286,0.00309408093947861,0.0268068692002505,0.0389356664830067,2.82172209984136e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.07047575065685,0.00664174584935069,0.0574579287921226,0.0834935725215774,3.37260951135046e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0669830508743705,0.00632006782194398,0.0545957179433603,0.0793703838053807,3.85882408693222e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0291868978061433,0.00276035416546495,0.0237766036418319,0.0345971919704546,4.80869490019966e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPR,Nucleoprotein TPR,37021,0.0494177478358914,0.00467714139661628,0.0402505506985235,0.0585849449732593,5.45515682569218e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0599347525272094,0.0056751884274018,0.0488113832095019,0.0710581218449169,5.5376057710143e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1B,Meprin A subunit beta,39868,0.120817380235639,0.0114415315269431,0.0983919784428301,0.143242782028447,5.58641431695224e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0370066801924687,0.00350381139589756,0.0301392098565095,0.0438741505284279,5.64980699991221e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC3B,Tetranectin,37138,0.0222220866988704,0.00210458277232814,0.0180971044651072,0.0263470689326335,5.85531188175538e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0649056292132025,0.00614983444789553,0.0528519536953272,0.0769593047310777,6.17650116269245e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.102044560592079,0.00967576988784627,0.0830800516119005,0.121009069572258,6.42137405758338e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0293419205836834,0.00278215641696919,0.0238888940064238,0.034794947160943,6.68958646665948e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXN,"Frataxin, mitochondrial",40030,0.0767565176483085,0.00728683682041768,0.0624743174802898,0.0910387178163271,7.33534682099401e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0350345630932963,0.00332566306237344,0.0285162634910443,0.0415528626955482,7.56204349487421e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBS,Cystathionine beta-synthase,37043,0.053451999279225,0.0050743750985422,0.0435062240860823,0.0633977744723677,7.651059663511e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C4BPB,C4b-binding protein beta chain,39913,0.0413617941772676,0.0039354653857927,0.0336482820211139,0.0490753063334213,9.41788296512246e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0388104948137965,0.00369255181120976,0.0315730932638254,0.0460478963637677,9.42051365708301e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0235293919273091,0.00223814061820506,0.0191426363156272,0.027916147538991,9.46442264369401e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL5,Insulin-like peptide INSL5,37382,0.10095543149759,0.00963193864964031,0.0820768317442952,0.119834031250885,1.31951232681098e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIT2,Slit homolog 2 protein,39489,0.053708651143859,0.00512709592810516,0.0436595431247729,0.0637577591629451,1.36143331826572e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0918316452340398,0.0087825102306684,0.0746179251819298,0.10904536528615,1.6592480624214e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL8,Interleukin-8,39750,0.0685400830945895,0.00656192130989079,0.0556787173272035,0.0814014488619754,1.86498113227937e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR3,Small proline-rich protein 3,37388,0.0680077379404439,0.00651099354782996,0.0552461905866972,0.0807692852941906,1.92872257655946e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0698037476687376,0.00668398908871555,0.0567031290548551,0.08290436628262,1.96126945063006e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0686490920485027,0.00657757203606965,0.0557570508578062,0.0815411332391992,2.04107902820825e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPL,Periplakin,37056,0.0332353905731539,0.00319008110312234,0.0269828316110341,0.0394879495352737,2.56326206760331e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0331323300972469,0.00318172942217209,0.0268961404297896,0.0393685197647042,2.68469390347156e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARCO,Macrophage receptor MARCO,39868,0.0271106362031084,0.00260460120952521,0.022005617832439,0.0322156545737779,2.72372688784793e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0509616233379332,0.00489645036840535,0.0413645806158587,0.0605586660600077,2.76150425029765e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARFIP1,Arfaptin-1,37411,0.0715597388049926,0.0068836986926536,0.0580676893673915,0.0850517882425936,3.23198089563501e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0694191063999436,0.00669880095315608,0.0562894565317576,0.0825487562681295,4.40338934745705e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRIB,Protein scribble homolog,37043,0.0929975859503396,0.00898322993687608,0.0753904552740625,0.110604716626617,5.09134110264537e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0282958655847106,0.00274065544358583,0.0229241809152824,0.0336675502541389,6.54085788630439e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0371049485768089,0.00359385361024698,0.0300609955007248,0.044148901652893,6.54800438228654e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0482464693864167,0.00467409039128728,0.0390852522194937,0.0574076865533398,6.92160285586986e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0927028321829782,0.00898355176615478,0.0750950707213148,0.110310593644642,7.13476057394195e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.111727408800741,0.0108345242212664,-0.132963076274423,-0.0904917413270586,7.77473300836788e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0358602071583624,0.0034800724622056,0.0290392651324394,0.0426811491842854,8.33868525642543e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0628938111516079,0.00610403766474537,0.0509298973287069,0.0748577249745088,8.42568028770494e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0786289551398932,0.00764073916908314,0.0636531063684902,0.0936048039112962,9.30593173630889e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.030598437229253,0.00297660099955534,0.0247642992701246,0.0364325751883815,1.04221106129446e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD248,Endosialin,37437,-0.0404836143527566,0.00394282702927994,-0.0482115553301453,-0.0327556733753679,1.21287574301771e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0765767692713725,0.00747227587402114,0.0619311085582911,0.091222429984454,1.44228825366191e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PER3,Period circadian protein homolog 3,37056,0.119736031892696,0.0116802593879601,0.0968427234922938,0.142629340293098,1.44575570312135e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0600816420504512,0.00586955467543749,-0.0715859692143087,-0.0485773148865937,1.62228902028463e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0841819630185492,0.00824855219526737,0.0680148007158251,0.100349125321273,2.22178486144846e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.0301390163282788,0.00295733162350083,0.0243426463462172,0.0359353863103404,2.57185545257327e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0907359828482005,0.00890085385551624,0.0732903092913887,0.108181656405012,2.59041534867637e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0300321297224895,0.00295246396234334,0.0242453003562966,0.0358189590886824,3.13154247732607e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SWAP70,Switch-associated protein 70,37382,0.0363195131608575,0.0035695685619834,0.0293231587793701,0.043315867542345,3.14227573657229e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFP,Alpha-fetoprotein,39699,0.068185903773418,0.00670777141411971,0.0550386718017434,0.0813331357450927,3.36395742326879e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0298072442234752,0.00293211859220826,0.024060291782747,0.0355541966642034,3.46146433880107e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOB,Elongin-B,37021,0.0396526048982218,0.00390261596115158,0.0320034776143647,0.0473017321820789,3.6527765754546e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENR,Density-regulated protein,37056,0.0583512383243557,0.0057483175550043,0.0470845359165473,0.0696179407321642,4.02154701035248e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0334689784736876,0.0033082727115018,0.0269847639591441,0.0399531929882312,5.4865540119074e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0386878858062008,0.00383255004346886,0.0311760877210018,0.0461996838913997,6.87332592368484e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0317532006578849,0.00315662772473413,0.025566210317406,0.0379401909983638,9.83940305012692e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0404259414981423,0.00402171916134974,0.0325433719418969,0.0483085110543878,1.09700769156839e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB2,Plexin-B2,39984,0.0235168962862333,0.00234509614329566,0.0189205078453738,0.0281132847270928,1.34481174028481e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0482988660060149,0.00481503086614319,0.0388614055083743,0.0577363265036556,1.34975450427142e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0524559244226554,0.00523146277898361,0.0422022573758476,0.0627095914694633,1.40713875232175e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE6,Ribonuclease K6,37386,0.0274828388823164,0.00274565605770539,0.0221013530092138,0.0328643247554189,1.67017074606104e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.029794416710317,0.0029766898039636,0.0239601046945483,0.0356287287260857,1.67446598587137e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA11,Integrin alpha-11,39866,-0.0337796102051019,0.00337877930163036,-0.0404020176362975,-0.0271572027739064,1.82990456797791e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0186596594174956,0.00186946510275362,0.0149955078160985,0.0223238110188927,2.21630769710305e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSG,Basigin,40040,0.0192284815846623,0.00193136683692929,0.0154430025842809,0.0230139605850437,2.7731342092226e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0335058168855464,0.00336669458847056,0.0269070954921441,0.0401045382789487,2.89504653864342e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0342233600256894,0.00343902000499765,0.027482880815894,0.0409638392354848,2.90610886889002e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA4,Annexin A4,39783,0.0716738046357765,0.00720533619729819,0.0575513456890721,0.0857962635824809,3.0284689083874e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0618999121204815,0.00622332034107954,0.0497022042519656,0.0740976199889974,3.05260920084532e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGT,Angiotensinogen,37445,0.0221482229111092,0.00222848929242761,0.017780383897951,0.0265160619242673,3.39074933154147e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG4,Regenerating islet-derived protein 4,39885,0.046341230442654,0.00466564764848716,0.0371965610516192,0.0554858998336889,3.51003914333805e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA2,Carbonic anhydrase 2,39821,0.0669718876644671,0.00674379192889012,0.0537540554838425,0.0801897198450918,3.5664591174873e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPL14,60S ribosomal protein L14,37043,0.0400008540633218,0.00402869964347673,0.0321046027621074,0.0478971053645362,3.75522912296779e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0250650519513905,0.00252539052048461,-0.0300148173715404,-0.0201152865312407,3.87643956998212e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIT,Citron Rho-interacting kinase,37039,0.0445700060692049,0.00450530718146465,0.0357396039935342,0.0534004081448756,5.38079052565939e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDA,Cytidine deaminase,37422,0.0456364768700313,0.00461422928960964,0.0365925874623964,0.0546803662776662,5.48189327898043e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0329696233247664,0.00333940179947605,0.0264243957977934,0.0395148508517395,6.33996158201518e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0474130090629331,0.00480847903540042,0.0379883901535483,0.0568376279723179,7.38797710560625e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.116221789806574,0.0117937515883215,0.0931060366934641,0.139337542919684,7.82225197642742e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.096759607631297,0.00982712741619369,0.0774984378955574,0.116020777367037,8.26251464692961e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0280961699806926,0.00285440304903032,-0.033690799956792,-0.0225015400045931,8.51796526372248e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0674064200444198,0.00684733200764958,0.0539856493094266,0.080827190779413,8.65974931238231e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA1,BolA-like protein 1,36991,0.0537996365660805,0.0054659683786672,0.0430863385438928,0.0645129345882682,8.84118611874677e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0356709868616896,0.00362450975558554,0.028566947740742,0.0427750259826373,8.91720838977385e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPG,Macrophage-capping protein,39739,0.0566529565863735,0.00576746333619181,0.0453487284474375,0.0679571847253094,1.04187367178711e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB8,Serpin B8,40058,0.0537049024034199,0.00546929346393255,0.0429850872141121,0.0644247175927277,1.0753794073258e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0597385611164217,0.00608971010244953,0.0478027293156207,0.0716743929172228,1.18536600874346e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0706608570827274,0.00723322300737435,0.0564837399882736,0.0848379741771811,1.77514133840885e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0970379353327621,0.00996029376451166,0.0775157595543192,0.116560111111205,2.3027365171356e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0353481662692053,0.00362812321790047,0.0282370447621204,0.0424592877762902,2.3547198155729e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0455319690139678,0.00468010899831695,0.0363589553772666,0.0547049826506691,2.61616443065988e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0842399923106734,0.00866982201997368,0.067247141151525,0.101232843469822,2.95559806354436e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0281119182208628,0.00290751606273816,0.022413186737896,0.0338106497038296,4.71559949656209e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0390052077927613,0.00403747201629337,0.0310917626408263,0.0469186529446964,5.08267826822493e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0243156361793443,0.002518110830252,0.0193801389520504,0.0292511334066382,5.4391365449313e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0710303068297281,0.00736854144803178,0.0565879655915859,0.0854726480678704,6.22576900212594e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0586220659398001,0.00608843555793476,0.046688732246248,0.0705553996333522,7.12324362288909e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0733803912470632,0.00763088818038019,0.058423850413518,0.0883369320806084,8.0580099353639e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0632823449073284,0.00658243893605448,0.0503807645926617,0.0761839252219952,8.20622985174548e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL20,C-C motif chemokine 20,40058,0.080407573347817,0.00836793718601166,0.0640064164632341,0.0968087302323998,8.37477162604736e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0587941047320047,0.00614005997969922,0.0467595871717942,0.0708286222922151,1.18659139630207e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0253379095166634,0.00264828538571053,-0.0305285488726561,-0.0201472701606708,1.24885399995299e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.0459949604917492,0.00481331387593016,0.0365608652949261,0.0554290556885723,1.40507749340263e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ULBP2,UL16-binding protein 2,39749,0.0346271697814403,0.00362608637959173,0.0275200404774405,0.0417342990854401,1.48947498471998e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0208199354348036,0.0021799400278247,0.0165472529802672,0.02509261788934,1.50646109273544e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A12,Protein S100-A12,39615,0.0707115296228969,0.00741843283413224,0.0561714012679977,0.0852516579777961,1.76512403107017e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX6,Syntaxin-6,39477,0.0645954793177203,0.00678036487721645,0.051305964158376,0.0778849944770645,1.8543134898265e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM1,Dynamin-1,37382,0.108631611440654,0.0114049117342853,0.0862779844414548,0.130985238439853,1.92707635219169e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0219557586598689,0.00230566648545912,0.017436652348369,0.0264748649713687,1.92869740711776e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMB1,Laminin subunit beta-1,37043,0.0288438721704906,0.00302858992890587,0.0229078359098351,0.0347799084311461,1.9556145832444e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTN,Pleiotrophin,39585,0.0475682799868557,0.00500432357220545,0.0377598057853331,0.0573767541883784,2.27353780458993e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIT,Vitrin,37437,0.034725319530554,0.00365877704087544,0.0275541165304382,0.0418965225306699,2.66497056829104e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0394763288140394,0.00416069448761021,0.0313213676183234,0.0476312900097554,2.68113243182141e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0413915949701597,0.00436304403863337,0.0328400286544383,0.0499431612858811,2.70828505504348e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0316302374843782,0.00333763206459534,0.0250884786377713,0.038171996330985,3.04838938605138e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMD,Osteomodulin,39931,-0.0409047158556756,0.00431900368988835,-0.0493699630878567,-0.0324394686234944,3.15254073668244e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA2,Integrin alpha-2,37124,0.0316083828380638,0.00334421230008618,0.0250537267298949,0.0381630389462327,3.88639824399373e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.051042117380226,0.00541587916142824,0.0404269942238267,0.0616572405366254,4.90115638840593e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0345270995869959,0.00367375349588927,0.0273265427350529,0.0417276564389388,6.27715557952006e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.068027120971732,0.00723835247909167,0.0538399501127123,0.0822142918307517,6.29088482990519e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOL1,Apolipoprotein L1,37445,0.057314844876448,0.00610134113556648,0.0453562162507377,0.0692734735021583,6.69578659281146e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0397772503795175,0.0042482206533811,-0.0481037628601445,-0.0314507378988906,8.74156695159126e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0484073138310752,0.00517176632216078,-0.0585439758225103,-0.03827065183964,9.01717680608244e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0872681697746668,0.00932553625035396,0.0689901187239731,0.105546220825361,9.17257407781927e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0377566425609949,0.00403961366607474,0.0298389997754884,0.0456742853465014,1.04521830855396e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.046627704662004,0.00500775037671051,0.0368125139236514,0.0564428954003566,1.46271343444179e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0849104489880372,0.0091217958552333,0.0670317291117799,0.102789168864294,1.49850701861368e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0290146558196704,0.00311989770741609,0.0228996563131349,0.0351296553262059,1.62469693352578e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP8,Caspase-8,39984,0.0569255451803902,0.00612728480506321,0.0449160669624663,0.0689350233983141,1.72754644633601e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0432942368975048,0.0046647153571612,0.0341513947974688,0.0524370789975408,1.89120937665233e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0742688599780945,0.00801507742268467,0.0585593082296326,0.0899784117265565,2.22539943512672e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0775054067858529,0.00836628752328912,0.0611074832402062,0.0939033303314995,2.26191096899452e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBD,Thrombomodulin,39868,0.0249933062523341,0.00270317578639331,0.0196950817110032,0.030291530793665,2.62046405866458e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR3,Toll-like receptor 3,40058,0.0559537665606065,0.00605523969964379,0.0440854967493047,0.0678220363719084,2.75043387308343e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0481543766865819,0.00521137572541931,0.0379400802647601,0.0583686731084038,2.83141521717562e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0768021928144971,0.00833375620022386,0.0604680306620583,0.0931363549669358,3.54730295998611e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0627197672509563,0.0068191719119168,0.0493541903035994,0.0760853441983133,4.10432234298529e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0340586050026923,0.00370635391799861,0.026794151323415,0.0413230586819696,4.54055409386882e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0445300167187045,0.00485543625226552,0.0350133616642641,0.054046671773145,5.23749855208964e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0516193773286801,0.00563119126568,0.0405822424479473,0.062656512209413,5.46947636857617e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0462401628589175,0.00504436869517485,-0.0561271255014602,-0.0363532002163748,5.56899653750576e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0369863897090082,0.00404598100499749,0.0290562669392131,0.0449165124788033,7.04775425628375e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP12,Macrophage metalloelastase,39900,0.0455940655340362,0.00499393083464129,0.0358059610981393,0.0553821699699332,7.65762579888424e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH1,Cadherin-1,39315,0.036526441115858,0.0040032383090091,0.0286800940302002,0.0443727882015158,8.10079781448481e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0231757010421538,0.00254344603344859,-0.0281608552677131,-0.0181905468165946,9.21072884169244e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VGF,Neurosecretory protein VGF,37411,0.0264276026822375,0.00290832145440318,0.0207272926316072,0.0321279127328677,1.15861272821872e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0545397641356022,0.0060232849369868,0.0427341256591081,0.0663454026120964,1.52268543255269e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0427595127540746,0.00472822652161991,0.0334921887716996,0.0520268367364497,1.69353599388019e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0483736330144896,0.00534928191490006,0.0378890404612855,0.0588582255676937,1.72811979894845e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA,Lymphotoxin-alpha,39866,0.0354884683007013,0.00392547212202259,0.027794542941537,0.0431823936598656,1.73389602772081e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0473406799576402,0.00523661585951043,0.0370769128729997,0.0576044470422806,1.77769614594073e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0470612344934662,0.00521242493964967,-0.0572775873751795,-0.0368448816117528,1.93205423984468e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0591144727041206,0.00655220620460274,0.0462721485430993,0.071956796865142,2.05131500894988e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0378340798939261,0.00419284513964992,0.0296161034202122,0.0460520563676399,2.0647041353811e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMS,Spermine synthase,36991,0.0576104974625823,0.0063844644196178,0.0450969472001314,0.0701240477250332,2.07128228692562e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0245843411371746,0.00272897486398707,0.0192355504037599,0.0299331318705892,2.31754528412764e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0257141460126475,0.00285486158001618,-0.0313096747094792,-0.0201186173158158,2.34620164632869e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0294269148488254,0.00326891993832178,-0.0358339979279361,-0.0230198317697147,2.50684139036909e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0300953784889084,0.00334702555451556,0.0235352084020579,0.0366555485757589,2.762810304935e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.102032366044812,0.0113662960437864,0.0797544257989902,0.124310306290633,3.1524474315492e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0223157406137961,0.00248859856101075,0.017438087434215,0.0271933937933771,3.43474889643733e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0439606291913574,0.00492665535332051,0.0343043846988492,0.0536168736838656,5.13394360399587e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM2,Junctional adhesion molecule B,40009,0.0222174403643074,0.00249227280291895,0.0173325856705863,0.0271022950580286,5.41351206116724e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMB,RGM domain family member B,40009,0.0225519628991992,0.0025333884286945,0.0175865215789579,0.0275174042194404,6.06334407618647e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0368687683318325,0.00414156249949259,0.0287513058328271,0.044986230830838,6.06625273617048e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO2,Roundabout homolog 2,40009,0.0201110568920281,0.00225993111509237,0.015681591906447,0.0245405218776091,6.22463376057704e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0572165066000327,0.00643423909165499,0.0446053979803889,0.0698276152196765,6.74286850051483e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0377622908007907,0.00424935578939802,0.0294335534535706,0.0460910281480108,6.96109797853232e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM,Paralemmin-1,37299,0.0251318882389891,0.00283175914270291,0.0195816403192914,0.0306821361586868,7.86752730742854e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.075137961462559,0.00847873996977835,0.0585196311217934,0.0917562918033245,8.67967292141656e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.065038751702433,0.0073627248527505,0.050607810991042,0.0794696924138239,1.14006652682627e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0396394655100372,0.00449227484624959,-0.0484443242086864,-0.030834606811388,1.21725365359591e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0279948467140647,0.00317476566950074,0.0217723060018433,0.0342173874262862,1.28381198884477e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSM,Oncostatin-M,39785,0.0625923217892843,0.00710527631677047,0.0486659802084142,0.0765186633701545,1.38741549492404e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0235979334589348,0.00268385789177507,-0.028858294926814,-0.0183375719910557,1.60811727514821e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFC1,Cryptic protein,39477,0.04081313966286,0.00464232476974291,0.0317141831141639,0.0499120962115561,1.62689673375167e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0311231895080024,0.00355151136286132,0.0241622272367942,0.0380841517792106,2.118378092217e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0228933652575101,0.00261882896292857,0.0177604604901701,0.0280262700248501,2.5203900076977e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0295251812432258,0.0033786198402948,0.0229030863562479,0.0361472761302036,2.58655755578252e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMM2,Phosphomannomutase 2,37021,0.0523257045422493,0.0059877711211296,0.0405896731448353,0.0640617359396633,2.63934062960902e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0439590504815495,0.00503134787850521,0.0340976086396793,0.0538204923234197,2.67979924478051e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0617025320997145,0.00707828280840931,0.0478290977952322,0.0755759664041967,3.18715758111113e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPO,Myeloperoxidase,39858,0.0392237113346621,0.00450407650756523,0.0303957213798342,0.0480517012894899,3.37602030416042e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA6,Carbonic anhydrase 6,39817,-0.0550278764250979,0.00631921126251483,-0.067413530499627,-0.0426422223505689,3.39054209506893e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0211724851023588,0.00243479466258151,-0.0259446826410185,-0.016400287563699,3.84515983993457e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0458529155557826,0.00527405326079639,0.0355157711646216,0.0561900599469435,3.89418845923744e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0808413604200152,0.00930377095977597,0.0626059693388543,0.0990767515011761,4.00186024558946e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN3,CCN family member 3,40042,0.0279515227808131,0.00321751448840085,0.0216451943835474,0.0342578511780788,4.06111442561019e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0368606094263468,0.00425065137599484,0.0285293327293969,0.0451918861232966,4.74824483167806e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP2,Retinol-binding protein 2,39788,-0.0657515600675542,0.00758541401233832,-0.0806189715317373,-0.0508841486033711,4.80852178314582e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0290032432993176,0.00334638345709459,0.0224443317234122,0.035562154875223,4.85517315939074e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRSF1,G-rich sequence factor 1,36874,0.0696635103873681,0.00803954268328629,0.0539060067281269,0.0854210140466092,5.03908406804011e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0295737840703534,0.00341453902909217,0.0228812875733328,0.0362662805673741,5.11272671194645e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0556129650081406,0.00643517507093715,0.0430000218691038,0.0682259081471774,6.05034860079134e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0307414258824402,0.00355727100352302,0.0237691747155351,0.0377136770493453,6.14562189997096e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0502728367147012,0.00581721816240762,0.0388710891163823,0.0616745843130202,6.15102372272022e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C5,Complement C5,37453,0.0130674901524894,0.00151325987673978,0.0101015007940794,0.0160334795108994,6.50187274991373e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POMC,Pro-opiomelanocortin,37043,0.060984581639299,0.00707413735444247,0.0471192724245918,0.0748498908540063,7.40201364528702e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0456561816537212,0.00529964797393447,0.0352688716248096,0.0560434916826327,7.78576539210042e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0525005739110366,0.00609562072907474,0.0405531572820501,0.0644479905400231,7.91298425060362e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0511453024405282,0.00594621509014925,0.0394907208638357,0.0627998840172208,8.60484616955129e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.04112248738164,0.00479406263902702,0.0317261246091471,0.050518850154133,1.05617945712426e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH5,Cadherin-5,40052,-0.025965284608033,0.00303120496624241,-0.0319064463418682,-0.0200241228741979,1.16667519556706e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0478303332206509,0.00558598444226633,0.0368818037138089,0.0587788627274929,1.22546322724053e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0409140793097937,0.00478042424215033,0.031544447795179,0.0502837108244083,1.24493177863118e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0422762430063857,0.00494207645911792,0.0325897731465146,0.0519627128662568,1.31123714608034e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0493364530329686,0.00576982984376557,0.038027586539188,0.0606453195267491,1.33466474859339e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0412044327224227,0.00481794991833715,-0.0506476145623635,-0.0317612508824818,1.33515037316675e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0189709182229578,0.00221898635625203,0.0146217049647039,0.0233201314812118,1.36881693441204e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0359793553708464,0.00421298962476381,0.0277218957063094,0.0442368150353835,1.4830759486787e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHPS,Deoxyhypusine synthase,37368,0.0348240988315304,0.00407931364250112,0.0268286440922282,0.0428195535708326,1.52656461297998e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0372041539190186,0.00437367654451036,0.0286317478917783,0.0457765599462589,1.95129092080543e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXN,Thioredoxin,37289,0.0364514288959664,0.00429733873903448,0.0280286449674588,0.0448742128244739,2.43630190799945e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0348288155351542,0.00411116563638033,0.0267709308878488,0.0428867001824597,2.66692992871432e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MET,Hepatocyte growth factor receptor,39879,-0.0164382595217025,0.00194094370266679,-0.0202425091789295,-0.0126340098644756,2.68249607326437e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CX3CL1,Fractalkine,39749,-0.0278262238901623,0.00329624923901922,-0.03428687239864,-0.0213655753816847,3.39201390113428e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0305285231339123,0.00363900382060013,0.023396075645536,0.0376609706222885,5.38755524445807e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRG,Histidine-rich glycoprotein,37380,0.0263888108116493,0.00314815679310701,0.0202184234971595,0.032559198126139,5.69907195416356e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0648610166112924,0.00774034097264974,-0.0800320849176859,-0.0496899483048989,5.74672745541218e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7,Complement component C7,37149,-0.0266760252325624,0.00318998888509875,-0.0329284034473559,-0.0204236470177689,6.75200326701704e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP3,Stromelysin-1,39858,-0.03958785465724,0.00473841486957263,-0.0488751478016023,-0.0303005615128777,7.0949164000454e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS4,Galectin-4,39862,0.0436823147317593,0.0052411482363905,0.0334096641884339,0.0539549652750847,8.40873467448268e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN8,Septin-8,37357,0.0264090361964894,0.0031724571759071,0.0201910201317115,0.0326270522612673,9.27913389850401e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSHB,Follitropin subunit beta,37043,0.054294408183917,0.0065221411213855,0.0415110115860014,0.0670778047818326,9.28708064305876e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.019627911590525,0.00236528874098932,-0.0242638775228641,-0.014991945658186,1.13909658934862e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0274056232154914,0.00330280941557824,-0.0338791296700248,-0.0209321167609581,1.14707567053173e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD59,CD59 glycoprotein,39173,0.0174271269656368,0.00210079816713953,0.0133095625580433,0.0215446913732303,1.17074939471269e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAM,Integrin alpha-M,39858,-0.0259822709311264,0.00313476743460835,-0.0321264151029588,-0.0198381267592941,1.23782952226302e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0205165930982561,0.00248158825833741,0.0156526801119148,0.0253805060845975,1.47358714724369e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.027229044675378,0.00330524034029863,-0.0337073157423633,-0.0207507736083927,1.88290235792027e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SBSN,Suprabasin,37420,-0.0277872378057779,0.00338059496106201,-0.0344132039294594,-0.0211612716820963,2.22542576632315e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0741501813843055,0.00902296299857465,-0.0918351888615118,-0.0564651739070992,2.23183965036111e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0282871725000004,0.00344369248128147,0.0215375352366888,0.0350368097633121,2.29820957663008e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOM,Apolipoprotein M,39908,0.0217170437201184,0.00264561246979155,0.0165316432793269,0.0269024441609098,2.40433292922921e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAEP,Glycodelin,39749,-0.118077465181447,0.0143903292063272,-0.146282510425849,-0.0898724199370461,2.4741885923251e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0198668780382904,0.00242292945540837,0.01511793630569,0.0246158197708908,2.59484842577843e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0338699910238233,0.00413100678285522,0.0257732177294271,0.0419667643182195,2.64745676513824e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300A,CMRF35-like molecule 8,37124,0.0234816447507021,0.00287796912830769,0.017840825259219,0.0291224642421851,3.67738311469428e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB2,Lamin-B2,37388,0.0222104120836621,0.00272235457066231,0.016874597125164,0.0275462270421603,3.68859853467766e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0207078646969539,0.002539272998233,0.0157308896204172,0.0256848397734906,3.79640210254557e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRN,Progranulin,39787,0.0200109210397655,0.00245476504822801,0.0151995815452386,0.0248222605342924,3.84786094514677e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI2,Serpin I2,37382,0.0464653623421949,0.00570035538750559,0.035292665782684,0.0576380589017059,3.9146835791695e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0328648694835118,0.00403410920454165,-0.0407717235244134,-0.0249580154426102,4.0135526390201e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGCR6,Protein DGCR6,36991,0.0350206814584381,0.00431528715806894,0.026562718628623,0.0434786442882532,5.26632488282762e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD209,CD209 antigen,39885,-0.0313039808839515,0.00386419964205824,-0.0388778121823856,-0.0237301495855173,5.83929306674287e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP9,Caspase-9,37056,0.0510105533668377,0.00630553398374589,0.0386517067586957,0.0633693999749796,6.49525753207036e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0434911221572534,0.00537791323185329,0.0329504122228209,0.0540318320916858,6.63107498735919e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0304741549215975,0.00376994420270567,0.0230850642842944,0.0378632455589007,6.82653782424551e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEK,Angiopoietin-1 receptor,39913,0.0173502193122057,0.00215268693801653,0.0131309529136933,0.0215694857107181,8.17616539782859e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0386764205324093,0.00480269058525503,0.0292631469853095,0.0480896940795092,8.74772447652913e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0233028593237744,0.00289914521091427,0.0176205347103824,0.0289851839371664,9.78237877002552e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0294551233299666,0.0036683911372741,0.0222650767009093,0.0366451699590238,1.04801649298538e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0235397952335266,0.00293601171517914,0.0177852122717755,0.0292943781952777,1.15189938363e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0280869147573093,0.0035035306945617,0.0212199945959684,0.0349538349186503,1.16221604388812e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0253141681882399,0.0031597973690492,0.0191209653449035,0.0315073710315763,1.21157659985016e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0260993985841637,0.00325779039288963,0.0197141294141,0.0324846677542273,1.22899376016041e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0550458378825835,0.00687855205254039,0.0415638758596043,0.0685277999055627,1.31775090734021e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300E,CMRF35-like molecule 2,39991,0.0305720920899998,0.00382271855758063,0.0230795637171417,0.0380646204628578,1.3555348186021e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0402817530965514,0.00503664690360398,0.0304099251654876,0.0501535810276152,1.36977930671061e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0419981839091033,0.00525260230474061,0.0317030833918117,0.0522932844263949,1.37752978768074e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0335239396639578,0.00419628980225421,0.0252992116515395,0.041748667676376,1.47003508145935e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP2,Neuropilin-2,39858,-0.0226332579924183,0.00283540017188837,-0.0281906423293195,-0.0170758736555171,1.53209628631561e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0222323151453292,0.00278914425591343,0.0167655924037388,0.0276990378869195,1.67838916926703e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0446689673251772,0.00560645506620286,0.0336803153954196,0.0556576192549348,1.74940550545345e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK6,Kallikrein-6,39889,0.0234081644834095,0.00293910631129314,0.0176475161132749,0.0291688128535441,1.77124114105362e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA4,Carbonic anhydrase 4,40052,-0.0185211134543603,0.00232890805850799,-0.0230857732490359,-0.0139564536596846,1.94456144642886e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX5,Sorting nexin-5,37043,0.0241372011616451,0.00303705206640745,0.0181845791114865,0.0300898232118037,2.05583306089238e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.0222532867210187,0.00280127785640193,-0.0277437913195665,-0.0167627821224709,2.08746145226441e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0399329776992155,0.0050317640455504,0.0300707201699367,0.0497952352284943,2.25274861766156e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAX,Apoptosis regulator BAX,39456,0.0721175551275321,0.00910978395800837,0.0542623785698357,0.0899727316852285,2.60650549504881e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0180546004854852,0.00228301654605852,-0.0225293129157599,-0.0135798880552105,2.77919596171025e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.022885451811916,0.00289392187921773,0.0172133649286493,0.0285575386951828,2.81525826675362e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPE,Carboxypeptidase E,39906,-0.0302990868215688,0.00383482368519374,-0.0378153412445486,-0.0227828323985891,2.9442570268726e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0936316058366706,0.0119261701984919,0.0702563122476264,0.117006899425715,4.44774827501352e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0511717747485652,0.00653011917265992,0.0383727411701518,0.0639708083269787,4.9963569411624e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH15,Cadherin-15,39973,0.0417476214772161,0.00533288535793199,0.0312951661756694,0.0522000767787628,5.24940413151476e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0508012472048804,0.0064941296083862,0.0380727531724434,0.0635297412373173,5.49081008266093e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0208976982107671,0.00267155137472174,0.0156614575163125,0.0261339389052217,5.50694513074961e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0463082075349401,0.00593524710877495,0.0346751232017412,0.057941291868139,6.4516336558159e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN1,Contactin-1,40052,-0.0206628695138734,0.00264955242151338,-0.0258559922600397,-0.0154697467677072,6.63768324435503e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0287130468728235,0.00368293409647076,0.0214944960437408,0.0359315977019062,6.8414230936776e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL21,C-C motif chemokine 21,39931,0.0303077113181207,0.00389079603970024,0.0226817510803082,0.0379336715559332,7.1311973541099e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0311155423140922,0.00400091122547276,0.0232737563121656,0.0389573283160188,7.97105950068953e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0369306742312913,0.0047501972538554,0.0276202876137347,0.0462410608488478,8.02995685334586e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO1,Roundabout homolog 1,39885,0.0182372925017691,0.0023462867063706,0.0136385705572828,0.0228360144462555,8.13881854410879e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK7,Kallikrein-7,36818,0.0301790043003368,0.00388473021385066,0.0225649330811895,0.0377930755194841,8.52981358646876e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0216795577697762,0.00279144536948231,-0.0271507906939615,-0.0162083248455908,8.55980997813915e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0341648102028168,0.00440143125719127,0.0255380049387219,0.0427916154669117,8.96085401749872e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.056826022110296,0.00733559899757444,0.0424482480750501,0.0712037961455419,1.00150367827923e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0500930540243469,0.00647882333591845,0.0373945602859467,0.062791547762747,1.12277669671509e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0413179306480885,0.00534524610919038,0.0308412482740754,0.0517946130221017,1.14078370883897e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0486868280629046,0.00630089063414236,0.0363370824199856,0.0610365737058237,1.16647056621994e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA9,Carbonic anhydrase 9,40030,-0.0332124081585247,0.00430276793376808,-0.0416458333087101,-0.0247789830083393,1.24219022184338e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0330317117514312,0.00427966182811453,-0.0414198489345356,-0.0246435745683267,1.24795225466222e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0321278778292721,0.00416456252321677,0.0239653352837672,0.0402904203747769,1.28691850617399e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAT,Catalase,37252,0.0405493966839033,0.00525746195062309,0.0302447712606821,0.0508540221071246,1.31826163508548e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0303464115757144,0.00393631569015783,0.022631232823005,0.0380615903284237,1.33890880198071e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0200244191344275,0.00259865624722546,0.0149310528898656,0.0251177853789894,1.3913949505635e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0361090556619578,0.00468720320258143,0.0269221373848982,0.0452959739390174,1.40034395622928e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE3,Eosinophil cationic protein,39791,0.0821868456886125,0.0106963604711301,0.0612219791651976,0.103151712212027,1.6361866809824e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0274427055139247,0.00357450332007318,0.0204366790065812,0.0344487320212681,1.71659735589567e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0358756043237556,0.00467505916085547,0.0267124883684789,0.0450387202790324,1.76786617140487e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0289658900328793,0.00378430703531338,0.0215486482436651,0.0363831318220935,2.07867653132758e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0257019615310431,0.00336846400413732,0.019099772082934,0.0323041509791523,2.50105947311786e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHCY,Adenosylhomocysteinase,39868,0.0513134222758637,0.0067431128804431,0.0380969210301952,0.0645299235215322,2.89868295385391e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0248692657980063,0.003283812488801,0.0184329933199564,0.0313055382760563,3.87325401012923e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRK1,Protein BRICK1,39489,0.0334723766037424,0.0044303491213254,0.0247888923259446,0.0421558608815402,4.41178665309571e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PZP,Pregnancy zone protein,37453,0.0412146562090232,0.00547698739867564,0.030479760907619,0.0519495515104275,5.60037795792713e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0430317621475343,0.00572875861856242,0.031803395255152,0.0542601290399167,6.15175806570202e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0179333267636149,0.00239278063859986,0.0132434767119592,0.0226231768152706,6.99109534775445e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0277030248916002,0.00369828388419501,0.020454388478578,0.0349516613046224,7.21252046759944e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0601014476603045,0.00805449042717868,0.0443146464230343,0.0758882488975747,8.98006757572751e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0166428010990602,0.0022317804437422,0.0122685114293255,0.021017090768795,9.29362761220979e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GC,Vitamin D-binding protein,37453,0.0191879031631091,0.0025729364071127,0.0141449478051682,0.02423085852105,9.34527344886858e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0402267545750642,0.00539986960890596,-0.0508104990085198,-0.0296430101416085,9.8411093739502e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0305678460442945,0.00410464731118758,0.0225227373143669,0.0386129547742222,1.0130975937922e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.073023338123691,0.0098181257273861,0.0537798116980142,0.0922668645493677,1.08872251529865e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0173155006100858,0.00233199146255409,0.0127447973434798,0.0218862038766918,1.18257713007182e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPF,Centromere protein F,37169,0.0398756075669193,0.00537124885320541,0.0293479598146367,0.0504032553192019,1.20627779402729e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX2,Sorting nexin-2,37368,0.0595603748067567,0.00803069544720545,0.043820211730234,0.0753005378832794,1.2733286806251e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX1,Heme oxygenase 1,39691,-0.0351208240078533,0.00474281293877551,-0.0444167373678533,-0.0258249106478533,1.37684869123955e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A13,Protein S100-A13,37056,0.0256019963838184,0.00346181442024609,0.0188168401201361,0.0323871526475008,1.49326557778043e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0264336622645151,0.0035808623456661,-0.0334521524620207,-0.0194151720670095,1.63738180975693e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.044146270783084,0.00598192466020056,0.0324216984490909,0.0558708431170771,1.66325325179311e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPB,Natriuretic peptides B,39585,-0.0929021502531768,0.0125921584413972,-0.117582780798315,-0.0682215197080383,1.68986879627798e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.018693259098707,0.0025398605979449,0.013715132326735,0.023671385870679,1.94581339120665e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL3,Follistatin-related protein 3,39803,0.0218977081879458,0.00297994478830508,0.0160570164028679,0.0277383999730238,2.10371147338584e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0390221414611833,0.00531584795320146,0.0286030794729085,0.0494412034494582,2.24591499478352e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0265645760874029,0.00362731448729294,0.0194550396923087,0.033674112482497,2.55293236373322e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0258716923257976,0.00353329220210655,-0.0327969450419264,-0.0189464396096688,2.55304009216506e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.037165935810456,0.00509944698399621,0.0271710197218234,0.0471608518990886,3.29087199825105e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPQ,Carboxypeptidase Q,37430,0.0274102185468726,0.00376045359113841,0.0200397295082413,0.0347807075855039,3.2934956015912e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1B,Interleukin-1 beta,39478,0.0404240926415511,0.00555118436436461,0.0295437712873965,0.0513044139957058,3.44424657914654e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1,Programmed cell death protein 1,39998,0.0295204250033649,0.00407035314524255,0.0215425328386895,0.0374983171680403,4.27568985578636e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR2,Folate receptor beta,40009,-0.0207929713476028,0.00286722642005532,-0.0264127351309113,-0.0151732075642944,4.29449726100551e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0307495295272669,0.00424218414222445,-0.0390642104460268,-0.022434848608507,4.44831576803956e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0262303670120745,0.00364314512260394,0.0190898025717708,0.0333709314523782,6.35166392327832e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0181450585925945,0.00252254930451774,0.0132008619557398,0.0230892552294493,6.67132504654331e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300C,CMRF35-like molecule 6,40009,0.023770980804582,0.00330844406549496,0.0172864304362119,0.0302555311729521,7.01721022529923e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0256044647330265,0.00356366577810236,0.0186196798079459,0.0325892496581072,7.08937908532107e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPB2,Coatomer subunit beta',37021,0.0305349967514919,0.00425749127999261,0.0221903138427064,0.0388796796602774,7.78239469187338e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA1,Carbonic anhydrase 1,39531,0.0422588389645777,0.00590899202893109,0.0306772145878727,0.0538404633412826,8.95536586222266e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0235441901912365,0.00329193775229042,-0.0299963881857257,-0.0170919921967472,8.98687106156615e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALY,RNA-binding protein Raly,37368,0.0346669542326916,0.00484992577135202,0.0251610997208417,0.0441728087445416,9.26155460434069e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0401082816169393,0.00561181470885241,0.0291091247875886,0.0511074384462901,9.32912829655166e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN3,Calsyntenin-3,37388,0.0215151740287547,0.00301207351378812,0.01561150994173,0.0274188381157794,9.59990568883022e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYGD,Gamma-crystallin D,37388,0.0684046985375095,0.00959313103535174,0.0496021617082201,0.0872072353667989,1.05011668247369e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0347707547910568,0.00488678616562951,0.0251926539064229,0.0443488556756906,1.17302683172876e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALCAM,CD166 antigen,40052,0.0137213489637087,0.00193071126533838,0.00993715488364552,0.017505543043772,1.23637334834558e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL1,Chordin-like protein 1,39908,0.0216304715881874,0.0030481676547174,0.0156560629849413,0.0276048801914335,1.33576795761983e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0334252305950607,0.00471384410759112,0.0241860961441821,0.0426643650459393,1.38990314583344e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFAP1,Actin filament-associated protein 1,37124,0.059900065249308,0.00844793659603646,0.0433421095210765,0.0764580209775395,1.40398175043945e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCOR1,REST corepressor 1,39585,0.0316875415222499,0.00447073600504315,0.0229248989523653,0.0404501840921345,1.42083691255781e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A11,Protein S100-A11,39703,0.0318957290065977,0.00452239195096596,0.0230318407827044,0.040759617230491,1.82544500400147e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZU1,Azurocidin,39344,0.0537705284965068,0.00762383266794381,0.038827816467337,0.0687132405256767,1.82575060955497e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD93,Complement component C1q receptor,39238,-0.0215812451557509,0.00306338875834152,-0.0275854871221002,-0.0155770031894015,1.93479774728855e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0546682996484467,0.00776298304163356,0.0394528528868449,0.0698837464100485,1.98641610666173e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XG,Glycoprotein Xg,39985,0.0210415416851354,0.00299028955572392,0.0151805741559165,0.0269025092143543,2.04879663216575e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0196211197416302,0.00279118355344527,0.0141503999768775,0.0250918395063829,2.17201086557474e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0245574023969193,0.00349481359096982,0.0177075677586185,0.0314072370352202,2.2170527928427e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0720714394616629,0.010296248461928,0.0518907924762841,0.0922520864470417,2.68458360751794e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0250100851804509,0.0035819828524463,0.0179893987896561,0.0320307715712456,3.02242658150247e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS4,Thrombospondin-4,39892,0.0309996574809993,0.00444469961586167,0.0222880462339104,0.0397112687280881,3.18902289711355e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0371685378722124,0.00532970904848026,0.0267223081371911,0.0476147676072337,3.2274612374679e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0413663715156573,0.00594771260057688,0.0297088548185266,0.053023888212788,3.68766541035727e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.025039774663089,0.00360359142341328,0.017976735473199,0.032102813852979,3.85957638683266e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0366259101614404,0.00527341814915963,0.0262900105890875,0.0469618097337932,3.94963634030007e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0427587353126432,0.00616448417386586,0.0306763463318661,0.0548411242934203,4.20779838771088e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHISA5,Protein shisa-5,37437,0.0158128315865666,0.00228309775915611,0.0113379599786206,0.0202877031945125,4.52253559731505e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP6,Gastrotropin,39564,0.0372052654236206,0.00537889718690495,0.0266626269372869,0.0477479039099543,4.79470474052201e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST5,Cystatin-D,39559,0.0372618443956325,0.00539664491573923,0.0266844203607836,0.0478392684304813,5.22636954436736e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A14,Protein S100-A14,37411,0.0350666941218308,0.00508694429422921,0.0250962833051415,0.0450371049385201,5.68571252444103e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0396905133346763,0.00575967070970073,-0.0509794679256897,-0.0284015587436629,5.74158287525784e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0245838960750096,0.00356879153138806,0.017589064673489,0.0315787274765302,5.85715849106038e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0290859150377353,0.00422849742840835,0.0207980600780549,0.0373737699974156,6.31916481387321e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS1,Nephrin,37056,0.0234585180913134,0.00341231647210422,0.0167703778059891,0.0301466583766377,6.49317681219111e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0276990416237387,0.00403856362089899,0.0197834569267767,0.0356146263207007,7.2127743647457e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVALB,Parvalbumin alpha,39971,0.0778761093376656,0.0113554287368609,0.0556194690134182,0.100132749661913,7.23436927969794e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0258547282923765,0.00376940331537303,0.0184666977942453,0.0332427587905076,7.23901884264276e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0572798373517854,0.00837186666963082,0.040870978679309,0.0736886960242618,8.10274384237475e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA12,Serpin A12,39405,0.080359449222409,0.0117583899917001,0.0573130048386768,0.103405893606141,8.55162368432356e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.080141480349943,0.01173045709074,0.0571497844520926,0.103133176247793,8.6845988163229e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0411414172771836,0.00602153980408665,0.0293391992611738,0.0529436352931934,8.71844248522909e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0291166507361958,0.00426303018458119,-0.0374721898979749,-0.0207611115744167,8.79507573470499e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0248599530153206,0.00364624290304231,0.0177133169253577,0.0320065891052836,9.62622790687058e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B2M,Beta-2-microglobulin,37453,0.0208767664967966,0.00306512641097043,0.0148691187312946,0.0268844142622987,1.00953468903339e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCT,Secretin,37039,0.0299560859125121,0.00440019280432282,0.0213317080160394,0.0385804638089848,1.03320008557298e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO3,R-spondin-3,40030,0.018151028643969,0.00268006650823099,0.0128980982878363,0.0234039590001018,1.30842330382238e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0259262815704493,0.00383192910571581,0.0184157005232463,0.0334368626176523,1.37151985301629e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0164334004751006,0.00243020187571612,-0.0211965961515042,-0.011670204798697,1.40603089339666e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0173789556539274,0.00257627294235805,-0.0224284506209491,-0.0123294606869056,1.58377885365013e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGA,Fibrinogen alpha chain,37149,0.0207165484425774,0.00307173319281637,0.0146959513846573,0.0267371455004975,1.6017677100222e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBI3_IL27,Interleukin-27,40011,-0.0206405880759716,0.00306162109451517,-0.0266413654212213,-0.0146398107307219,1.61825239888604e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL2,Fc receptor-like protein 2,39990,0.031020684795466,0.00460384979009769,0.0219971392068745,0.0400442303840575,1.66029166640221e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0284470990903551,0.00422727033313495,0.0201616492374106,0.0367325489432996,1.76090982447857e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0281102999197073,0.00417762599710156,0.0199221529653883,0.0362984468740264,1.77972522746815e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0175373606442696,0.00263314974434239,0.0123763871453585,0.0226983341431807,2.82321541439448e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0271733054631505,0.00408110865688385,0.0191743324956581,0.0351722784306428,2.86171296118344e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM3,Myomesin-3,37124,-0.0619961788096578,0.0093266895265117,-0.0802764902816207,-0.0437158673376948,3.10446730487772e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN5,CCN family member 5,39858,0.0254336810277833,0.0038279858135918,0.0179308288331434,0.0329365332224232,3.14831015259722e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0175543540121424,0.00264331012131871,0.0123734661743578,0.0227352418499271,3.21378783186004e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB6,Integrin beta-6,39587,0.0196073497712556,0.00295282301233663,0.0138198166670758,0.0253948828754354,3.23508873050843e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D17,TBC1 domain family member 17,39489,0.0290353933076829,0.00437856640381222,0.0204534031562109,0.0376173834591548,3.43757181017476e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMBS,Porphobilinogen deaminase,40030,0.0282587833158516,0.00427458115832241,0.0198806042455397,0.0366369623861636,3.93972467275834e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0365957685335106,0.00554546463895582,0.0257266578411572,0.047464879225864,4.26153217820372e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0273829873197881,0.00415269817908465,0.0192436988887821,0.035522275750794,4.43930113089228e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.033431935002026,0.00508338566405866,0.023468499100471,0.0433953709035809,4.96257590514986e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0152414093411238,0.0023175881396464,0.0106989365874169,0.0197838820948307,4.96734433052607e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA1,Ephrin-A1,39826,0.0171952047163254,0.00262086769260531,0.012058304038819,0.0223321053938318,5.513552382887e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0207681739973011,0.00317145242591868,0.0145521272425005,0.0269842207521018,5.99188027564546e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRLB,Fc receptor-like B,39477,0.0376882349266374,0.00576160980763173,0.0263954797036792,0.0489809901495956,6.28953553181528e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0157397329808549,0.00241480992177434,0.0110067055341772,0.0204727604275326,7.38437266942843e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0391473417320487,0.00601025980815009,0.0273672325080745,0.0509274509560229,7.61263730085684e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0161696436624767,0.0024855714811341,0.0112979235594539,0.0210413637654995,8.02126518797434e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRH,Corticoliberin,39455,0.0563036378122058,0.00865703686727889,0.0393358455523392,0.0732714300720725,8.06987372270422e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0293951386757427,0.00454137187940577,0.0204940497921074,0.038296227559378,9.96422025447885e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6,Interleukin-6,39788,0.0454913762949433,0.00703679998943598,0.0316992483156487,0.0592835042742378,1.04395062128391e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMPD3,AMP deaminase 3,37388,0.0456098564565884,0.00705502262263204,0.0317820121162296,0.0594377007969472,1.04860075815749e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0267071619079105,0.00413217441217186,0.0186081000600536,0.0348062237557673,1.05461022776146e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK4,Kallikrein-4,40030,-0.038603988037223,0.00598481287813405,-0.0503342212783657,-0.0268737547960803,1.1477871625675e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.0153682254121347,0.00238636130807334,-0.0200454935759584,-0.0106909572483109,1.22875418963093e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.153343653485806,0.0238137259426948,0.106668750638124,0.200018556333488,1.24082835454359e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0364706580024415,0.00566787870651729,0.0253616157376676,0.0475797002672154,1.27360421751654e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB37,Ras-related protein Rab-37,39587,0.0532580567998776,0.00829662646023353,0.0369966689378199,0.0695194446619353,1.40876801427439e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1A,Protein phosphatase 1A,39477,0.0194972859036978,0.00304035552872124,0.0135381890674042,0.0254563827399915,1.46946129221479e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPA,Apolipoprotein(a),37186,-0.112257212592196,0.017517413155972,-0.146591342377901,-0.0779230828064906,1.52081544501354e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSH,Pro-cathepsin H,39546,0.0460972622015326,0.00719553308686802,0.0319940173512713,0.0602005070517939,1.53268789419793e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0112078789720232,0.00174969026957378,0.00777848604365854,0.0146372719003878,1.53921370007469e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0258749562742575,0.00404076061434668,0.017955065470138,0.033794847078377,1.56206652039237e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0605560430274561,0.0094574224436718,-0.0790925910170529,-0.0420194950378594,1.56578782275072e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDN1,Endothelin-1,37043,0.0179383208626829,0.00280222237996938,0.0124459649979429,0.0234306767274229,1.59109272352812e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0171207665640302,0.00267518641809271,-0.0223641319434919,-0.0118774011845685,1.60691266444054e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0254690740234549,0.00398976081291919,0.0176491428301333,0.0332890052167766,1.7772382510843e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNC,Tenascin,39931,-0.0298025850797087,0.00468116174448527,-0.0389776620988998,-0.0206275080605175,1.98643888334203e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA7,Carbonic anhydrase 7,37169,-0.0213347588335203,0.00335372271617402,-0.0279080553572214,-0.0147614623098192,2.06310970623397e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0305724268581203,0.00481078478348562,0.0211432886824885,0.0400015650337522,2.15320341745198e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0443387379574899,0.00700026774979726,0.0306182131678873,0.0580592627470925,2.45647542233826e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLVRB,Flavin reductase,39858,0.0404889633502468,0.00641455247602005,0.0279164404972475,0.0530614862032461,2.82618868616139e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0242362194463603,0.00385673914724561,0.0166770107177589,0.0317954281749617,3.382820852357e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17D,Interleukin-17D,39587,0.0211181412947513,0.00337263243646068,0.0145077817192883,0.0277285008702142,3.90889877874006e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0212163669488653,0.0034010432098196,-0.0278824116401117,-0.0145503222576189,4.55789561321622e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.024896226998671,0.00399221511897647,0.0170714853654771,0.0327209686318648,4.59602654292073e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.032004815563811,0.00513295914212321,0.0219442156452495,0.0420654154823725,4.62923418286635e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0171080119586701,0.00275577888019202,0.0117066853534937,0.0225093385638464,5.49684766823039e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0370691169644194,0.00597453738392231,0.0253590236919316,0.0487792102369071,5.65073729930442e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY75,Lymphocyte antigen 75,39866,0.0238611938088501,0.00384734483142769,0.0163203979392518,0.0314019896784483,5.7122737262496e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE1,Ribonuclease pancreatic,37445,0.0138286848710311,0.0022303174368597,0.00945726269478606,0.0182001070472761,5.79795841594089e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0282268202377422,0.00455503253318024,0.0192989564727089,0.0371546840027755,5.93256785182074e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15,Interleukin-15,39866,0.0199947241937173,0.00323128772922258,0.0136614002444411,0.0263280481429936,6.24745120621032e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.019176600872157,0.00310008565358427,-0.0252527687531822,-0.0131004329911318,6.32750325121384e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0375511250537721,0.00608724012002499,0.0256201344185232,0.0494821156890211,7.08115897253716e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0220794088544181,0.00358923381017795,0.0150445105864693,0.0291143071223669,7.89552041381237e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0338942829807109,0.00552022751436004,0.0230746370525652,0.0447139289088566,8.48229116836107e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0220137264694873,0.00359246343326311,0.0149724981402916,0.029054954798683,9.12172894430916e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0155536482725655,0.0025388537979111,0.0105774948286598,0.0205298017164713,9.20741239211742e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0112926718447702,0.00184703527100022,0.00767248271360977,0.0149128609759306,9.9858941859157e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0201079236926285,0.00329111967635084,0.0136573291269809,0.0265585182582762,1.02072386462395e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.018523954780868,0.00303228388604837,-0.0244672311975228,-0.0125806783642132,1.03153992234312e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0435536855699428,0.00714854725812235,0.029542532944023,0.0575648381958627,1.14111453930891e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0212000519892167,0.00348223872149262,0.0143748640950912,0.0280252398833423,1.16964626385229e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0236957760831548,0.00389245694212378,0.0160665604765922,0.0313249916897174,1.17267539259514e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0197729435964915,0.00324927735552878,-0.0261415272133279,-0.0134043599796551,1.19450048839147e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN3,Matrilin-3,39720,-0.018950396671826,0.00311626490198188,-0.0250582758797105,-0.0128425174639415,1.22079051829412e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR1,Complement receptor type 1,37420,0.0215902753396148,0.00355012277691055,0.0146320346968702,0.0285485159823595,1.22219504784155e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0227488941941785,0.00375184264436378,0.0153952826112255,0.0301025057771315,1.36274466777429e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0231728274263529,0.0038269887393307,0.0156719294972647,0.0306737253554411,1.44134499668507e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN8,Tetraspanin-8,37382,0.0590766106808353,0.00976548350952984,0.0399362630021568,0.0782169583595138,1.49101153062876e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0259015858902528,0.0042881305489964,0.0174968500142198,0.0343063217662857,1.57294739503577e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GM2A,Ganglioside GM2 activator,37178,0.0217721442999187,0.00360457968378148,0.014707168119707,0.0288371204801305,1.58088652260317e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0422531168787023,0.00700432462056842,0.0285246406223882,0.0559815931350164,1.65835139731206e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.037750134126301,0.00626587891722994,-0.0500312568040717,-0.0254690114485303,1.73157554798892e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0266469167821234,0.00442312431546836,0.0179775931238054,0.0353162404404414,1.74090296901514e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0188021551599607,0.00312125407389597,0.0126844971751246,0.0249198131447967,1.74782341558206e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0529325605409036,0.00880239603719418,0.035679864308003,0.0701852567738042,1.85593715305151e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR15L,Protein GPR15L,37382,0.0367124067012412,0.00611844187550943,0.0247202606252427,0.0487045527772397,2.02003450037336e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0180903300917268,0.00301716685846881,0.012176683049128,0.0240039771343257,2.06943523606054e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0123263931373544,0.0020582984061955,0.00829212826121122,0.0163606580134976,2.16161503318156e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPOCK1,Testican-1,39749,0.0151125265587027,0.00252485538234344,0.0101638100093096,0.0200612431080959,2.20363036892452e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0217862328920185,0.00364485479006651,0.0146423175034882,0.0289301482805489,2.31831388165663e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0351719536610437,0.00588528704135134,-0.0467071162620923,-0.0236367910599951,2.33175555696648e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENSA,Alpha-endosulfine,37368,0.0312472571321373,0.00523776595950717,0.0209812358515032,0.0415132784127713,2.49587143213035e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LUZP2,Leucine zipper protein 2,37368,0.0259843492287539,0.00435695779333234,0.0174447119538225,0.0345239865036853,2.52479001138989e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0155895057610077,0.0026147141906333,0.0104646659473664,0.020714345574649,2.54040919510018e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST7,Cystatin-F,39882,0.0545751742698894,0.00918062812060304,0.0365811431535074,0.0725692053862713,2.82883263191516e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0212632555432499,0.00357784640905077,0.0142506765815104,0.0282758345049894,2.86855900598975e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0320750431251126,0.00541991678716155,0.021452006222276,0.0426980800279492,3.33984558042665e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDM1,Nuclear protein MDM1,37039,0.018432206198342,0.00311796438745655,0.0123209959989271,0.0245434163977568,3.47148806729301e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA12,Carbonic anhydrase 12,39788,-0.0186095304517932,0.00316668076324039,-0.0248162247477444,-0.0124028361558421,4.26962665133957e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD1,Polycystin-1,37437,0.0153391435409506,0.0026116011217758,0.01022040534227,0.0204578817396311,4.36770090819027e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGA4,Pepsin A-4,37445,0.0362833242932482,0.00619611849755629,0.0241389320380378,0.0484277165484585,4.8564627207456e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.0144201444940957,0.00246381173207529,-0.0192492154889633,-0.00959107349922814,4.92767398982195e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0284403200306691,0.00486253675081611,0.0189097479990695,0.0379708920622687,5.06377914477622e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK14,Kallikrein-14,40030,-0.0262509161642666,0.00449062405967496,-0.0350525393212295,-0.0174492930073037,5.14103827107089e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0151557457120091,0.00259584880296529,0.0100678820581971,0.0202436093658211,5.37030179540864e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN10,Ataxin-10,39489,0.0424086632842687,0.00728625414804266,0.0281276051541051,0.0566897214144323,5.98693333562149e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLU,Clusterin,37453,0.0184668914113774,0.00317277429335311,0.0122482537964054,0.0246855290263495,6.00223891902949e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0276025354789264,0.00474992852725751,0.0182926755655017,0.0369123953923511,6.34827259058467e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPO,Erythropoietin,39866,0.0446280961013437,0.0076849600402604,0.0295655744224333,0.059690617780254,6.4730606988237e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSR,Insulin receptor,37056,0.00963115290208839,0.00165857716120365,0.00638034166612925,0.0128819641380475,6.51146150479064e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD276,CD276 antigen,39862,-0.0202871898962654,0.00350059679226598,-0.0271483596091067,-0.0134260201834241,6.94604780334677e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH1,Protocadherin-1,40018,0.0119906159030851,0.00206969130311607,0.00793402094897762,0.0160472108571926,7.02452251971037e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLFM4,Olfactomedin-4,36654,0.0709151635893008,0.0122574171568245,0.0468906259619247,0.0949397012166768,7.39942188487457e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.0150450988324399,0.00260659479760926,0.00993617302912577,0.0201540246357541,7.98102792668635e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00891779708296665,0.00155960676528588,0.00586096782300633,0.011974626342927,1.09699894165255e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0148115531581567,0.00259413179331599,-0.019896051473056,-0.00972705484325735,1.15658870508381e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0326644525164277,0.00572373345839013,0.021445934937983,0.0438829700948723,1.17137856808602e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN2,Calsyntenin-2,40058,-0.0222590119579172,0.00392079452328429,-0.0299437692235544,-0.01457425469228,1.39289346881593e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP4,Guanylate-binding protein 4,39489,0.0276034080895661,0.00486850814389009,0.0180611321275415,0.0371456840515906,1.45501775513667e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0282740165610093,0.00499063614066935,0.0184923697252974,0.0380556633967212,1.49247361135595e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0296952095651158,0.00525391019298117,0.0193975455868727,0.0399928735433589,1.613241541622e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0381969783264073,0.00675925387802417,0.0249488407254799,0.0514451159273347,1.62781118670984e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA1,Annexin A1,37072,0.0246027631099833,0.00435661431315464,0.0160637990562002,0.0331417271637664,1.66423635592736e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL3,Insulin-like 3,37388,0.0407696875016308,0.00722400955152779,0.0266106287806364,0.0549287462226253,1.69837837933458e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR1,Cadherin-related family member 1,39489,0.0239354224616286,0.00425297170257059,0.0155995979245902,0.032271246998667,1.85517956901861e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0120250352205423,0.00213681221956113,-0.0162131871708821,-0.0078368832702025,1.85896840780531e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0126885042626384,0.00225865202022467,0.00826154630299806,0.0171154622222788,1.96662277298455e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST1,Cystatin-SN,35640,0.0558289475482054,0.0100297503952702,0.0361706367734758,0.0754872583229349,2.65843013086753e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCN,Decorin,39585,-0.0120265554722581,0.00216262188135458,-0.016265294359713,-0.00778781658480308,2.72446308387113e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0198271357657519,0.00356925829611029,0.0128313895053757,0.026822882026128,2.82155567731974e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0427930383615783,0.00773057736518633,0.0276411067258131,0.0579449699973435,3.16172778079978e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0173247519747861,0.00312981766034654,-0.0234591945890653,-0.0111903093605069,3.16483994451564e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0166683550211597,0.0030120207398369,0.0107647943710794,0.02257191567124,3.17980766811715e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLGN,Calmegin,37039,0.0239562435954927,0.00435098846278697,0.0154283062084303,0.0324841809825552,3.74093691769658e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN3,Perilipin-3,39868,0.0235390669414934,0.00427606166032842,0.0151579860872497,0.0319201477957371,3.7516842983836e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0139899480561239,0.00254398124512233,0.00900374481568415,0.0189761512965637,3.87285501616382e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD7,T-cell antigen CD7,37037,0.0233741257764571,0.00426455712918626,0.0150155938032521,0.0317326577496622,4.30654664281292e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0374408742172804,0.00683178719868013,0.0240505713078673,0.0508311771266934,4.32182271269789e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF15,Growth/differentiation factor 15,40052,0.0231071960649948,0.00422132034421546,0.0148334081903325,0.0313809839396571,4.46716419036443e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0308961942960899,0.00565362774533931,0.0198150839152249,0.041977304676955,4.70236468106954e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0277240336545003,0.00508428990382199,0.0177588254430092,0.0376892418659914,5.04309908775628e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0212473362434433,0.00390072201112143,0.0136019211016453,0.0288927513852413,5.21152892661694e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SATB1,DNA-binding protein SATB1,37411,0.0162775305651921,0.00298909325202733,0.0104189077912185,0.0221361533391657,5.25186615284365e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0187085802182832,0.0034388017156362,0.0119685288556363,0.0254486315809302,5.40732872398852e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0165543441881445,0.00304586348719225,-0.0225242366230413,-0.0105844517532477,5.5604602516471e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG3,Desmoglein-3,39964,0.0180149428557385,0.0033178519040879,0.0115119531237262,0.0245179325877508,5.72661696305076e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL34,Interleukin-34,39456,0.0192933182972315,0.00356331796968307,0.0123092150766527,0.0262774215178104,6.23955495493409e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0298175202927151,0.00550849328004473,0.0190208734638274,0.0406141671216027,6.28669007095922e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0238951567697382,0.00442225159149974,-0.0325627698890777,-0.0152275436503987,6.65311003677462e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CABP2,Calcium-binding protein 2,37039,0.0354090815851372,0.00655780896637807,0.0225557760110362,0.0482623871592382,6.79745127860815e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0168182994181062,0.0031227162406996,0.010697775586335,0.0229388232498774,7.33630608784665e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0258861226776313,0.00480909570823426,0.0164602950894922,0.0353119502657705,7.44180119792946e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0151081707791991,0.00281381016507441,0.00959310285565327,0.0206232387027449,8.01786986473725e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.018335267696185,0.00341779632994605,0.0116363868894908,0.0250341485028793,8.22222930144705e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MBL2,Mannose-binding protein C,37257,-0.0573237522514019,0.0107087685760293,-0.0783129386604194,-0.0363345658423845,8.79471975037326e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0268293003657451,0.00501716952665269,0.0169956480935059,0.0366629526379844,9.06296709217602e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTB,Lymphotoxin-beta,37368,0.0182048780231883,0.00340656901348113,0.0115280027567653,0.0248817532896113,9.23686693943032e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.014895198070211,0.00278763153203634,0.0094314402674198,0.0203589558730023,9.27382033368806e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.028075273655607,0.00525705778023594,0.0177714404063445,0.0383791069048694,9.42246138878901e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0224073829198908,0.00420095238497757,0.0141735162453347,0.0306412495944468,9.74654443214218e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARCL1,SPARC-like protein 1,39871,-0.0144442994888056,0.00270988223894647,-0.0197556686771407,-0.00913293030047048,9.94172064363457e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.0111178317339528,0.00209041956234011,-0.0152150540761395,-0.00702060939176622,1.06353939943718e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0178979641833552,0.0033775740992877,0.0112779189487513,0.0245180094179591,1.17951260439993e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN2,Prefoldin subunit 2,39489,0.0294409476415117,0.00555974089133485,0.0185438554944954,0.040338039788528,1.20376156349134e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.0133811843324835,0.00252901341254282,0.00842431804389958,0.0183380506210674,1.2319313302427e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0149031507996787,0.00282520953057997,-0.0204405614796155,-0.00936574011974197,1.34445587713272e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0315926884824214,0.00598999569326705,0.019852296923618,0.0433330800412249,1.35052639461439e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.02032458999728,0.00385406898196487,0.0127706147926289,0.0278785652019312,1.35878604533255e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC1,Syndecan-1,39868,0.0208613693787484,0.00395620565289308,0.013107206299078,0.0286155324584189,1.3590064873406e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN4,Contactin-4,39858,-0.012515087298553,0.00237483391378004,-0.0171697617695619,-0.00786041282754417,1.38285304612007e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LXN,Latexin,39682,-0.0350262100733439,0.00665153891164477,-0.0480632263401677,-0.0219891938065202,1.41344313522409e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRL,Prolactin,40009,-0.0397391155165859,0.00754769802399522,-0.0545326036436166,-0.0249456273895553,1.41935423159413e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCP1,Plastin-2,37437,0.0246167257319153,0.00467888484963506,0.0154461114266305,0.0337873400372,1.45264967430969e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0148567065001226,0.00282661451671151,0.00931654204736803,0.0203968709528772,1.49511499571755e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0363568466216638,0.0069387585402732,-0.0499568133605992,-0.0227568798827283,1.62898811855354e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0329106078449647,0.00628987039560572,0.0205824618695774,0.0452387538203519,1.69919387383006e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0176896166267392,0.00339864364136793,0.011028275089658,0.0243509581638203,1.96926773585032e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.0185338244323813,0.00356085857682545,0.0115545416218034,0.0255131072429592,1.96958129122589e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0364559988519083,0.00701872989852671,-0.0502127094530207,-0.022699288250796,2.08698465735639e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0140795766178873,0.00271559775922034,0.00875700500981549,0.0194021482259592,2.1905345221067e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRC1,Macrophage mannose receptor 1,37445,0.0142163961429012,0.00274383942246497,0.0088384708748699,0.0195943214109326,2.23613029505636e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0169196113531788,0.00326696142936096,0.0105163669516314,0.0233228557547263,2.25775993361776e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP1,Caspase-1,39489,0.0344263439271583,0.0066607354098791,0.0213713025237953,0.0474813853305213,2.38823479293482e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0167308523703316,0.00324036878135778,0.0103797295588703,0.0230819751817928,2.46224986887716e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0226739324127954,0.00439354951574574,0.0140625753619337,0.0312852894636571,2.49566684748072e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0365119399918214,0.00709222440099461,0.0226111801658719,0.0504126998177708,2.66797974881824e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0191074240345543,0.00371387091304264,0.0118282370449907,0.0263866110241179,2.70854741001079e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA4,Apolipoprotein A-IV,37453,0.018140829748321,0.00352629615506786,0.011229289284388,0.025052370212254,2.72050478850345e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR2,Complement receptor type 2,39931,0.023108513382105,0.0045114437912112,0.014266083551331,0.0319509432128789,3.05485851309062e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0145955636588089,0.00284985571717582,0.00900984645314425,0.0201812808644735,3.06680248053235e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFR,Epidermal growth factor receptor,40052,0.00815108539246505,0.00159654869761589,0.00502184994513791,0.0112803208397922,3.33764506851634e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0133109037498948,0.00261522936466333,-0.0184367533046349,-0.00818505419515468,3.63474661050959e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0202628664195041,0.00398152951388882,0.012459068572282,0.0280666642667262,3.64505485119595e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0286285416635064,0.00563726522170358,0.0175795018289673,0.0396775814980454,3.85726626618947e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0264646284938302,0.00524574940208113,0.0161829596657512,0.0367462973219092,4.59491394432849e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAN,Versican core protein,40009,-0.0148438584576316,0.00294342201589201,-0.0206129656087799,-0.00907475130648322,4.63106190424923e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0306210225511274,0.00610972501453914,0.0186459615226307,0.0425960835796242,5.44950676153115e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0293985996454552,0.00587226181072596,0.0178889664964324,0.0409082327944781,5.61814073035381e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0305182682063206,0.0061179496358645,0.0185270869200262,0.042509449492615,6.16883295002413e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX18,Sorting nexin-18,37382,0.0224684379850816,0.00450850823503137,0.0136317618444201,0.0313051141257431,6.3195904619769e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0125756236129147,0.00252598013126619,0.00762470255563298,0.0175265446701965,6.47415861106229e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC16,Mucin-16,39788,0.0920477911171154,0.0184980231314122,0.0557916657795475,0.128303916454683,6.55590333304865e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0139343303527005,0.00280145063300778,-0.0194251735933957,-0.00844348711200521,6.62693965854446e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLC,Galectin-10,39841,-0.0329484415503773,0.00663229746020393,-0.045947744572377,-0.0199491385283776,6.83890158380104e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.0132336284371755,0.00267202150547157,-0.0184707905878997,-0.00799646628645118,7.39498964717481e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0291536233536451,0.00589034690018086,0.0176085434292906,0.0406987032779996,7.53427263879491e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0121422638117328,0.00245541046914252,0.00732965929221347,0.0169548683312521,7.68740085474357e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.019679523368135,0.00398921962326202,0.0118606529065414,0.0274983938297285,8.17153995986178e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0131312459045411,0.00266481565060427,0.00790820722935676,0.0183542845797255,8.42131461700859e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0205820633738935,0.00417936344996437,0.0123905110119634,0.0287736157358237,8.53323934782944e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0187331545418346,0.00380732738497754,0.0112707928672786,0.0261955162163906,8.72791396954779e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0254853041566433,0.00519292610865444,0.0153071689836806,0.035663439329606,9.30753424150829e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.0125563580683032,0.00256200472699969,-0.0175778873332226,-0.00753482880338378,9.62885364221294e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F3,Tissue factor,39931,-0.013214210108859,0.00270373680828544,-0.0185135342530985,-0.00791488596461953,1.03168195968836e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIF,Leukemia inhibitory factor,39489,0.0249783968949377,0.00511588964053528,0.0149512531994885,0.0350055405903868,1.05777245553204e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0134219310807205,0.00275516094674207,-0.018822046536335,-0.00802181562510608,1.1199502769482e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0319363846854225,0.00656321868402643,-0.0448002933061143,-0.0190724760647307,1.15184251925864e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMB,Granzyme B,39866,0.0310109390881657,0.00638204312142016,0.0185021345701822,0.0435197436061492,1.19041500355309e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0186017614942035,0.00383196869086019,0.0110911028601176,0.0261124201282895,1.21942070582457e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAL,Galanin peptides,39931,-0.0310423079337342,0.00640565470228158,-0.0435973911502061,-0.0184872247172623,1.2710072420254e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOSB,Protein fosB,39489,0.0188500983968659,0.00389172286278672,0.011222321585804,0.0264778752079279,1.28704019937641e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG4,Desmoglein-4,39725,0.0236336714381985,0.00488008045677368,0.0140687137429221,0.0331986291334749,1.29173760788209e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0251942039273113,0.00520606031485273,0.0149903257101999,0.0353980821444226,1.31433213595358e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK8,Kallikrein-8,39315,0.016661438708406,0.00346004600249892,0.00987974854350816,0.0234431288733039,1.4831100085255e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.020089920192265,0.0041759008632214,-0.028274685884179,-0.0119051545003511,1.51858649501525e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROCR,Endothelial protein C receptor,37021,-0.0174941624574683,0.00364248226362107,-0.0246334276941656,-0.010354897220771,1.58175377927845e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0206720414822733,0.00430929066728509,0.0122258317743945,0.0291182511901521,1.62735625975082e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0212053447626576,0.00442710040512979,0.0125282279686032,0.029882461556712,1.68638703587264e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLMP,CXADR-like membrane protein,40030,0.00975199060317266,0.00203822052685325,0.00575707837054028,0.013746902835805,1.72874364075939e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH1,Neurexophilin-1,39489,0.017833897259171,0.00374055536154508,0.0105024087505426,0.0251653857677993,1.88007522716161e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR1,Folate receptor alpha,39809,0.0129948838720029,0.0027260570235908,0.00765181210576488,0.0183379556382408,1.88718503364233e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0190233287851956,0.00399153504579868,0.0111999200954302,0.026846737474961,1.89688832758807e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0193726178921242,0.00406621947757329,0.0114028277160806,0.0273424080681678,1.91190848688788e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3D,Protein FAM3D,37382,0.0396185548974922,0.00832191221735037,0.0233076069514855,0.055929502843499,1.94872459227494e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0126656388021023,0.00266653363123673,0.00743923288487828,0.0178920447193263,2.05343724036683e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNU13,NHP2-like protein 1,37021,0.0292868614662612,0.00617005607358435,0.0171935515620358,0.0413801713704865,2.09030013796021e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOC,Brother of CDO,39585,-0.011054493627497,0.00233203550045545,-0.0156252832083897,-0.00648370404660431,2.15296133980847e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.024174905779765,0.00510101639964863,0.0141769136364537,0.0341728979230763,2.16421862722484e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP9,Matrix metalloproteinase-9,39843,0.0285507427080456,0.00602957707508677,0.0167327716408756,0.0403687137752157,2.20809456779752e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTL1,Cytokine-like protein 1,37437,0.0107950042176645,0.00228159954009197,0.00632306911908427,0.0152669393162448,2.25299563376526e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0159249038207903,0.00336780137317679,-0.0225257945122168,-0.00932401312936382,2.28451292864738e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0331244295884674,0.00700756666138245,0.0193895989321578,0.046859260244777,2.30208465981627e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAM,Basal cell adhesion molecule,39858,-0.0110677553181601,0.00234349115087546,-0.015660997973876,-0.00647451266244419,2.34635772558973e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0194347116799195,0.00411521919490715,0.0113688820579015,0.0275005413019375,2.35198550562172e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.0218532176841498,0.00462925018753557,0.0127798873165801,0.0309265480517195,2.37095794893626e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0219638734002803,0.00466006880288616,0.0128301385466235,0.0310976082539372,2.45899764537262e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD1,Leiomodin-1,37411,-0.0165208510282606,0.00351045856936486,-0.0234013498242158,-0.00964035223230551,2.54897962357442e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANPEP,Aminopeptidase N,39891,0.0130719622604424,0.00277896855632855,0.00762518389003844,0.0185187406308463,2.57379869411729e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0302465545726698,0.00643939194610478,0.0176253463583044,0.0428677627870351,2.6650191878952e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.022589539079734,0.00481001695960074,0.0131619058389166,0.0320171723205515,2.67446038339567e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYT1,Synaptotagmin-1,37388,0.0173320965749325,0.00369148767581014,0.0100967807303446,0.0245674124195203,2.69024218454524e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNG,Interferon gamma,39587,0.0533979808105653,0.0113907430577587,0.0310721244173582,0.0757238372037724,2.78420642041287e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2,Ataxin-2,36991,0.0519710959138773,0.0111025292310953,0.0302101386209305,0.0737320532068241,2.88314029612494e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0146994465739518,0.0031480853257109,0.00852919933555847,0.0208696938123452,3.04641693126143e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSHB,Thyrotropin subunit beta,39868,0.0347983231468462,0.00745811947949948,0.0201804089670272,0.0494162373266652,3.09860988835175e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMS1,PMS1 protein homolog 1,37039,0.0230169153341516,0.00495986141830278,0.0132955869542781,0.032738243714025,3.50684414035172e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTG,Protogenin,40030,0.0114848662629288,0.00247783781196914,0.00662830415146927,0.0163414283743883,3.59664296483471e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0170081766786894,0.00367132338679947,0.00981238284056241,0.0242039705168163,3.64280140051044e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.015534582708109,0.0033607147099265,-0.022121583539565,-0.0089475818766531,3.82812024849606e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0650030266129969,0.0140924737122028,0.0373817781370794,0.0926242750889144,4.00807031271498e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSPN,Persephin,39866,0.0432118905498652,0.00938559605663078,0.0248161222788688,0.0616076588208615,4.17510770790316e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0122434099264195,0.00266771621976163,0.0070146861356867,0.0174721337171523,4.48350493900727e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRUNE2,Protein prune homolog 2,37169,0.0130335127640002,0.00284069102609122,0.00746575835286144,0.018601267175139,4.51278631386161e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS53,Serine protease 53,37388,0.0170504764163177,0.00371845088543319,0.00976231268086859,0.0243386401517667,4.57243744299021e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0173306535436658,0.00378017029309382,-0.0247397873181297,-0.00992151976920197,4.59005642689729e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYAL1,Hyaluronidase-1,39747,0.0103743839770887,0.0022701538035678,0.00592488252209579,0.0148238854320816,4.91623382129003e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI3,Elafin,39594,0.0240619422726266,0.00527677070280094,0.0137194716951367,0.0344044128501164,5.15455209022444e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN1,Tetraspanin-1,39585,0.0183138014412558,0.00401892465986968,0.0104367091079112,0.0261908937746004,5.23070724981411e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMH,Granzyme H,39585,0.0341475003742939,0.00749799560894742,0.019451428980757,0.0488435717678308,5.29758383675741e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN1,Calsyntenin-1,39489,0.0228453236039968,0.00501659986701817,0.0130127878646412,0.0326778593433524,5.30466196198725e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0176017913192858,0.00387289325475026,0.0100109205399753,0.0251926620985963,5.53815465899982e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY2,Protein canopy homolog 2,39585,0.0272673593904771,0.00599976963942254,0.0155078108972089,0.0390269078837453,5.54142997261252e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.0132656225219644,0.00292028377686965,0.00754186631929988,0.0189893787246289,5.59921738366761e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0436935228273054,0.0096463045950526,0.0247867658210023,0.0626002798336085,5.96251945223631e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0133386336260687,0.0029532218494217,0.00755031880120214,0.0191269484509352,6.33780162780026e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB1,Calbindin,39788,0.0187935348411034,0.0041673550652148,0.0106255189132824,0.0269615507689244,6.53817818905151e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0135689092464335,0.00300964906616471,0.00766999707675067,0.0194678214161163,6.57649808100354e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0149989735642322,0.0033321852924129,0.00846789039110289,0.0215300567373615,6.81362427361605e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0158522857236615,0.00353619614217467,0.00892134128499909,0.0227832301623238,7.41602523176322e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0205005442827308,0.00459232375922584,0.0114995897146481,0.0295014988508134,8.10709795505424e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP8,Neutrophil collagenase,39985,0.0317841249959791,0.00713477915237614,0.0177999578573219,0.0457682921346363,8.45302396190288e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0127476870163483,0.00286184522611525,0.00713847037316242,0.0183569036595342,8.48188943168172e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0241460365720039,0.00542490007458053,-0.0347788407181818,-0.0135132324258261,8.60644825826597e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH3,Cadherin-3,40009,0.0153496072923794,0.00344933809837923,0.00858890461955612,0.0221103099652027,8.64385922233546e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLN,Mesothelin,39766,0.0231948189329207,0.00522130692324893,0.0129610573633528,0.0334285805024886,8.95863656381048e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0175031984922435,0.00395127337914187,0.00975870266912544,0.0252476943153616,9.50975011224197e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G1B,Phospholipase A2,40031,-0.0179482732768705,0.00406826205381849,-0.0259220669023548,-0.0099744796513863,1.03187374816531e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0131583272626005,0.0029892083787067,0.00729947884033536,0.0190171756848656,1.07997337427741e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP1,Dipeptidase 1,39713,-0.0207365459426268,0.00471504318610683,-0.0299780305873962,-0.0114950612978574,1.09987715819208e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0141986952917858,0.00323106034590056,0.00786581701382071,0.0205315735697509,1.11902111249161e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0192580224727077,0.00439502261196616,0.010643778153254,0.0278722667921613,1.18462387950185e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0159875572589458,0.00365342908732284,0.00882683624779304,0.0231482782700986,1.2160994234095e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB44,Ras-related protein Rab-44,37368,0.0183662163490293,0.00421267799462301,0.0101093674795682,0.0266230652184904,1.31175290378942e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00995053554968141,0.00228578466408249,0.00547039760807973,0.0144306734912831,1.3498767929747e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLASP1,CLIP-associating protein 1,36962,0.0317269201454036,0.00729714789036174,0.0174245102802946,0.0460293300105126,1.38514914518603e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0133286459698209,0.00306719134419687,-0.0193403410044467,-0.00731695093519502,1.39954688152145e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAP,Cartilage-associated protein,37039,0.0213387652506883,0.00492688672123948,0.0116820672770589,0.0309954632243177,1.49473432347433e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0268317925710857,0.00619950051385094,-0.0389828135782336,-0.0146807715639379,1.51547956079545e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0168665970412929,0.00390508155060025,0.00921263720211645,0.0245205568804694,1.57783802931559e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0110470651947519,0.00256116896020891,0.00602717403274244,0.0160669563567614,1.61978281800423e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK11,Kallikrein-11,39779,0.012474856999838,0.00289631267116387,0.0067980841643568,0.0181516298353192,1.66361040233655e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI1,Neuroserpin,37088,0.0131336840869382,0.00307137987758037,0.00711377952688068,0.0191535886469958,1.91486294416295e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA4,Carboxypeptidase A4,36868,0.018509891963718,0.00434344242970962,0.00999674480148716,0.0270230391259489,2.04423551249979e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM2,Myomesin-2,37021,-0.0218749147257999,0.00513564376509845,-0.0319407765053929,-0.011809052946207,2.06372625973473e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0183948850528156,0.00432851274362866,0.00991100007530344,0.0268787700303278,2.15526132251066e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF3,Trefoil factor 3,39839,0.0205099202954258,0.00482674178662329,0.0110495063936442,0.0299703341972074,2.15725282355509e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0138322465695474,0.00325904056850751,0.00744452705527269,0.0202199660838221,2.20768588945469e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.0185931068260477,0.00440679734993215,0.00995578402018068,0.0272304296319147,2.46536331131701e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH6,Cadherin-6,39868,-0.015939027939321,0.00378889589299768,-0.0233652638895965,-0.00851279198904555,2.60452421661091e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOB,Apolipoprotein B-100,37445,0.00949266384219358,0.00225847440059171,0.00506605401703384,0.0139192736673533,2.6493185007489e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF7,SLAM family member 7,39866,-0.0241018124932136,0.00574839500998945,-0.0353686667127929,-0.0128349582736342,2.7702595622156e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0363858354662442,0.00868581136401351,0.0193616451927777,0.0534100257397107,2.81873980174511e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0244894699949874,0.00584644315416354,0.0130304414128268,0.0359484985771479,2.81972898611852e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.043968427838303,0.0105000316683418,0.0233883657683531,0.0645484899082529,2.83614458601985e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.024939494366526,0.00596422407557955,0.01324961517839,0.0366293735546619,2.91399187551909e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0137418493996883,0.00329602713234925,-0.0202020625790929,-0.00728163622028381,3.07605794328746e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0353032308288116,0.00847238301122663,-0.0519091015308158,-0.0186973601268074,3.10499990757662e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.015679015007177,0.00377116651165788,0.00828752864432756,0.0230705013700265,3.23635291161147e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0370902150648627,0.00892384925626554,0.0195994705225822,0.0545809596071431,3.25117287949054e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0349507928785301,0.00845366672372077,0.0183816061000374,0.0515199796570228,3.57749357905161e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.010355765140773,0.00250830921251667,0.00543947908424037,0.0152720511973057,3.66835669219936e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0215711371424963,0.00523123702820795,0.0113179125672088,0.0318243617177839,3.75047388518141e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF16,Fibroblast growth factor 16,37056,0.0198577323235096,0.00481598114272151,0.0104184092837755,0.0292970553632438,3.75769826077318e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0242954265091124,0.00591774707959125,0.0126966422331135,0.0358942107851112,4.05767851061001e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100G,Protein S100-G,37411,-0.0183514490422032,0.00447867513206393,-0.0271296523010485,-0.00957324578335792,4.20035306758117e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPS10,40S ribosomal protein S10,37021,-0.0175088138790815,0.00427934219514355,-0.0258963245815629,-0.00912130317660016,4.3119585884388e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0327505791235866,0.00802337621517986,0.0170247617418341,0.0484763965053392,4.48860015125082e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARTN,Artemin,39587,0.0182049122006935,0.00446381418191,0.00945583640414988,0.0269539879972371,4.55835167035079e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC1,Sialoadhesin,39931,0.0169131539391,0.0041584709087106,0.00876255095802725,0.0250637569201728,4.78171461556629e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSPN,Claspin,39453,0.0139568434539598,0.00343271204598589,0.0072287278438275,0.0206849590640922,4.80955969183006e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0159129644433293,0.00393499421019622,0.00820037579134474,0.0236255530953139,5.28458118141672e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX3,Syntaxin-3,37388,0.0153185394438285,0.00379028668360451,0.00788957754396366,0.0227475013436933,5.33984740479278e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFLAM,Pikachurin,37382,0.0123504839524874,0.00305656663132964,0.00635961335508132,0.0183413545498935,5.36004556890688e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00770498368902316,0.00190941244311286,-0.0114474320775244,-0.00396253530052196,5.48394454101298e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MILR1,Allergin-1,39587,-0.019803846865115,0.00493150063426013,-0.0294695881082648,-0.0101381056219651,5.95233648466958e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0246511539690374,0.00615558384100413,0.0125862096406693,0.0367160982974055,6.24429511396828e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.0242330070611991,0.00607074561806539,-0.0361316684726073,-0.012334345649791,6.59273018786921e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0128165890449013,0.00322019012997082,-0.0191281616996441,-0.00650501639015846,6.92058220721378e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFD,Complement factor D,37453,0.00723913295611997,0.00181967656318067,0.00367256689228585,0.0108056990199541,6.97836596150516e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0145643116969544,0.00366637927346254,-0.021750415072941,-0.00737820832096781,7.1521303490082e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICOSLG,ICOS ligand,39788,0.00742229041261977,0.00187508140928041,0.00374713085043017,0.0110974499748094,7.57865012447578e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.0124983719008773,0.00315796712502151,0.00630875633583511,0.0186879874659194,7.59930225509188e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0266572263177379,0.00673803311661403,0.0134506814091744,0.0398637712263014,7.6530135637819e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0395668704047328,0.0100042116227984,0.0199586156240479,0.0591751251854178,7.69282249290057e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIM,Vimentin,39585,0.0461126856283482,0.0116730468800573,0.0232335137434358,0.0689918575132605,7.83757365697838e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0295832068437743,0.00749151159304869,0.0148998441213989,0.0442665695661498,7.89179163929691e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAFB2,Scaffold attachment factor B2,37411,0.0107823620413326,0.00273187552658407,0.00542788600922779,0.0161368380734374,7.95787231531222e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.0105738547455152,0.0026810915589189,0.00531891529003416,0.0158287942009962,8.0582711154251e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.016251804947378,0.00412799411109699,0.00816093648962787,0.0243426734051281,8.29295519067264e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC1,Glypican-1,40030,0.0113593834025637,0.00288639949484418,0.00570204039266916,0.0170167264124583,8.33760387269681e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.017135143232833,0.00436345817210984,0.00858276521549767,0.0256875212501683,8.64586762584908e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0255050778557302,0.00651354261237803,0.0127385343354693,0.0382716213759912,9.0516698486109e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNR,Tenascin-R,39749,-0.0163367007304549,0.00417592755988553,-0.0245215187478305,-0.00815188271307924,9.18729314620589e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN2,Alpha-actinin-2,37021,-0.0229540336318344,0.00588873154767608,-0.0344959474652795,-0.0114121197983892,9.74879088497654e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RETN,Resistin,39790,0.0157396236027454,0.00406172430813077,0.00777864395880909,0.0237006032466817,0.000107003977640906
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSB,Lupus La protein,39489,0.023412108476516,0.00604900987783317,0.0115560491159629,0.035268167837069,0.000109096994361608
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF4,Neurotrophin-4,39477,0.0153215232797834,0.00396241549463056,0.00755518891030751,0.0230878576492593,0.00011075920268619
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.0101483136837754,0.0026351823355331,-0.0153132710614203,-0.00498335630613053,0.000118055375598645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0140952081874535,0.0036618571650492,-0.0212724482309499,-0.00691796814395704,0.00011906543634426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0117863953698559,0.00306602534267582,-0.0177958050415005,-0.00577698569821128,0.000121518529729162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0177032231324052,0.00460968586281424,0.00866823884128932,0.0267382074235211,0.000123287128806604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0108303153196194,0.00282422514222917,0.00529483404085026,0.0163657965983886,0.000126157394019917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0297081199466934,0.00776893250740967,0.0144810122321704,0.0449352276612163,0.000131833310911408
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C8B,Complement component C8 beta chain,37453,0.0115436319799009,0.00302187534964567,0.00562075629459543,0.0174665076652065,0.000134033045915471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99,CD99 antigen,39858,-0.00727131963730595,0.00190591281812808,-0.011006908760837,-0.00353573051377491,0.000136618902382441
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0116427910011017,0.00305959002321637,0.00564599455559758,0.0176395874466058,0.000142137225192705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD55,Complement decay-accelerating factor,39315,0.00961297359174942,0.00252892864960056,0.00465627343853233,0.0145696737449665,0.000144547567057586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0106454843106036,0.00280100955855187,-0.0161354630453653,-0.00515550557584195,0.000144891680050728
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.0121205496351615,0.00319730102709713,-0.0183872596482719,-0.00585383962205116,0.000150790233299354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0165757669450436,0.00438712275677082,0.0079770063417728,0.0251745275483144,0.000158489392784864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0245358161112565,0.00650046881346737,0.0117948972368604,0.0372767349856525,0.000161054778709914
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0128882570428909,0.00341698977804812,0.0061909570779166,0.0195855570078652,0.000162657515593186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEFL,Neurofilament light polypeptide,39438,0.0163257879836124,0.0043321809447017,0.00783471333199702,0.0248168626352277,0.000164842477997177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTPN,Myotrophin,39585,0.0121726790599305,0.00323062100335082,0.00584066189336288,0.0185046962264981,0.000165223021937008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP2,Guanylate-binding protein 2,39587,0.0222520321796953,0.00590668862035946,0.0106749224837907,0.0338291418755998,0.000165651058772457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC2,Mucin-2,37437,0.0336816654939078,0.00899638292650208,0.0160487549579637,0.0513145760298519,0.000181925098943268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0154934739263807,0.00413943220585647,-0.0236067610498594,-0.00738018680290205,0.000182683772680096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAD,Chondroadherin,37124,0.0187978410164978,0.00502553804089656,0.00894778645634053,0.028647895576655,0.000184454802447693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERC2,ERC protein 2,37039,0.0278497404096623,0.00747732723272366,0.0131941790335239,0.0425053017858007,0.000196473633760222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.00939017499180917,0.00252206697328734,-0.0143334262594524,-0.00444692372416598,0.000197375550956448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDK2,Protein sidekick-2,37124,0.0137623604528101,0.00370435066783693,0.00650183314384967,0.0210228877617704,0.000203885915804144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR4,Complement factor H-related protein 4,37409,0.026640149076801,0.00717214703721938,0.012582740883851,0.040697557269751,0.000204512582551481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0133899714458543,0.0036147167370844,0.00630512664116886,0.0204748162505397,0.000212845833848446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0230357352986128,0.00625174409528697,-0.0352891537253752,-0.0107823168718503,0.00022990221307816
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.0107210926697895,0.00291383994202479,-0.0164322189561581,-0.00500996638342089,0.000234741898539559
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.019129264815682,0.00520851745691536,0.0089205706001279,0.0293379590312361,0.000240812730659416
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAVL4,ELAV-like protein 4,36991,0.0309267981326518,0.00843024778934343,0.0144035124655387,0.0474500837997649,0.00024489314271093
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST6,Cystatin-M,39524,0.0171234242530968,0.00467093548069964,0.00796839071092546,0.0262784577952681,0.000247234867755123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCC1,Regulator of chromosome condensation,37368,0.0184679557722377,0.00505231600845976,0.00856541639565654,0.0283704951488188,0.000257810760843297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYMP,Thymidine phosphorylase,39764,0.024667006632773,0.00675152306570462,0.0114340214239919,0.037899991841554,0.000259473799501278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0102989935206247,0.00282327784358115,0.00476536894720565,0.0158326180940438,0.000265406413291342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEO1,Neogenin,37411,0.00783170397130087,0.00215399412932009,0.00360987547783349,0.0120535324647683,0.000278039802940198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWF,von Willebrand factor,40052,-0.0264456669797147,0.00727747943153678,-0.0407095266655268,-0.0121818072939026,0.000280027660824491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0128356876700516,0.00353684745394723,-0.0197679086797881,-0.005903466660315,0.000285252054547434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0157322372917688,0.0043410102142197,0.00722385727189819,0.0242406173116394,0.000290894124077019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0199294173455143,0.00551466339559562,0.00912067709014689,0.0307381576008817,0.000302724945196194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECM1,Extracellular matrix protein 1,37106,0.0130364823306515,0.00360948024115172,0.00596190105799416,0.0201110636033089,0.000305280976074637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON1,Spondin-1,39885,0.0114441630744963,0.00317076700717056,0.005229459740442,0.0176588664085506,0.000307992315354776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0125072529847033,0.00347247964059811,0.00570119288913105,0.0193133130802756,0.000316940585769896
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0207266679821129,0.00576133944702188,0.00943444266595005,0.0320188932982758,0.000322229428265887
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL28,C-C motif chemokine 28,39815,0.0212893807073264,0.00593565880788181,0.00965548944387808,0.0329232719707748,0.000335900580116537
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.019531944480153,0.0054488511989475,0.00885219613021588,0.0302116928300901,0.000338625908036545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0139715020012489,0.0039115850541947,-0.0216382087074705,-0.00630479529502726,0.000355727103161922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.066427695247852,0.0186086005952357,0.0299548380811901,0.102900552414514,0.000358398707974183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPP1,Osteopontin,40012,-0.0159843856994725,0.00448241989011774,-0.0247699286841032,-0.00719884271484171,0.000363495278505041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNXB,Tenascin-X,39858,-0.00911733903611563,0.00256049432493031,-0.014135907912979,-0.00409877015925222,0.000370837637981143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0078614914792664,0.00221619043620338,0.00351775822430777,0.012205224734225,0.000390316155754397
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO4,Roundabout homolog 4,37043,-0.00631376160408524,0.00178143060486024,-0.00980536558961131,-0.00282215761855917,0.000395156602797068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK2,Protein AHNAK2,37043,0.0103702450510431,0.002930657673486,0.00462615601101049,0.0161143340910756,0.000403732881923973
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG1,Arginase-1,39754,0.0182168157991061,0.00514970967008702,0.00812338484573549,0.0283102467524766,0.000405169403099194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0202812247128181,0.00574555870244227,-0.031542519769605,-0.00901992965603128,0.000417142711514604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0161309836997132,0.0045749065474316,-0.0250978005326791,-0.00716416686674722,0.00042312509719204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNLY,Granulysin,39858,0.0178595803760572,0.00507343978422567,0.00791563839897486,0.0278035223531395,0.000432401829674989
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSC2,Desmocollin-2,39673,-0.011658367304457,0.00331515021536248,-0.0181560617265674,-0.0051606728823465,0.000438182430926054
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPTC,Opticin,39788,-0.0154168839221688,0.00438745509056597,-0.0240162958996781,-0.00681747194465952,0.000442877677101415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0154511097243125,0.00440694916921026,0.00681348935266041,0.0240887300959646,0.000456011998545174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH4,Myosin-4,37021,-0.0166151400280745,0.00476434176169265,-0.0259532498809921,-0.00727703017515689,0.000489342980818238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL4,Delta-like protein 4,37043,0.0299497049159333,0.00859841503293004,0.0130968114513904,0.0468025983804762,0.000497128758822897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0256868893314441,0.00737603525726893,0.011229860227197,0.0401439184356912,0.000498414055646218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0208291869989113,0.00599573509826728,0.00907754620630747,0.0325808277915152,0.000514126240794586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.00599833810293949,0.00173325446001294,-0.00939551684456485,-0.00260115936131412,0.00054010592623395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0125486913853334,0.00363158140401239,0.00543079183346908,0.0196665909371976,0.000551094938092766
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0201072236871325,0.00582086444551724,0.00869832937391866,0.0315161180003463,0.000553102811220362
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX2,Peroxiredoxin-2,37249,0.0209397991389544,0.00606590116586233,0.00905063285386423,0.0328289654240446,0.000558061262668348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0177986315278844,0.0051731280597784,0.00765930053071878,0.0279379625250501,0.000582220895100336
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0113218840009853,0.00329604261958838,0.00486164046659211,0.0177821275353786,0.000594069665021783
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0108958787424025,0.00317546984247741,-0.0171197996336582,-0.00467195785114674,0.000602604661851389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00926762197051598,0.00270416972271163,0.00396744931400118,0.0145677946270308,0.000611745552875192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.0074600716417954,0.00217727018369772,-0.0117275212018429,-0.00319262208174787,0.000613634773330699
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF1,Trefoil factor 1,39789,0.025625317089954,0.00748937580170882,0.0109461405186047,0.0403044936613033,0.000624203181843411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0221295638783817,0.00647450430056761,0.00943953544926921,0.0348195923074942,0.000632841043723154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0102004526088322,0.00298723083600369,-0.0160554250473994,-0.00434548017026495,0.00064049336975115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0142318953269472,0.00416825124359267,0.00606212288950562,0.0224016677643889,0.000640895418063628
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0116909140229751,0.00342915611848784,0.00496976803073889,0.0184120600152112,0.000652970023839965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUK1,Guanylate kinase,37021,-0.0140389329773792,0.00413121143149754,-0.0221361073831144,-0.00594175857164405,0.000680167795416615
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACHE,Acetylcholinesterase,37124,0.0110692510544981,0.00325986521794808,0.00467991522731983,0.0174585868816763,0.000686750891897884
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0239875688224547,0.00706484543967413,0.0101404717606934,0.037834665884216,0.000687078386559155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBB,Inhibin beta B chain,37124,0.0167352543700277,0.00493377030967143,0.00706506456307167,0.0264054441769837,0.000695919465088238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD9,COMM domain-containing protein 9,37368,0.0132626177373158,0.00391593951001196,0.00558737629769233,0.0209378591769392,0.000709070498761497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO6,Unconventional myosin-VI,37411,0.0127946019276456,0.00380460890577042,0.0053375684723356,0.0202516353829556,0.000773357564247773
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0207622934237379,0.00618501802189741,0.008639658100819,0.0328849287466568,0.000790140626104415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0365573561688575,0.0109301985756978,0.0151341669604898,0.0579805453772252,0.000826250724252798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF2,Trefoil factor 2,39908,0.0189724213320841,0.00567982274893643,0.00783996874416868,0.0301048739199995,0.000838729077729692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0233965536686148,0.00700426903875383,0.00966818635265732,0.0371249209845723,0.000839096646186031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0244423535758568,0.00731918797123529,0.0100967451522356,0.0387879619994779,0.000841584274803403
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.0115092316517265,0.00344661238112486,-0.0182645919187312,-0.00475387138472176,0.000842272036140122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0230768435627681,0.00691788582840341,-0.0366358997864388,-0.00951778733909743,0.000852465781930497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0159182682320479,0.00477845826817502,0.00655249002642483,0.0252840464376709,0.000866541346698202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRELP,Prolargin,39862,0.00734949554839276,0.00220802511415542,0.00302176632464813,0.0116772247721374,0.000875000941351508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.013134452553163,0.00394649763761303,0.00539931718344144,0.0208695879228845,0.000876333421853078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.0119569702766487,0.00360772947151674,0.00488582051247587,0.0190281200408215,0.000921337667559901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.0108594417594299,0.00329130119138978,-0.0173103920945539,-0.00440849142430592,0.00097091482788623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0152550084706785,0.00462583108721031,0.00618837953974629,0.0243216374016107,0.000977081842741957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKCQ,Protein kinase C theta type,39587,0.014193366628877,0.00432129316159563,0.00572363203214954,0.0226631012256044,0.00102380121689161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.029365690730896,0.00896439255438641,0.0117954813242986,0.0469359001374933,0.00105629370178959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAG,S-arrestin,36991,-0.0173016431837504,0.00530262200437587,-0.0276947823123271,-0.00690850405517375,0.00110580907494106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00923481289563496,0.00283659374905815,0.00367508914748098,0.0147945366437889,0.00113431974695287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00913686280046537,0.00280700997989809,0.00363512323986511,0.0146386023610656,0.00113670138487923
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0108499003947996,0.00333466486331843,0.00431395726269549,0.0173858435269037,0.00114162669172364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RYR1,Ryanodine receptor 1,37021,-0.0109293783175787,0.00337516110977772,-0.0175446940927431,-0.00431406254241441,0.00120593126132054
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0137878349646385,0.0042729312918022,-0.0221627802965708,-0.00541288963270619,0.00125495987172963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXTL1,Exostosin-like 1,37021,0.0153260210827642,0.00476080223309467,0.00599484870589864,0.0246571934596297,0.00128856146324558
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,0.0387529858571867,0.0120631937220742,0.0151091261619213,0.062396845552452,0.0013190188232225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0134419012432817,0.00418617398621138,0.00523700023030734,0.021646802256256,0.00132580227696213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0138437132426588,0.0043221552072196,-0.0223151374488092,-0.00537228903650838,0.00136343682503716
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0174276892087036,0.00545217683881791,0.00674142260462048,0.0281139558127867,0.00139399736496486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCLRE1C,Protein artemis,36962,-0.00986511722083849,0.00309296411853489,-0.0159273268931669,-0.00380290754851011,0.0014283737978676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0323971831885529,0.0101807575994637,0.0124428982936042,0.0523514680835017,0.00146443333532741
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH12,Protocadherin-12,37411,0.00801388426007382,0.0025232940687346,0.00306822788535401,0.0129595406347936,0.00149675509425076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAN,Brevican core protein,39749,-0.0105165372146539,0.00331416115402932,-0.0170122930765514,-0.00402078135275643,0.0015104935424657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0117687798511036,0.00373853589621585,-0.0190963102076866,-0.00444124949452052,0.00164778074707454
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0219594762437623,0.00698108883424885,0.00827654212863453,0.03564241035889,0.0016607656111288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBN,Ameloblastin,39587,-0.00892179397859695,0.00284327058589201,-0.0144946043269453,-0.00334898363024861,0.00170498584639468
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.011128972041954,0.00354809722064328,0.00417470148949317,0.0180832425944148,0.00171234822785218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHB,Lutropin subunit beta,39477,0.0276155790300776,0.00881793999019319,0.0103324166492989,0.0448987414108562,0.00174088915201563
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0187014161603869,0.00597350339482827,0.00699334950652345,0.0304094828142503,0.00174754004923268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0113733732789483,0.0036364623805483,0.00424590701307366,0.018500839544823,0.00176627984478157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0157692774968947,0.00504199232900427,0.00588697253204637,0.0256515824617431,0.00176631012959421
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD109,CD109 antigen,39858,-0.010492887642089,0.00335934868166182,-0.0170772110581462,-0.00390856422603186,0.00179039736803326
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0185249682022054,0.00594003536551832,0.00688249888578951,0.0301674375186213,0.00182067411032307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00920266891709041,0.00295445087932728,0.00341194519360895,0.0149933926405719,0.00184364074840444
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0278313111141819,0.00896182261436028,-0.045396483438328,-0.0102661387900357,0.00190335465434637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.010666637635997,0.00344096457310397,0.00392234707271328,0.0174109281992808,0.00193922498472347
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00574192339949127,0.00185691888198034,0.0021023623908098,0.00938148440817273,0.0019909606519077
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00978275711224166,0.00316729783673159,-0.0159906608722356,-0.00357485335224775,0.00201468613656392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0150922253067498,0.00488892878628573,-0.0246745257278698,-0.00550992488562975,0.0020251786576486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPJ,Centromere protein J,37169,0.0223132140032805,0.00724080988441693,0.00812122662982334,0.0365052013767377,0.00206318032814265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0121792604758464,0.00395839820227967,0.00442079999937825,0.0199377209523146,0.00209654440030747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA7A,Semaphorin-7A,40002,0.00824126095418218,0.00268289162385165,0.00298279337143295,0.0134997285369314,0.00213138387798971
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0149729793705244,0.00488307898042349,0.00540214456889435,0.0245438141721544,0.00217096617141196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0173748128932225,0.00567883521766571,0.00624429586659774,0.0285053299198473,0.00222025566480545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.00857535980384312,0.00280371214404983,0.00308008400150545,0.0140706356061808,0.00222759337188976
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG3,Secretogranin-3,39885,-0.00986902958743925,0.00322704392645341,-0.0161940356832879,-0.00354402349159057,0.00223018781481921
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00246236661057229,0.000805998431196065,-0.00404212353571658,-0.000882609685428005,0.00225464545270599
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0124287407679983,0.00406925776937098,-0.0204044859959654,-0.00445299554003117,0.00226038046839029
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF3,Neurotrophin-3,39866,0.0102408687675813,0.00335418005607345,0.00366667585767735,0.0168150616774853,0.00226812191762987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.00971750895170298,0.00318537860589833,0.00347416688414225,0.0159608510192637,0.00228791742299944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD48,CD48 antigen,39908,0.00878690390547746,0.00288180028193832,0.00313857535287835,0.0144352324580766,0.00229900160540609
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.0084656076176594,0.00277761359682926,-0.0139097302674447,-0.00302148496787404,0.00230981336770724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0142111164032317,0.00466629348282234,-0.0233570516295635,-0.00506518117689991,0.00232681643757899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMOD4,Tropomodulin-4,36962,-0.0123823169684736,0.00406575207347097,-0.0203511910324767,-0.00441344290447051,0.00232742138909921
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSN,Gelsolin,37383,-0.0056612073496056,0.00185899471505132,-0.00930483699110618,-0.00201757770810501,0.0023289115489319
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF8,SLAM family member 8,39477,0.0157179295461038,0.0051850561804487,0.00555521943242433,0.0258806396597832,0.00243829138616438
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BEX3,Protein BEX3,36962,-0.0141102517367059,0.00466475325471994,-0.023253168115957,-0.00496733535745484,0.00249225653329262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB1,Lamin-B1,37348,0.0174951413083035,0.00578530787328938,0.00615593787665634,0.0288343447399507,0.00249872684862386
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.013660396904687,0.00452113154529327,0.0047989790759122,0.0225218147334618,0.00252033663509197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY6D,Lymphocyte antigen 6D,39761,0.0108491018215464,0.00360092816795452,0.00379128261235557,0.0179069210307373,0.0025920329043145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN1,Nectin-1,37056,0.00960314960672409,0.00320028197967072,0.00333059692656949,0.0158757022868787,0.00269845529624453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0180589988157179,0.0060337272627605,0.00623289338070737,0.0298851042507285,0.00276670793662964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0108289919768975,0.00362503538432427,0.00372392262362191,0.0179340613301731,0.00281912854190378
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP10,Bone morphogenetic protein 10,37124,-0.00840741484606187,0.00281932577847738,-0.0139332933718775,-0.0028815363202462,0.00286830757718259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00903951179882475,0.00303796524162683,0.00308509992523616,0.0149939236724133,0.00292944275383111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPS,Calcyphosin,37388,0.0258083216222117,0.0086775145425609,0.00880039311879238,0.0428162501256311,0.00294309674701233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00770265526570215,0.00259042416971518,0.00262542389306039,0.0127798866383439,0.00294854492999995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0117668071920359,0.00396015875617116,-0.0195287183541313,-0.0040048960299404,0.00297064528644411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRAXIN,Draxin,39749,0.0124293270229839,0.00418581562649854,0.00422512839504679,0.0206335256509211,0.00298835394191958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0124284771629519,0.00418717206562219,0.00422161991433244,0.0206353344115714,0.00300055662614277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.00688801725157891,0.00233996089070438,-0.0114743405973595,-0.00230169390579834,0.003248309648507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD160,CD160 antigen,40058,0.0131430213965543,0.00446649651645437,0.00438868822430377,0.0218973545688049,0.00325951444277062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00892907169452032,0.00303625676677305,-0.0148801349573955,-0.00297800843164514,0.0032782936226913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.0107135351230414,0.00364440893695648,-0.0178565766394761,-0.00357049360660667,0.00329081978907457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA10,Annexin A10,39489,0.0229551901107476,0.00780997867929516,0.00764763189932907,0.0382627483221661,0.00329528291818503
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0208106129939126,0.00712459226429108,-0.0347748138319231,-0.00684641215590206,0.00349554287004335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0284546005380413,0.00976217964167378,0.00932072844036064,0.0475884726357219,0.003565421436022
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB1A1,Uteroglobin,39903,0.0158140294677283,0.00544615475765307,0.00513956614272828,0.0264884927927283,0.00369277683681763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00629070490929511,0.00217027780912565,-0.0105444494151814,-0.00203696040340884,0.0037546721229604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0845858562134864,0.0292742340469919,0.0272083574813823,0.14196335494559,0.00386458869650944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.0109358363580106,0.0037882590333168,-0.0183608240633116,-0.00351084865270972,0.00389744675165298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH7B,Myosin-7B,36962,-0.0126530144526949,0.00438513839053374,-0.021247885698141,-0.00405814320724873,0.00391515910982123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00700079536882215,0.00243066846687856,-0.0117649055639041,-0.00223668517374018,0.00397958583921344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NINJ1,Ninjurin-1,39477,0.0161990878069495,0.005624404113877,0.00517525574375055,0.0272229198701484,0.00398035439280414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL,Podocalyxin,39788,0.00430150997062892,0.00149589111944068,0.00136956337652517,0.00723345656473266,0.00403858677549311
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0145511168199526,0.0050628091252989,-0.0244742227055384,-0.00462801093436675,0.00405804899171596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0126311327397492,0.00441380564481898,-0.0212821918035945,-0.00398007367590405,0.00421988734114069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0112977702653547,0.00396495874692083,-0.0190690894093195,-0.00352645112138987,0.00438674283335845
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL19,Interleukin-19,39419,0.0194744376981634,0.00683808691120002,0.00607178735221133,0.0328770880441154,0.00440613586695379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00935739624053025,0.00328666352884696,-0.0157992567570703,-0.0029155357239902,0.00441780931243947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KEL,Kell blood group glycoprotein,39489,0.0100633614927019,0.00353669946169911,0.00313143054777166,0.0169952924376322,0.00444119097675334
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00816292909945993,0.00287355936858246,-0.0137951054618816,-0.00253075273703831,0.00450834525249489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0172051848087762,0.00612618015350316,0.00519787170791004,0.0292124979096424,0.00498404443224763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00883998698399722,0.00314819195905182,-0.0150104432237388,-0.00266953074425565,0.00499165661285997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00786565257172192,0.00280883092527283,-0.0133709611852567,-0.00236034395818717,0.0051125026202575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.041641635886873,0.0148744138847144,0.0124877846728328,0.0707954871009132,0.00512354756494346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0180450826027843,0.00646484047728604,0.00537399526730364,0.0307161699382649,0.00525759397613947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0146515309694669,0.00525662450444894,0.00434854694074695,0.0249545149981868,0.00532326581265979
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00825450109784112,0.0029625993420936,0.00244780638733767,0.0140611958083446,0.00534001492047792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0146149628801838,0.00525769305164388,-0.0249200412614058,-0.00430988449896179,0.00544816420593593
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP7,Retinoid-binding protein 7,37382,0.0166878516403716,0.00601378807756678,0.00490082700834067,0.0284748762724024,0.00552890898391434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0117921235932237,0.00425146464920458,0.00345925288078269,0.0201249943056647,0.00555077375541567
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH23,Cadherin-23,37388,-0.00742497594272538,0.00267856799818519,-0.0126749692191684,-0.00217498266628241,0.00557901295933099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,37056,0.0153172853032194,0.00552967853032894,0.00447911538377463,0.0261554552226641,0.00561322889830016
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00949572697064309,0.00342860348642505,0.00277566413724998,0.0162157898040362,0.00561968076397562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGA,Chromogranin-A,37437,-0.0216047281690418,0.00781805015361406,-0.0369281064701253,-0.0062813498679582,0.00572722997575092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0169607064300161,0.00614673969453922,-0.029008316231313,-0.00491309662871925,0.00580053562473339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0332597331559004,0.0120742105542481,0.00959428046957421,0.0569251858422266,0.00588297996937365
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00808247339932355,0.00293778795867755,0.00232440900031555,0.0138405377983316,0.00594565473141414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00801730140253803,0.00292067946884464,0.00229276964360254,0.0137418331614735,0.00605753227311624
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00812596474363377,0.00296532654200555,0.00231392472130288,0.0139380047659646,0.00614605955958019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EP300,Histone acetyltransferase p300,37056,0.008077140139429,0.0029518408620651,0.0022915320497814,0.0138627482290766,0.00622163099451229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0187280939814196,0.00685384342007083,0.00529456087808079,0.0321616270847584,0.00629395405706067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.0058185262515753,0.00213252378764785,0.00163877962778551,0.0099982728753651,0.00637111667983392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00908025386458527,0.00333156162789717,0.00255039307390683,0.0156101146552637,0.00642840147019919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0143821014307971,0.00529462392820497,0.00400463853151533,0.0247595643300788,0.00660903327635133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.00960642246611136,0.00355734022613161,0.00263403562289341,0.0165788093093293,0.00693315892608437
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171B,Protein FAM171B,37368,0.00742015500958605,0.00276539938739076,0.00199997221030015,0.0128403378088719,0.00730073903211163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALB,Ras-related protein Ral-B,37056,0.0078225967269275,0.00291752917221892,0.00210423954937843,0.0135409539044766,0.00734410384606808
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.0152806566667819,0.00570172283087233,0.00410527991827211,0.0264560334152917,0.00736950912837598
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0140768689200352,0.00525496767388075,0.00377713227922895,0.0243766055608415,0.00739840271956421
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0172922341191144,0.00645796857686984,-0.0299498525297792,-0.00463461570844948,0.00742147871955532
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0186154782395908,0.00697828406832098,0.00493804146568172,0.0322929150134999,0.00764658472682515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0126369499719722,0.0047412323196161,-0.0219297653184198,-0.00334413462552466,0.00770066221968931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00765580657668811,0.00287539020371705,-0.0132915713759735,-0.00202004177740269,0.00776503201059241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAV,Integrin alpha-V,40030,-0.00438390038302538,0.00164675582274768,-0.00761154179561084,-0.00115625897043992,0.00777215584226713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAN,Aggrecan core protein,39730,0.00747071744122916,0.00280674249014723,0.00196950216054058,0.0129719327219177,0.00778245437462676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.00671836185606662,0.00252632089397078,0.00176677290388388,0.0116699508082494,0.00783706281688344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00533570646206522,0.00201138813632354,-0.00927802720925935,-0.00139338571487108,0.00799351928932607
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.00593048074658653,0.00223761641392898,-0.0103162089178873,-0.00154475257528572,0.00804862061354332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL3,Myosin light chain 3,37043,-0.01912382542753,0.00727510572033429,-0.0333830326393853,-0.00486461821567483,0.00858198314322012
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0109199859769074,0.00416028718250738,0.00276582309919291,0.0190741488546218,0.00867965815731448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00808174808756389,0.00308434877781296,-0.0141270716920773,-0.00203642448305049,0.00879489616034316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00864050787909868,0.00329792658928014,-0.0151044439940878,-0.00217657176410961,0.00880322938021009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.0088510678797022,0.00337831027903521,-0.0154725560266112,-0.00222957973279318,0.00880384046337472
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.0144852270947242,0.00556789266144324,0.00357215747829542,0.0253982967111529,0.00929042008371583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN5,Contactin-5,39897,-0.00932313030100555,0.00358472809168893,-0.0163491973607158,-0.00229706324129525,0.00930943218153856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0160962336402234,0.00621304113711402,0.0039186730114799,0.0282737942689669,0.00958817485744118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00583189541971366,0.00225493102157343,0.00141223061742974,0.0102515602219976,0.00971029749811596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00969033309392399,0.00376469892416498,0.00231152320256062,0.0170691429852874,0.0100623300594381
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.0105140110379381,0.0041054896263384,-0.0185607707055614,-0.00246725137031488,0.0104492677654674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0148782999891146,0.00582067185780748,0.00346978314781196,0.0262868168304173,0.0105958540199909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.0142209970850388,0.00558220450674763,-0.0251621179182641,-0.00327987625181343,0.0108571149124511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POF1B,Protein POF1B,37056,0.0114599495827202,0.00451275052375237,0.0026149585561656,0.0203049406092749,0.0111137494559909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESPL1,Separin,36962,-0.0136075611111431,0.00536299918774584,-0.024119039519125,-0.00309608270316127,0.011182473554387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GL3,Endophilin-A3,37083,0.0208894473190248,0.00823407026042733,0.00475066960858728,0.0370282250294624,0.0111935989125774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00681842120437079,0.0026902614728564,0.00154550871757225,0.0120913336911693,0.011270711818729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB2,Integrin beta-2,39731,-0.00725630165622759,0.00286327797388648,-0.0128683264850451,-0.00164427682741008,0.0112779179418486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.0050810045519211,0.00201024765168311,0.00114091915462219,0.00902108994922,0.0114956005165303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.0197212518746535,0.00781333198398488,0.00440712118604314,0.0350353825632639,0.0116106581554237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOC,Myocilin,39858,-0.0115250803724166,0.00457531261997247,-0.0204926931075627,-0.00255746763727057,0.0117794972828371
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDRG1,Protein NDRG1,39489,0.01737355677106,0.00690436037439565,0.00384101043724448,0.0309061031048754,0.0118687918507432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.012558214467786,0.00499423321374751,0.00276951736884092,0.0223469115667312,0.0119301842314732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL2,Chordin-like protein 2,39868,0.0140722373653673,0.00561218870048468,0.0030723475124173,0.0250721272183172,0.0121706762897577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00702893915248853,0.00280610567446568,0.00152897203053579,0.0125289062744413,0.0122593833969006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK15,Kallikrein-15,37351,0.0125845128983602,0.0050280005714036,0.00272963177840913,0.0224393940183112,0.0123302457497292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0156166748571899,0.00625863476797594,-0.0278835990024227,-0.00334975071195704,0.0126000187582594
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36A,Interleukin-36 alpha,37056,-0.0146185040905415,0.00586976469192735,-0.0261232428867191,-0.00311376529436391,0.0127694376170356
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPN1,Epsin-1,37169,0.0106688051975998,0.00429475909631447,0.00225107736882348,0.0190865330263762,0.0129984899630516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00664309491147837,0.00267907455563561,0.00139210878243257,0.0118940810405242,0.0131625304883637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM1,Myomesin-1,36991,0.0116933966415454,0.00472972593915885,0.00242313380079408,0.0209636594822968,0.0134364993300085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPS,Colipase,39836,0.0169805720328874,0.00689507386914499,0.0034662272493632,0.0304949168164116,0.0137995850953838
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR4,Proline-rich protein 4,37031,-0.0171320682970573,0.00696832329649109,-0.0307899819581798,-0.00347415463593477,0.0139621674880547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0124173246428025,0.00505924969949754,0.00250119523178727,0.0223334540538176,0.0141256633967359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00871688297415612,0.00355227671294613,0.0017544206167817,0.0156793453315306,0.0141446378917307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN15,Tetraspanin-15,37021,-0.012061209593518,0.00492426165744943,-0.0217127624421189,-0.0024096567449171,0.0143246213787079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1B,Lithostathine-1-beta,40052,0.0132367342655359,0.00541223747955458,0.00262874880560893,0.0238447197254629,0.014467509624467
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0099314550629137,0.00407111205838221,-0.0179108346973428,-0.00195207542848456,0.0147209449483541
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.0112150801967077,0.00460037331248651,0.00219834850423414,0.0202318118891813,0.0147873658725395
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0209603667912247,0.00861814563955952,0.00406880133768808,0.0378519322447614,0.0150240239969059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNN,Tenascin-N,37437,0.0103788856450392,0.0042873910144573,0.00197559925670292,0.0187821720333755,0.0154997270166544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBLN2,Fibulin-2,37437,-0.00724197435119589,0.00301963807032331,-0.0131604649690296,-0.0013234837333622,0.0164851320095025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_DRA,,39799,-0.0084680984461457,0.00353486710538422,-0.0153964379726988,-0.00153975891959263,0.0166050239225137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0116044694129586,0.00484451705381747,-0.0210997228384408,-0.00210921598747631,0.0166144852681086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.00604551464031722,0.00252502752992483,0.00109646068166456,0.0109945685989699,0.0166662765215989
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.011729178232176,0.00490091770172266,-0.0213349769275524,-0.00212337953679955,0.0167107667596361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.0116774232537867,0.00489150798250504,-0.0212647788994966,-0.00209006760807682,0.0169872836172874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0151023690541802,0.00633253001319399,0.00269061022831994,0.0275141278800404,0.0170984352934366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.00862689651242852,0.00362209562434104,0.00152758908872009,0.0157262039361369,0.0172450777996071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX33,Testis-expressed protein 33,37169,-0.00943097722288221,0.00395976605724835,-0.017192118695089,-0.00166983575067544,0.017246871874489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0305513589099615,0.0128527623481251,-0.0557427731122866,-0.00535994470763634,0.0174644063341547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00647807590320904,0.00272832706125939,0.00113055486314063,0.0118255969432774,0.0175901989200609
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00628471395852856,0.0026540308660015,-0.0114866144558915,-0.00108281346116562,0.0178994481524553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00849347110625253,0.00360217289040011,0.00143321224106831,0.0155537299714367,0.0183940654932975
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,37124,0.00928412954567106,0.00394527693153089,0.00155138675987051,0.0170168723314716,0.0186258185195361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRTN,Neurturin,39587,0.0115873435587374,0.00494712971542469,0.00189096931650496,0.0212837178009697,0.0191810133048415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00757463645615319,0.00323484937651581,-0.0139149412341242,-0.00123433167818221,0.0192175322264171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REST,RE1-silencing transcription factor,36962,-0.00831034886765994,0.00355767616794465,-0.0152833941568315,-0.00133730357848842,0.0195118517154695
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX5,Syntaxin-5,37056,0.00947818750538919,0.00406192915447744,0.00151680636261341,0.017439568648165,0.0196410429367351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGM2,Phosphoglucomutase-2,37039,0.0140401459033831,0.00603978226343315,0.00220217266705409,0.025878119139712,0.0201078709610753
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXDNL,Peroxidasin-like protein,37368,0.0137557099625033,0.00593846514719339,0.00211631827400423,0.0253951016510023,0.0205527120220379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00846593729194418,0.00365787521091686,-0.0156353727053412,-0.00129650187854714,0.0206588457923986
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.00783982827012179,0.00338837943853792,0.00119860457058747,0.0144810519696561,0.0206946025641303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.0070678752248409,0.00305581451783886,0.00107847876987673,0.0130572716798051,0.0207395042278213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00693262129723321,0.00300941476536733,-0.0128310742373532,-0.00103416835711325,0.0212553728627399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.0073068300737245,0.00317846254224967,0.00107704349091515,0.0135366166565338,0.0215282170990689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.015976761073627,0.00695028765499882,0.00235419726982934,0.0295993248774247,0.0215335522632114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFAP,Glial fibrillary acidic protein,39453,0.00997319165120235,0.00435759109688216,0.00143231310131331,0.0185140702010914,0.0221104608108668
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,37382,0.0181094041554037,0.00791309130589777,0.00259974519584409,0.0336190631149633,0.0221216056334836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.0085542397329743,0.00373873312575448,0.00122632280649551,0.0158821566594531,0.0221529758547345
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0128597194254896,0.00562054998627876,0.00184344145238324,0.023875997398596,0.0221543289854289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC1,Hamartin,37056,0.0174259231507157,0.00762301517236687,0.00248481341287664,0.0323670328885548,0.0222722569832243
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0162821769613902,0.00714615526457791,-0.0302886412799629,-0.00227571264281746,0.0227155683917949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0126777951576017,0.00556479077324337,-0.0235847850731587,-0.00177080524204472,0.0227268389173819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00470684320906226,0.00207098840026247,0.000647705944547813,0.00876598047357671,0.0230543860534698
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL11,Interleukin-11,39587,0.0140724045727903,0.00620100710202019,0.00191843065283068,0.0262263784927498,0.02325907055574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEG1,Protein LEG1 homolog,36703,-0.0158187891360187,0.00697801373592843,-0.0294956960584384,-0.00214188221359899,0.0234100003021405
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.00701736789525345,0.00310149659529805,-0.0130963012220376,-0.00093843456846927,0.0236781231997772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.0105820650095766,0.00470880028848779,-0.0198113135750126,-0.00135281644414051,0.0246376321003876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERVV_1,,37021,-0.0107748142884927,0.00479805880197533,-0.0201790095403644,-0.00137061903662111,0.0247422454152554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTNNA1,Catenin alpha-1,36991,-0.00785937707511239,0.00350533108491841,-0.0147298260015525,-0.000988928148672318,0.0249701666014974
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPE4,NXPE family member 4,37021,-0.00781310838328969,0.00348534106311853,-0.014644376867002,-0.000981839899577372,0.0249970039482411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0138164423831253,0.00617940337452217,0.0017048117690618,0.0259280729971887,0.0253732036556919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00738971845090627,0.00331258050702127,-0.013882376244668,-0.000897060657144586,0.0257079105255215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00742407339140044,0.00333669499853812,-0.0139639955885352,-0.000884151194265712,0.0260995921035734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0125255928279184,0.00562955569582147,-0.0235595219917284,-0.00149166366410828,0.0261001730226571
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00834327046773543,0.00376048308455898,0.00097272362199982,0.015713817313471,0.0265257514881893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00443486322247199,0.00200951486192557,0.000496214093097871,0.00837351235184612,0.0273359426083815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCG22,Protein PBMUCL2,37021,-0.0118853591444347,0.00540416984006946,-0.0224775320309708,-0.00129318625789855,0.027874341999941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00554832359977077,0.002528609883595,-0.010504398971617,-0.000592248227924561,0.0282366199015616
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00499547625882735,0.0022904163586856,-0.00948469232185114,-0.000506260195803574,0.0291985035699811
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.00729587231760999,0.00334977090943225,0.000730321335122777,0.0138614233000972,0.0294190073263536
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00878230793386919,0.00403451262591986,-0.0166899526806721,-0.000874663187066268,0.0295135605355458
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00783251300359384,0.00360653053653762,0.000763713151980114,0.0149013128552076,0.0298916595048902
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MELTF,Melanotransferrin,37437,0.00629473290536131,0.00289884524131827,0.000612996232377503,0.0119764695783451,0.0299135085133246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00744307086548513,0.00343158817757276,-0.0141689836935277,-0.00071715803744253,0.0301014530849734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.0117141541586811,0.00540973250740676,0.00111107844416381,0.0223172298731983,0.0303730016815516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.00632791241345291,0.00292459627415006,0.000595703716118796,0.012060121110787,0.0305057967082533
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKAP12,A-kinase anchor protein 12,37124,-0.00452918197945522,0.00210284083329677,-0.00865075001271689,-0.00040761394619355,0.0312707082965416
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0097226960905273,0.00454219569877711,0.00081999252092417,0.0186253996601304,0.0323274706954913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MN1,Transcriptional activator MN1,37039,-0.012633085791374,0.00590358329967114,-0.0242041090587294,-0.00106206252401854,0.0323810488260148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDS,Iduronate 2-sulfatase,40058,0.00191502347377999,0.000897006925928768,0.000156889898959601,0.00367315704860037,0.0327838333850933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO1,Alpha-enolase,39830,0.0167493425784914,0.00787328038918362,0.00131771301569145,0.0321809721412913,0.0334050313352251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0127014832828303,0.00597209953481353,-0.0244067983710649,-0.00099616819459581,0.0334514954301745
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GKN1,Gastrokine-1,39123,0.00595068319400607,0.00279960747760217,0.000463452537905818,0.0114379138501063,0.0335574281500824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.0110333468845939,0.00519303733587593,0.000854993706277087,0.0212117000629107,0.0336348478341282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00861240313256663,0.00406652044649928,-0.0165827832077052,-0.000642023057428033,0.0342005420794388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0123623255376369,0.00584606632087525,-0.0238206155265524,-0.00090403554872143,0.0344758823629136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.00732774358111089,0.00346739186724308,0.000531655521314455,0.0141238316409073,0.0345879654867582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.0078804739271641,0.00374248166809658,0.000545209857694805,0.0152157379966334,0.0352507859136253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0126824711069069,0.00603353309364891,-0.0245081959704588,-0.000856746243355022,0.0355693606559831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUCL3,Mucin-like protein 3,36962,-0.00941601238718187,0.00448338272656799,-0.0182034425312551,-0.000628582243108614,0.0357300836491652
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00682609163706953,0.00325452527790116,0.000447222092383262,0.0132049611817558,0.0359728355460113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0142785793504258,0.006822812729886,0.000905866399849293,0.0276512923010024,0.0363887210770163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0167622507594634,0.0080157210413271,-0.0324730640004645,-0.00105143751846229,0.0365318681890947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0184922739342413,0.00884899333242725,0.00114824700268384,0.0358363008657987,0.0366584967242355
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0180837669823271,0.00876976707679701,0.000895023511804937,0.0352725104528492,0.0392187338835328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0141675106806275,0.00687564902701236,0.000691238587683307,0.0276437827735718,0.0393640017206948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0131327999368491,0.00642865686750208,-0.0257329673971531,-0.000532632476544986,0.0410867106729496
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN1,Prorelaxin H1,37411,-0.0164295120270527,0.00804388663867694,-0.0321955298388596,-0.000663494215245922,0.0411228295755867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPE,Coatomer subunit epsilon,39489,0.0095496300571113,0.00471622517810448,0.000305828708026522,0.0187934314061961,0.042900139555789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.007937447200298,0.00392617243727387,0.000242149223241217,0.0156327451773548,0.0432295200717982
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.00998498744343388,0.00495429408363978,-0.0196954038473678,-0.000274571039499922,0.043880863477577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00482339023061848,0.00239408460574997,0.000130984403348535,0.00951579605788843,0.0439514760482805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00640725798147116,0.00318468233535488,0.000165280604175603,0.0126492353587667,0.0442510120827544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00957819995667976,0.00476454218854029,-0.0189167026462187,-0.000239697267140793,0.0444189046448605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0117020362930364,0.00582826305229298,0.000278640710542205,0.0231254318755307,0.0446840880284301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0139409508664728,0.00695132637919037,0.00031635116325968,0.0275655505696859,0.0449284883347935
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.0124552375812932,0.00623078451123952,-0.0246675752233226,-0.000242899939263703,0.0456304005725924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.0103164052664051,0.00517202557450874,0.000179235140367917,0.0204535753924422,0.046102107148044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0121849574233009,0.00611153800614082,-0.0241635719153369,-0.000206342931264897,0.0461986260838469
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00729724856803696,0.00367413685136413,-0.0144985567967107,-9.59403393632676e-05,0.0470415603272125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00861166741781734,0.00433679533503806,-0.0171117862744919,-0.000111548561142732,0.0470850271881732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKLR,Pyruvate kinase PKLR,39881,0.0126379533832413,0.00636591287392338,0.000160764150351511,0.0251151426161312,0.0471332524154149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00505108695322115,0.00254619285651974,-0.0100416249519998,-6.05489544424614e-05,0.0473004562536066
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGN,Mimecan,39858,0.00780063955939057,0.00393230146716279,9.33286837515113e-05,0.0155079504350296,0.0473025816437197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN2,Contactin-2,40030,0.00875204484219238,0.00441270864525622,0.000103135897490196,0.0174009537868946,0.0473427271813498
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPA33,Cell surface A33 antigen,39788,0.0258518137044816,0.0130629298029771,0.000248471290646569,0.0514551561183167,0.0478308247031744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00586788419401718,0.0029709381729176,-0.0116909230129357,-4.48453750986691e-05,0.0482782120435609
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00908861538025809,0.0046060316548997,-0.0181164374238615,-6.07933366546676e-05,0.048493825424041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00703123596024946,0.00357414497201904,2.59118150921413e-05,0.0140365601054068,0.0491751580035258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG3,Proteoglycan 3,37437,-0.00978754879408779,0.00498431505710282,-0.0195568063060093,-1.82912821662627e-05,0.0495887765600967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.0102924437974364,0.00525388975152859,-0.0205900677104324,5.1801155596682e-06,0.05013237039112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN2,Neuroligin-2,36991,-0.00920842632280683,0.00470426600128259,-0.0184287876853207,1.19350397070478e-05,0.0503142176499621
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31,Interleukin-31,37056,-0.0112165781975563,0.0057313083045009,-0.0224499424743781,1.67860792654826e-05,0.0503601554820389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.0132495634045857,0.00678282995083298,-0.0265439101082183,4.47832990469466e-05,0.0507936083704674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTKN2,Rhotekin-2,37021,-0.0100761313490515,0.0051832648039633,-0.0202353303648196,8.30676667165544e-05,0.0519198846721392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC3,Membrane primary amine oxidase,39931,-0.00580203337529709,0.00299170904669693,-0.0116657831068231,6.17163562288874e-05,0.052473673104918
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00834507194009251,0.00430979109624214,-0.0167922624887271,0.000102118608542087,0.0528516288327268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPLX2,Complexin-2,36962,-0.00577457282874053,0.00299034273521918,-0.0116356445897701,8.64989322890688e-05,0.0534954596428419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD70,CD70 antigen,39866,-0.00808956976212833,0.0042100331604825,-0.016341234756674,0.000162095232417383,0.0546867071477195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00491457574918214,0.0025598374196158,-0.00993185709162911,0.000102705593264824,0.054894271340428
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0145644210370364,0.00761106789682578,-0.0294821141148149,0.000353272040742172,0.0556943217908926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00705692198469332,0.00370267025671475,-0.0143141556878542,0.000200311718467584,0.0566849467104261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.0102869852884293,0.00540805380499705,-0.0208867707462235,0.000312800169364899,0.0571720092241539
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP2,Dipeptidase 2,39788,-0.00549829925117106,0.00289316887868975,-0.011168910253403,0.000172311751060846,0.0573931950651071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.00945384080497104,0.00498253686138409,-0.000311931443341773,0.0192196130532838,0.0577976539851456
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36G,Interleukin-36 gamma,37021,0.0127216124005047,0.00672699701471664,-0.000463301748339957,0.0259065265493493,0.0586292001498844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.0107075205532124,0.00573232199643218,-0.000527830559794698,0.0219428716662195,0.0617947858223996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.0202610380235867,0.0108637763455045,-0.0415540396607756,0.00103196361360211,0.0622017443191694
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA11,Serpin A11,40052,-0.00759429783470874,0.00407531850894152,-0.0155819221122341,0.000393326442816642,0.0624120488998995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0122640940513267,0.00658677894101111,-0.0251741807757085,0.000645992673055078,0.062635863847548
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00865544941420205,0.00465756542354518,-0.000473378815946496,0.0177842776443506,0.0631397275341526
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.00680049442740112,0.00366895084075787,-0.00039064922048431,0.0139916380752866,0.0638291696117231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAND5,DAN domain family member 5,37056,-0.00992633254366962,0.00535652845625897,-0.0204251283179372,0.000572463230597956,0.0638863305209394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0162300994880116,0.00875832146462044,-0.000936210582644495,0.0333964095586676,0.0638896646665374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_A,,37411,0.00596443673460777,0.00322007851826431,-0.000346917161190272,0.0122757906304058,0.0640096002849707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0154727506410588,0.00835505477262912,-0.0318486579954119,0.000903156713294238,0.0640615642153406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00723975568292777,0.0039199189965985,-0.000443285550405301,0.0149227969162608,0.0647818894046487
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0137449499932307,0.00748281644288869,-0.0284112702212925,0.000921370234831168,0.0662518950577181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.0102596267730863,0.00559980146341153,-0.0212352376413729,0.000715984095200347,0.0669530779808007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0154169970246568,0.00844625962545748,-0.00113767184123985,0.0319716658905535,0.0679776894052798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA3,Carbonic anhydrase 3,40017,0.0109505821326896,0.00600372217602517,-0.000816713332319731,0.0227178775976989,0.0681757505233802
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSMB,Beta-microseminoprotein,39780,0.0121500172710564,0.00668446366776321,-0.000951531517759539,0.0252515660598722,0.0691363894295956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.0104376688327237,0.00575819216450837,-0.000848387809712723,0.0217237254751601,0.0699064547012476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAGLN3,Transgelin-3,36962,-0.0108029888985281,0.00596163564923033,-0.0224877947710195,0.000881816973963376,0.0699959886218493
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00882723299359317,0.00488015186687388,-0.018392330652666,0.000737864665479633,0.0705044878036789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00461236227299493,0.00255488932146274,-0.00961994534306191,0.000395220797072046,0.0710494357388485
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00719695124683208,0.0040044505623096,-0.00065177185529474,0.0150456743489589,0.0723165216158792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00844599381992762,0.0047186663478017,-0.0176945798616189,0.000802592221763709,0.0734911666997481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,37437,0.00414667202529755,0.00232003954807561,-0.00040060548893065,0.00869394953952575,0.0739067634207349
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0117767570313136,0.00662968634633912,-0.0247709422701382,0.00121742820751109,0.075695486905109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00862630299566432,0.00486527466529212,-0.0181622413396369,0.000909635348308239,0.0762418783615258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00529951377050866,0.00299664710270268,-0.0111729420918059,0.000573914550788598,0.0770037222586752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00355286391861469,0.00201197939246253,-0.00749634352784124,0.000390615690611859,0.0774391371341567
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.0128057741980797,0.00725279390558888,-0.0014097018568745,0.0270212502530339,0.0774764946158235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00949420799073364,0.00538063065156951,-0.0010518280863426,0.0200402440678099,0.0776647013920187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD82,CD82 antigen,37169,-0.00741339897051545,0.00420276045813648,-0.0156508094684629,0.000824011527432052,0.0777657538014099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,-0.00560995323012645,0.00318644665649408,-0.0118553886768549,0.000635482216601957,0.0783348582528499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0121682544152155,0.00691955952825649,-0.0257305910905982,0.00139408226016726,0.0786806290850718
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.00827109634084638,0.00471422340980086,-0.0175109742240561,0.000968781542363314,0.0793643694059787
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17C,Interleukin-17C,39587,-0.0115481985181191,0.00662049269098786,-0.0245243641924553,0.0014279671562171,0.0811244024114941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00959299365780789,0.0055002055868948,-0.0203733966081217,0.00118740929250592,0.0811622406951009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00814563006650951,0.00467216413925808,-0.00101181164643633,0.0173030717794553,0.0812767402813837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF5,Fibroblast growth factor 5,39587,-0.00575051986102506,0.00330027906670557,-0.012219066831768,0.000718027109717862,0.0814520031426459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOP56,Nucleolar protein 56,37021,0.0191717846450119,0.0110068559481233,-0.00240165301330984,0.0407452223033336,0.0815661258800659
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0448818083601143,0.025796887969087,-0.0954437087795248,0.00568009205929631,0.0819148742049021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00857017128547325,0.0049330296985215,-0.00109856692362889,0.0182389094945754,0.082353259291202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLNL,Mesothelin-like protein,37039,-0.00627294697529932,0.00361969709265475,-0.0133675532769026,0.000821659326303986,0.0831184752221097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00447922321391647,0.00258537383314014,-0.00954655592687114,0.000588109499038203,0.0832037711629834
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00801480206094685,0.00462976500901681,-0.00105953735672609,0.0170891414786198,0.0834490526120928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00624653820202941,0.00360861997513843,-0.0133194333533007,0.00082635694924191,0.0834744654785083
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00805154577318382,0.00465380214676962,-0.00106990643448463,0.0171729979808523,0.0836357504134718
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00981266655727726,0.00568061274471687,-0.00132133442236781,0.0209466675369223,0.0841163618763939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTN3,Myeloblastin,39421,0.00792945422266177,0.004606949164006,-0.00110016613878999,0.0169590745841135,0.0852354648884755
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0103277524385211,0.0060009679255475,-0.0220896495725942,0.00143414469555196,0.0852716441005913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK12,Kallikrein-12,39477,-0.0236179245784357,0.0137288353755454,-0.0505264419145047,0.00329059275763328,0.0853949666368753
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00660742855021993,0.0038414604122105,-0.000921833857712643,0.0141366909581525,0.0854497932276978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.00301348752429425,0.00175496990491312,-0.000426253489335466,0.00645322853792396,0.0859806938948297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLHL41,Kelch-like protein 41,37411,0.00873310607208842,0.00509737147089958,-0.00125774201087475,0.0187239541550516,0.0866881885542623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00643646452248244,0.00377798975178716,-0.0138413244359853,0.000968395391020392,0.0884655358924774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00786077585290592,0.00463125373045638,-0.00121648145878858,0.0169380331646004,0.089653150767938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB5,Integrin beta-5,39913,0.00640477344912995,0.00377809772586131,-0.00100029809355821,0.0138098449918181,0.0900497435863245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH3,Neurexophilin-3,37056,0.0050211986581434,0.00296477658021322,-0.000789763439074512,0.0108321607553613,0.0903615168215814
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00668762493954996,0.00396290285796532,-0.00107966466206207,0.014454914541162,0.0915199714760707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00429484399651807,0.00255730814360861,-0.00930716795799095,0.000717479964954803,0.0930894396011466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WIF1,Wnt inhibitory factor 1,40030,-0.00558001583953598,0.00333790142183758,-0.0121223026263376,0.00096227094726568,0.0946001221738563
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00792096983723303,0.00477882958505703,-0.0172874758239448,0.00144553614947875,0.0974396714864601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0105842193632393,0.00639452130636565,-0.0019490423972374,0.0231174811237159,0.0979037689906591
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00715276681680417,0.00433797590035044,-0.015655199581491,0.00134966594788268,0.0991978437196025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM25,Transmembrane protein 25,37411,-0.00735444690901938,0.00446332003049098,-0.0161025541687817,0.00139366035074294,0.0994266463095173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5A,Cytochrome b5,36962,0.0117631289990003,0.00714441926857801,-0.00223993276741257,0.0257661907654132,0.0996893735846884
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD8,Frizzled-8,36991,0.00694547674254726,0.00424851959089928,-0.00138162165561532,0.0152725751407098,0.102115103275613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00746166663552557,0.00457833960322993,-0.0164352122578562,0.0015118789868051,0.103172778788713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRXN3,Neurexin-3,37039,0.0057037090157569,0.00350017580367911,-0.00115663555945415,0.012564053590968,0.103220687224329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3G,Semaphorin-3G,37124,0.00710560476831004,0.00436987186066012,-0.0014593440785838,0.0156705536152039,0.103964010255893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.010957030605133,0.00676445755615759,-0.0242153674152019,0.00230130620493588,0.105300371483256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00788944380293307,0.00487485781782191,-0.00166527751999787,0.017444165125864,0.105600921593817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00558123400186357,0.00345273621983903,-0.00118612898902094,0.0123485969927481,0.106013099760776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM132A,Transmembrane protein 132A,37043,0.0101237297336727,0.00626477120751566,-0.00215522183305796,0.0224026813004034,0.106123091989371
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL9,Interleukin-9,37169,-0.00919323178883341,0.00571136612898662,-0.0203875094016472,0.00200104582398036,0.107500630238827
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS2,Podocin,37056,-0.0163749273974782,0.0101798562620302,-0.0363274456710574,0.00357759087610111,0.107736125816904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVPL,Envoplakin,37169,-0.00527482710777072,0.00328280827725105,-0.0117091313311828,0.00115947711564133,0.108121251092197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00636368994214457,0.00396113655058477,-0.0141275175812907,0.00140013769700158,0.108181208395147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.0097460771369428,0.00607190734541117,-0.00215486126006309,0.0216470155339487,0.108493633778182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00651456695148933,0.00406352562556531,-0.0144790771775973,0.00144994327461866,0.108918757264899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0108004572532726,0.00673730508681611,-0.0240055752234322,0.00240466071688693,0.108940393017124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00428644977171928,0.00267444490557822,-0.000955462243214022,0.00952836178665259,0.109014593738215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00473037304867576,0.00295413830434556,-0.0105204841251931,0.00105973802784154,0.109340395123539
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00479313768939402,0.00300348721076763,-0.00109369724371053,0.0106799726224986,0.110540697343523
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX1B,Syntaxin-1B,37039,0.00675231568544643,0.00424000105175318,-0.0015580863759898,0.0150627177468827,0.111290348667879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA5,Annexin A5,39415,0.00478886339295681,0.00301628516981342,-0.0011230555398775,0.0107007823257911,0.112381461535094
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.00448637332813191,0.00282904241904786,-0.00105854981320189,0.0100312964694657,0.112802278776581
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00530173802586436,0.00334568721390123,-0.00125580891338205,0.0118592849651108,0.113070258593145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHIT1,Chitotriosidase-1,39906,0.0237884449702422,0.0150205090685828,-0.00565175280418011,0.0532286427446645,0.113274667676112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00682879978219595,0.00432634133554054,-0.0153084287998554,0.00165082923546351,0.114492268804605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN4,Alpha-actinin-4,39587,0.00489724699165956,0.00312916780468315,-0.00123592190551942,0.0110304158888385,0.117595582695795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00912116807375073,0.00583396585337951,-0.00231340499887311,0.0205557411463746,0.117964441941348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPT,Microtubule-associated protein tau,39489,0.00820586276964772,0.00524881861523498,-0.00208182171621284,0.0184935472555083,0.117985067908041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00721633599476017,0.0046195434166192,-0.00183796910181345,0.0162706410913338,0.118280970051025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00499978368492599,0.00321531243696624,-0.0113017960613798,0.00130222869152783,0.119972180595641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,39931,-0.00463772676122029,0.00298338565583469,-0.0104851626466563,0.00120970912421569,0.120080592971701
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL1,Interferon lambda-1,39489,0.00694895796544039,0.00447529166649806,-0.0018226137008958,0.0157205296317766,0.12050585274878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN1,Cerebellin-1,36991,-0.014883279266198,0.00959678034969592,-0.033692968751602,0.00392641021920599,0.120958925857023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0131025970821987,0.00848084132121827,-0.0297250460717865,0.00351985190738916,0.122378942027366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.0066894926565269,0.00433720055009869,-0.00181142042166653,0.0151904057347203,0.123011702104424
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.0101021375249537,0.00656883950053865,-0.0229770629460095,0.00277278789610205,0.124100221411562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00736711182690445,0.0047911177606498,-0.00202347898396917,0.0167577026377781,0.124155104631108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD27,CD27 antigen,39913,0.00591210395769048,0.00387371665833626,-0.0016803806926486,0.0135045886080296,0.126977348100236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNG,Uracil-DNA glycosylase,37368,0.00527302702450492,0.00346131535874886,-0.00151115107864284,0.0120572051276527,0.127677794541824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.0118568224784025,0.00779488966361286,-0.00342116126227875,0.0271348062190837,0.128258226359058
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROK1,Prokineticin-1,39866,0.00981318501304518,0.0064535843195833,-0.00283584025333808,0.0224622102794284,0.128385264384922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0147529300286818,0.00973908565249806,-0.00433567785021443,0.033841537907578,0.129842216387286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.010632766277511,0.00704005777329367,-0.00316574695814458,0.0244312795131666,0.13098043650286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENG,Endoglin,40052,-0.00254166644672552,0.00168788854978732,-0.00584992800430866,0.000766595110857615,0.132131356176944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.0109643418538867,0.0073163628853294,-0.0253044131091323,0.00337572940135895,0.134000037037
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAYN,Layilin,39713,0.00476160760705875,0.00321237586470016,-0.00153464908775355,0.0110578643018711,0.138288407772072
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00485650094169683,0.00327965419486353,-0.00157162128023568,0.0112846231636293,0.138684668172413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00574469425749974,0.00388487595050977,-0.00186966260549941,0.0133590511204989,0.139235620057724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0136519539040406,0.00924182337575777,-0.00446201991244466,0.0317659277205258,0.139648028876828
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00638426667958862,0.00433136150469035,-0.0148737352287817,0.00210520186960445,0.140515465881377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00533250828259981,0.00361785992028211,-0.0124235137263527,0.00175849716115313,0.140517774260088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00947592907524523,0.0064411071840211,-0.00314864100543613,0.0221004991559266,0.141266732672069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JUN,Transcription factor AP-1,39587,0.00758864163338234,0.00517324836314612,-0.00255092515838406,0.0177282084251487,0.142423066117271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH22,Cadherin-22,37169,-0.00423548059601839,0.00289070193351907,-0.00990125638571577,0.00143029519367899,0.142887705776487
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1,DNA topoisomerase 1,37382,0.0166351425989035,0.0113571023036513,-0.00562477791625318,0.0388950631140601,0.143016543995067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00732519876373816,0.00500252403165741,-0.00247974833831036,0.0171301458657867,0.143135727665159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP13,Collagenase 3,39489,-0.00467840837627111,0.00319880715590039,-0.0109480704018359,0.00159125364929366,0.143611262736172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN2,Prorelaxin H2,37095,0.0207072257769064,0.0141587450666357,-0.00704391455369952,0.0484583661075123,0.143626807007003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLINT1,Clathrin interactor 1,36962,-0.00712513921623491,0.00487703737302624,-0.0166841324673663,0.00243385403489652,0.144051372758332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00898747134183245,0.00617076124049821,-0.021082163373209,0.00310722068954405,0.145289156730206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0113650997746885,0.00781112524956961,-0.00394470571446794,0.0266749052638449,0.145692322296643
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSP90B1,Endoplasmin,39405,0.00975218319097352,0.00672464511098384,-0.00342812122655481,0.0229324876085019,0.147018666914115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,39858,-0.00411777290102514,0.00284907307358935,-0.00970195612526027,0.00146641032320998,0.148392477331473
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00567803384965841,0.00393516484877494,-0.00203488925394047,0.0133909569532573,0.149072867526649
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.0123123107824668,0.00854098252476152,-0.0290526365309994,0.00442801496606579,0.149450992692422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0172672161772427,0.0119956142308992,-0.00624418771531962,0.0407786200698051,0.150040058420373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0118507708651943,0.00829604648104606,-0.00440948023765601,0.0281110219680445,0.153176319919414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00464722345265326,0.00325530305414042,-0.00173317053346197,0.0110276174387685,0.153431177891092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.012141911095316,0.00850685926755107,-0.0288153552597161,0.00453153306908409,0.153514725750933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00491639686651508,0.00344564630195599,-0.0116698636183488,0.00183706988531866,0.153648912382264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00381750173095177,0.00268524894999798,-0.0090805896729478,0.00144558621104427,0.155145242470832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH17,Protocadherin-17,39868,0.00493392563449919,0.00348493424618347,-0.00189654548802041,0.0117643967570188,0.156857245431742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR1B,Cornifin-B,37169,0.0123430393400005,0.00874256848583402,-0.00479239489223422,0.0294784735722351,0.158022765816922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00393494957770777,0.00279149766962713,-0.0015363858547614,0.00940628501017694,0.15867505101162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.0101609001227972,0.00721603498267297,-0.0243043286888362,0.0039825284432418,0.159124766836766
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.00819424059224851,0.00583844014192654,-0.00324910208592751,0.0196375832704245,0.160487512713139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00732784379192174,0.00522625553026612,-0.0175713046312433,0.00291561704739986,0.160902411905114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB116,Beta-defensin 116,36991,-0.0108149720295712,0.00772456693727131,-0.025955123226623,0.00432517916748056,0.16151452646576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0135670088639111,0.00971471502964465,-0.0326078503220146,0.00547383259419239,0.162574852125831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B4,Protein ATP1B4,36962,-0.00582737919823581,0.00417523277271794,-0.014010835432763,0.00235607703629135,0.162828013604052
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEF,Thyrotroph embryonic factor,37021,0.00589720397719641,0.00423065902715278,-0.00239488771602305,0.0141892956704159,0.163365030489575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB5,Serpin B5,39585,0.00671550915903078,0.00484562116543825,-0.00278190832522819,0.0162129266432898,0.165799439062181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL33,Interleukin-33,39587,0.00537852020391239,0.00390102639461497,-0.00226749152953295,0.0130245319373577,0.167993033421948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00724738781781416,0.00527381466555514,-0.00308928892667391,0.0175840645623022,0.169396533182612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00659336139179206,0.0048214802281367,-0.01604346263894,0.00285673985535586,0.1714927901713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF12,Fibroblast growth factor 12,37056,0.00638712385168471,0.00467489689589813,-0.00277567406427562,0.015549921767645,0.171880704379987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00374991798482658,0.00277144523338377,-0.00168211467260561,0.00918195064225877,0.176061221910877
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0112364495959035,0.0083224356232423,-0.0275484234174584,0.0050755242256514,0.176994542250389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP73,Tumor protein p73,37039,-0.00464848825033233,0.00345361265327136,-0.0114175690507442,0.00212059255007954,0.178332614686983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00721669669452041,0.0053811500989048,-0.0177637508883738,0.003330357499333,0.179908993942759
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00330124560721558,0.00247296745444342,-0.00154577060349353,0.00814826181792469,0.181920679989476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00387722820738648,0.0029113750968245,-0.00182906698238954,0.00958352339716249,0.182964210342954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00787918007173012,0.00598155976564612,-0.00384467706893628,0.0196030372123965,0.187775686494392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00549809774273926,0.00417838158038936,-0.00269153015482387,0.0136877256403024,0.188249374355908
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00438755319586389,0.0033367503424945,-0.00215247747542534,0.0109275838671531,0.188556626643097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANK2,Ankyrin-2,37021,-0.00931481834366441,0.00708524338549314,-0.023201895379231,0.00457225869190215,0.188640826815557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WNT9A,Protein Wnt-9a,39587,0.00368283674201225,0.0028031643236148,-0.00181136533227275,0.00917703881629725,0.188927943904406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGB,Secretogranin-1,39952,0.00514903639592683,0.00393018746556287,-0.0025541310365764,0.0128522038284301,0.190172292360355
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1B,Protein phosphatase 1B,37056,0.00832127039862484,0.00636018670020032,-0.00414469553376779,0.0207872363310175,0.190781668332711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,39709,-0.00359256239982313,0.00275242021551714,-0.00898730602223671,0.00180218122259046,0.191830897431389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0220476201215614,0.0169902155054304,-0.0553484425122051,0.0112532022690822,0.194424366678162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX9,Transcription factor SOX-9,37039,0.00349281260351862,0.00269582716302592,-0.00179100863601219,0.00877663384304943,0.195123371673843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTTG1,Securin,37169,0.00531894942307964,0.00416224754285298,-0.0028390557609122,0.0134769546070715,0.201305850292601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00809536485464753,0.00635016429978057,-0.0205416868822174,0.00435095717292239,0.202392767106885
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSND,Barttin,36962,-0.00425014016557491,0.00336163574420137,-0.0108389462242096,0.00233866589305979,0.206142288592519
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17F,Interleukin-17F,39587,-0.00975874945671022,0.00772378035242137,-0.0248973589474561,0.00537986003403565,0.206439761964598
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.00858535264076557,0.00682067709470379,-0.00478317446485387,0.021953879746385,0.2081521648203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171A2,Protein FAM171A2,37411,0.0197179142695195,0.0156708349865246,-0.0109969223040687,0.0504327508431076,0.208321049020474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00608566872901749,0.00484011035203369,-0.0155722850190035,0.00340094756096854,0.208652629505862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00648467678494617,0.00517007741619251,-0.0166180285206835,0.00364867495079115,0.209765894001667
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTOA,Otoancorin,36991,-0.0066321429550572,0.00528813020852229,-0.0169968781637609,0.00373259225364649,0.209807447131478
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00539961359271371,0.00432136990625535,-0.0138694986089742,0.00307027142354679,0.211498599070882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00736418967160501,0.00593918641193175,-0.0190049950389912,0.00427661569578122,0.215022259064077
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REN,Renin,39868,0.00814171529822733,0.00656951038705108,-0.00473452506039279,0.0210179556568474,0.215245765240636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM2,Isthmin-2,37437,-0.0054721231961397,0.00443927406769949,-0.0141731003688307,0.00322885397655131,0.217723344179384
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB2,Beta-crystallin B2,37388,0.0069794170526821,0.0056646414180789,-0.00412328012675255,0.0180821142321167,0.217932330828049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.0102938751801385,0.00838128770906033,-0.00613344872961977,0.0267211990898967,0.219391283304504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00590128307423154,0.00481715912058738,-0.0153429149505828,0.00354034880211972,0.220576532948788
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00573219184330303,0.00468843013123623,-0.00345713121391998,0.014921514900526,0.221489806350409
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00775019301287831,0.00635054149727727,-0.0201972543475418,0.00469686832178514,0.222335708593848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00409159320340219,0.00335382589070891,-0.00248190554238727,0.0106650919491917,0.22249511300131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00863397152370417,0.00708554274462159,-0.00525369225575414,0.0225216353031625,0.223043097089383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGN,Secretagogin,39587,-0.00514685937811916,0.00429545040812567,-0.0135659421780455,0.00327222342180715,0.230852627743544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00653217647143924,0.00545956108404308,-0.00416856325328519,0.0172329161961637,0.231536557095575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00596837881008447,0.00499734803213403,-0.0157631809530672,0.00382642333289823,0.23237865488903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.0125333665502863,0.0104961244995765,-0.00803903746888355,0.0331057705694562,0.232462499689082
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00765940835343449,0.00643026080543082,-0.0202627195320789,0.00494390282520992,0.233615960990465
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO6,Coronin-6,36991,-0.00450192616373882,0.00378325590331017,-0.0119171077342268,0.00291325540674911,0.234083319645501
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCC,Netrin receptor DCC,37039,0.00267058712067375,0.00225627753452296,-0.00175171684699125,0.00709289108833876,0.236582778882403
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00678921020439532,0.0057419047902524,-0.00446492318449939,0.01804334359329,0.237069724991658
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00607180410350697,0.00515046522757384,-0.0161667159495517,0.00402310774253775,0.238465416460972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM3,Paralemmin-3,37021,0.00885928986258556,0.00754701990977325,-0.00593286916057001,0.0236514488857411,0.240464647622737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHPK,Sedoheptulokinase,37169,-0.00489865282626638,0.00417686412597206,-0.0130853065131716,0.00328800086063887,0.240894456179056
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMCN2,Hemicentin-2,37100,0.00663213782884764,0.00566494379710216,-0.00447115201347259,0.0177354276711679,0.24172710294271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.00458052657136819,0.00391450025843729,-0.0030918939351689,0.0122529470779053,0.241960842501166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00928105141417999,0.00795120757445123,-0.00630331543174441,0.0248654182601044,0.243130444747221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1A,Interleukin-1 alpha,39587,0.00618696525980107,0.00532152044022163,-0.00424321480303332,0.0166171453226355,0.244996841052199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.00755258080205649,0.00652997737867863,-0.0203513364642666,0.00524617486015362,0.247452584443665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00166775736385606,0.00144263959669753,-0.0011598162456711,0.00449533097338322,0.24768283426725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.00298165662307358,0.00258536851176237,-0.00804897890612783,0.00208566565998066,0.248815972260344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00581096309718795,0.00506752230569763,-0.0157433068163553,0.00412138062197941,0.251523599818022
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00851570765280141,0.00745922222493876,-0.00610436790807855,0.0231357832136814,0.253626671820844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLON5,IgLON family member 5,36962,0.0104872977736364,0.00919415343789782,-0.00753324296464331,0.0285078385119161,0.254037054884446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC2,Stanniocalcin-2,39831,0.00299522437860045,0.0026360782861385,-0.00217148906223101,0.00816193781943191,0.255872105853909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00296239270494932,0.00261633922199616,-0.00216563217016315,0.0080904175800618,0.257543218968799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH2,Growth hormone variant,39477,0.018548228222509,0.0163825555279835,-0.0135615806123386,0.0506580370573567,0.257570338530707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.00660147549043795,0.00585759020787461,-0.00487940131699628,0.0180823522978722,0.259765063461836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00379956393814049,0.00338478967734224,-0.00283462382945029,0.0104337517057313,0.261649357103813
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00375928349556583,0.00334907319544349,-0.0103234669586351,0.00280489996750341,0.261676969035225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00849610927382937,0.00758204532775779,-0.0233569181162346,0.0063646995685759,0.262497234252136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD10,Frizzled-10,37039,0.00665287961357083,0.00597526479014431,-0.005058639375112,0.0183643986022537,0.265555559225533
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00541995084704613,0.00488494494038326,-0.00415454123610506,0.0149944429301973,0.267225599395004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00699203497463234,0.00630640259883833,-0.00536851411909079,0.0193525840683555,0.267571006219702
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELL,L-selectin,37453,-0.00249744542752332,0.00225649319593457,-0.00692017209155507,0.00192528123650844,0.268407898039464
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDNRB,Endothelin receptor type B,37056,0.005143820541396,0.00465316362612616,-0.00397638016581128,0.0142640212486033,0.268986588301777
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00625305325526352,0.0056598405010049,-0.00484023412670609,0.0173463406372331,0.269261841612019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI16,Peptidase inhibitor 16,37445,-0.00262721982975822,0.00238086893392268,-0.00729372294024666,0.00203928328073023,0.269842223330706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK1,Kallikrein-1,39720,-0.0137973679035795,0.0125106628973805,-0.0383182671824452,0.0107235313752863,0.270109623371044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC8,Histone deacetylase 8,37056,0.00692361123475687,0.00630412492833501,-0.00543247362477976,0.0192796960942935,0.272108034328656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAP1,Antigen peptide transporter 1,37169,-0.00641632988174829,0.00586716561747785,-0.0179159744920049,0.00508331472850829,0.274150424432417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELENOP,Selenoprotein P,37453,0.00241855582547469,0.0022158281588437,-0.00192446736585897,0.00676157901680835,0.275076368342055
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN1,Transcobalamin-1,37235,0.0037172897817642,0.00341030528534758,-0.00296690857751706,0.0104014881410455,0.2757254163249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAPPA,Pappalysin-1,39587,0.005142625744026,0.00472957214768915,-0.00412733566544472,0.0144125871534967,0.276905784734313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00371767117438208,0.00343004352729841,-0.00300521413912281,0.010440556487887,0.278445652949539
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCA2A,Guanylin,39796,-0.00347101047716603,0.00321338406401874,-0.00976924324264275,0.00282722228831069,0.280081527800137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0156845667925774,0.0145395001671022,-0.0128128535349429,0.0441819871200976,0.280715948177469
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00370272901340191,0.00344728806769177,-0.0104594136260778,0.00305395559927397,0.28279795956766
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YY1,Transcriptional repressor protein YY1,37056,-0.00297020967181831,0.002769978925929,-0.00839936836663916,0.00245894902300253,0.283611194316327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH17,Cadherin-17,39868,-0.00706553514991749,0.00662027117709937,-0.0200412666570323,0.00591019635719729,0.28587159475784
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTH3,Cytohesin-3,36962,0.00766290262958719,0.0072098575453023,-0.00646841815920532,0.0217942234183797,0.287875512104337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELB,Transcription factor RelB,37056,0.00520109499786229,0.00490710700840211,-0.00441683473860585,0.0148190247343304,0.289204647657982
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00500721774514891,0.0047476577895761,-0.00429819152242026,0.0143126270127181,0.291594550025276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB118,Beta-defensin 118,36991,0.00608034157405529,0.00579871703390659,-0.00528514381240161,0.0174458269605122,0.29439688851017
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT2,Angiopoietin-2,40030,-0.0039726491837319,0.0037940508435884,-0.0114089888371652,0.00346369046970137,0.29508144197056
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00309101705269208,0.00296853788221385,-0.00890935130183122,0.00272731719644706,0.297773894807522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00481801729684343,0.00464270249372799,-0.0139177141845503,0.00428167959086344,0.299399722461465
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00299222934792132,0.00289127095220026,-0.00267466171839119,0.00865912041423382,0.300723506913669
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTN,Titin,37021,-0.00703887266435226,0.00682275663863402,-0.0204114756760749,0.00633373034737041,0.302242992758908
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00472414526648644,0.00460464371373175,-0.0137492469454007,0.00430095641242779,0.304932962438947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00559589644808699,0.00545612838538094,-0.0162899080834336,0.00509811518725965,0.305091222182878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00499879744734096,0.00487757672928904,-0.00456125294206556,0.0145588478367475,0.305452062990932
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10,Interleukin-10,39587,0.00808281269830007,0.00788933150173038,-0.00738027704509147,0.0235459024416916,0.305603405534242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00763227606647155,0.00750098125493516,-0.0223341993261445,0.00706964719320135,0.308932626991103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00926705604701944,0.00911116702561767,-0.0271249434172301,0.00859083132319119,0.309120043791667
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00507154650650103,0.00499451968238114,-0.0148608050839681,0.00471771207096601,0.309923332875551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.00864152739665472,0.00851194314231974,-0.0253249359556014,0.00804188116229197,0.310017855913039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTN,Neuroplastin,39477,0.00847327731220553,0.00836903107933717,-0.00793002360329532,0.0248765782277064,0.311335669687335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBN2,Fibrillin-2,37039,0.00605190227161881,0.00599645683374997,-0.00570115312253113,0.0178049576657687,0.31287502384508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00630245055852165,0.0062466840218487,-0.0185459512413451,0.00594105012430179,0.313028052728319
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00419145012715565,0.00415590715369836,-0.0123370281484044,0.00395412789409313,0.313207838654315
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00593442890297799,0.00590411951613858,-0.00563764534865362,0.0175065031546096,0.314850796695374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0117588915678455,0.0118153174762768,-0.0113991306856571,0.034916913821348,0.319642217433927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.0025274318583618,0.00254442237618583,-0.00751449971568603,0.00245963599896243,0.32057054473063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00722611073719419,0.00727954804356796,-0.00704180342819901,0.0214940249025874,0.320894238748804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00371618092393861,0.0037596874917683,-0.00365280655992727,0.0110851684078045,0.322958216797405
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00483923703584737,0.00490427778113373,-0.00477314741517474,0.0144516214868695,0.323789298528787
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0046200594259406,0.00468364763721853,-0.0138000087948889,0.00455988994300772,0.323943511577346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00453987662825085,0.00462724880615994,-0.0136092842883243,0.00452953103182264,0.326552680563956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00512885823532953,0.00523039545564647,-0.00512271685773755,0.0153804333283966,0.326811584054328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL4,Myosin light chain 4,37043,0.00507508913242104,0.00518622192263664,-0.00508990583594678,0.0152400841007889,0.327809688094936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMI,N-myc-interactor,37311,0.00701236617433333,0.0072017215104326,-0.00710300798611456,0.0211277403347812,0.330219582982339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.0039012447488398,0.00401961578304839,-0.00397720218593503,0.0117796916836146,0.331789426593398
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00836719024785872,0.00862992609614624,-0.0252818453963054,0.00854746490058791,0.332285841560294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF20,Fibroblast growth factor 20,37056,-0.0041386067968212,0.0042872745081346,-0.012541664832765,0.00426445123912261,0.334400499127207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00756193498363605,0.00788657590213242,-0.0230196237518156,0.0078957537845435,0.33765897147071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.00717005401795201,0.00756121757275901,-0.00764993242465566,0.0219900404605597,0.34301089570047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00581873996102736,0.00615818134079303,-0.00625129546692699,0.0178887753889817,0.344734859980752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00608596705071266,0.00644478841904756,-0.0187177523520459,0.00654581825062056,0.345021545647292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP4,Caspase-4,37169,-0.0154637051734497,0.0164423016109068,-0.0476906163308271,0.0167632059839277,0.346986933761421
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL1,Delta-like protein 1,39913,0.00264757183009206,0.00282929458160561,-0.00289784554985493,0.00819298921003906,0.349405180383452
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASN,Vasorin,39642,-0.00253706450839041,0.00272477172214936,-0.00787761708380317,0.00280348806702234,0.351810470429646
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00669193578064819,0.00720528149461127,-0.0074304159487899,0.0208142875100863,0.353033533094364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA6C,Semaphorin-6C,37056,0.00239754148733928,0.00261170626922644,-0.00272140280034454,0.0075164857750231,0.358636619517288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00515524594294318,0.00562191048594162,-0.0058636986095024,0.0161741904953888,0.35916380359942
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.002559267485086,0.00279386096807209,-0.00803523498250729,0.00291670001233529,0.359663586787732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00724217146434669,0.00793450055940728,-0.022793792560785,0.00830944963209159,0.361393746921203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS2,Thrombospondin-2,39858,0.0032756043487531,0.0035889288468095,-0.00375869619099352,0.0103099048884997,0.361415711301457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBQLN3,Ubiquilin-3,37021,-0.004274652513713,0.00468747826575567,-0.0134621099145941,0.00491280488716812,0.361822219402731
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00417114219016225,0.00458443928598184,-0.00481435881036215,0.0131566431906866,0.362916460375633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.0036390552567727,0.00402280322217757,-0.0115237495722407,0.00424563905869533,0.365690091737179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3,Interleukin-3,36962,-0.00530033287046168,0.00594449441378265,-0.0169515419214757,0.00635087618055232,0.372603751730948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.00384453383756089,0.00433424730919296,-0.0046505908884573,0.0123396585635791,0.375088130791892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13,Interleukin-13,39587,0.00430655496646571,0.00485827324180157,-0.00521566058746536,0.0138287705203968,0.375395442231184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00701999626413002,0.00792563184187789,-0.00851424214595065,0.0225542346742107,0.375774872087394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00461492362698133,0.00523269557255169,-0.0148710069491827,0.00564115969521999,0.377824888138701
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.0101611484879002,0.0115357877262731,-0.0124489954555952,0.0327712924313955,0.378421679802294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00816997002757822,0.00928932434125652,-0.026377045736441,0.0100371056812846,0.379145707605095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00404185684920178,0.00460360634018662,-0.0130649252759675,0.00498121157756399,0.379972634363177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00227113651623561,0.00258796589226687,-0.00280127663260746,0.00734354966507868,0.380187140072506
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0083594786978831,0.0095440322694543,-0.0103468245502473,0.0270657819460135,0.381108270216854
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00369787454693522,0.0042481211514797,-0.00462844290996498,0.0120241920038354,0.384054997635179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00488673997603024,0.00561466699576621,-0.015891487287732,0.00611800733567154,0.384123619839636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00319297785130388,0.00367388746128159,-0.00400784157280804,0.0103937972754158,0.384807927579476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00540040513077879,0.00622782249814689,-0.00680612696558911,0.0176069372271467,0.385880136498964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTO1,Protein LTO1 homolog,39587,0.00343561256773846,0.00402154647893443,-0.00444661853097303,0.01131784366645,0.392951054449221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00462039597492113,0.00541568016032191,-0.0152351290891521,0.00599433713930982,0.393590638755419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17A,Interleukin-17A,39558,0.00357383481583797,0.00421982723152388,-0.00469702655794884,0.0118446961896248,0.397055433533508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSD1,Tryptase delta,37411,0.00308528798007814,0.00364835880690987,-0.00406549528146521,0.0102360712416215,0.397754794749552
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00506842651882113,0.00601215568135588,-0.0168522516542787,0.0067153986166364,0.399227122282636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00841539649696331,0.00998991797353907,-0.0111648427311733,0.0279956357250999,0.39958558450988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEBP1,Heme-binding protein 1,39585,-0.00448885677830279,0.00535159262243988,-0.0149779783182849,0.00600026476167936,0.401600500537828
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20,Interleukin-20,39587,0.00406061891266766,0.00486635364527463,-0.00547743423207061,0.0135986720574059,0.404052845777472
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00263313720512051,0.00317839583975093,-0.00359651864079132,0.00886279305103234,0.407429133661623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00335017804646524,0.00407591013974625,-0.0113389619203679,0.00463860582743741,0.411122494596762
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4,Interleukin-4,39587,0.00735907030396501,0.00899699671227174,-0.0102750432520876,0.0249931838600176,0.413399599929028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",39585,0.0035101135766434,0.0043027325337365,-0.00492324218948015,0.011943469342767,0.414634284830983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNW1,Interferon omega-1,37021,-0.00287494762846818,0.003532422010091,-0.00979849476824654,0.00404859951131018,0.415731667009913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00675896640788635,0.00832351916452232,-0.00955513115457739,0.0230730639703501,0.41678517418362
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00453125867197645,0.00560326673452014,-0.0155136614716359,0.00645114412768302,0.418712969453429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,-0.00229516052268395,0.00285028067504911,-0.0078817106457802,0.0032913896004123,0.420692918423546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHH,Sonic hedgehog protein,37056,-0.00349507710336853,0.00435417894938913,-0.0120292678441712,0.00503911363743417,0.422165575314865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.00372982338607718,0.00464761202446266,-0.012839142954024,0.00537949618186963,0.422263966575786
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.0061100703277352,0.00766140582137292,-0.0211264257376261,0.00890628508215573,0.425167608036474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NENF,Neudesin,37368,0.00867468708454051,0.0109576426916303,-0.0128022925910548,0.0301516667601358,0.428574999039205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,0.0028087808966296,0.00356321024704749,-0.00417511118758347,0.00979267298084267,0.430548963098913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00429688660144774,0.00545138620856511,-0.00638783036733988,0.0149816035702354,0.430580452947459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00375402596346344,0.0049354609629365,-0.013427529450819,0.00591947752389211,0.446893659903117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00955299790281627,0.0126537883500911,-0.0152484272633623,0.0343544230689948,0.450289401284396
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00542561915529694,0.00724428169160946,-0.00877317296025759,0.0196244112708515,0.453899561206255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00321008399188123,0.00431504174146496,-0.0052473978213901,0.0116675658051526,0.456932453874255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00458711503734767,0.00619354531806966,-0.00755223378606887,0.0167264638607642,0.458929615190535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00566377239451714,0.00765355288411443,-0.0206647360473814,0.00933719125834714,0.45930149768005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00169844765105407,0.0023013576167862,-0.00281221327784687,0.00620910857995502,0.460513269630633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPN,Asporin,37437,0.00198565416452867,0.00269232216539589,-0.00329129727964729,0.00726260560870462,0.46081605868867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00289623856878349,0.00395896587170733,-0.00486333453976288,0.0106558116773299,0.464447555856124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00394100587738495,0.00538791966593188,-0.0145013284226114,0.00661931666784154,0.464515848174118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR2,Toll-like receptor 2,37169,-0.00165160501406456,0.00226379508414852,-0.00608864337899566,0.00278543335086654,0.465663734937514
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A3,Protein S100-A3,37368,0.00328193711344717,0.00450437179709456,-0.00554663160885816,0.0121105058357525,0.466251970044998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL21R,Interleukin-21 receptor,37056,-0.00393061671799468,0.00542352593397372,-0.0145607275485832,0.00669949411259382,0.46862773443144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00254559094012527,0.00353637274416688,-0.00438569963844181,0.00947688151869234,0.471639534562795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,-0.00312698301529685,0.0043569922641151,-0.0116666878529624,0.00541272182236874,0.472957050959774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00687905442555261,0.00958582496811395,-0.0119091625119507,0.0256672713630559,0.472999581472209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL6,Fc receptor-like protein 6,39866,0.00469929721443522,0.00657340716678638,-0.00818458083246608,0.0175831752613365,0.474684231386598
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPGN,Epigen,37368,-0.00355273024879198,0.00498060508176941,-0.01331471620906,0.00620925571147607,0.475664430628719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASQ2,Calsequestrin-2,37021,0.00346959660632296,0.00486425717580271,-0.00606434745825035,0.0130035406708963,0.475682709942006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXOSC10,Exosome component 10,37021,-0.0043367645918734,0.00608104088058503,-0.0162556047178201,0.00758207553407326,0.475758435364948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,-0.00226426875344356,0.0031913348487759,-0.00851928505704432,0.0039907475501572,0.478021529208967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,40052,0.00220436685507095,0.00311993484958588,-0.00391070545011736,0.00831943916025927,0.479860942000913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI2B,Protein EVI2B,36962,-0.00290244815338111,0.00411115924795355,-0.0109603202793701,0.00515542397260785,0.480205269923744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEB,Nebulin,37021,-0.00264025010792694,0.00374500855525805,-0.00998046687623271,0.00469996666037883,0.480819542288326
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRN1,Neuritin,37411,-0.00246773125708945,0.0035114616765681,-0.00935019614316292,0.00441473362898403,0.482214481190005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00428546520985475,0.00610960991486762,-0.00768937022328577,0.0162603006429953,0.483046633069359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,-0.00346335473002361,0.00496287205841906,-0.013190583964525,0.00626387450447774,0.485281182706409
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00240518304081834,0.0034713288331771,-0.00439862147220877,0.00920898755384544,0.488402361585517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.00723190301887677,0.0105268919341816,-0.0278646112098727,0.0134008051721192,0.492098756618268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00329925956560024,0.00480984953425158,-0.0127265646527333,0.00612804552153286,0.492764186071758
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00315709532471094,0.00460548822734812,-0.0121838522503133,0.00586966160089137,0.49303568458371
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00350000465481244,0.00516200610372476,-0.013617536618113,0.00661752730848809,0.497763406026676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN4,Prefoldin subunit 4,36962,0.00365829847972606,0.00542472641354285,-0.00697416529081793,0.0142907622502701,0.500084994355781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00395896591371829,0.0058720901056717,-0.00755033069339825,0.0154682625208348,0.500195711644641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMCH,Pro-MCH,37021,-0.00557050108211685,0.00826720314174688,-0.0217742192399407,0.010633217075707,0.500445723687732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00546424969427671,0.00811774476552039,-0.0104465300461433,0.0213750294346967,0.500880210928581
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00393274108627927,0.0058680562836762,-0.0154341314022846,0.00756864922972609,0.502745373838028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00324643188905109,0.00484498331904557,-0.00624973541627822,0.0127425991943804,0.502831014228042
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00168572348222181,0.00252320899036923,-0.00325976613890188,0.0066312131033455,0.504089755577285
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.0032543450735695,0.00489624012960819,-0.00634228558046255,0.0128509757276016,0.506276213053756
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00482571112576408,0.00728488285977248,-0.00945265927938998,0.0191040815309182,0.507708369234841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.0025918344300518,0.00393593115528053,-0.0103062594944016,0.00512259063429804,0.510224589618023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00429183754153178,0.00653425939011112,-0.0170989859461496,0.00851531086308601,0.511307499099656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00215837662964275,0.00328870811631791,-0.00860424453762586,0.00428749127834035,0.511641129334253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00272881717575957,0.00416649875351769,-0.0054375203811351,0.0108951547326542,0.51251591755557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,36962,-0.00270630243667263,0.00415481462792815,-0.0108497391074118,0.00543713423406654,0.514822073011647
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCIN,Adseverin,36991,0.00479863687283196,0.00737905127000968,-0.00966430361638701,0.0192615773620509,0.515506348205417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00167534093218726,0.00260234749667015,-0.00342526016128623,0.00677594202566074,0.519728878998265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.00747629524922843,0.0116288281644732,-0.0153162079531391,0.0302687984515959,0.520293428436261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR3,Folate receptor gamma,39858,-0.0121041315560729,0.0188283851099472,-0.0490077663715693,0.0247995032594235,0.520320165004235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00247562990857929,0.00389033379540601,-0.00514942433041649,0.0101006841475751,0.524556709242719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0108481338272204,0.017092020703472,-0.0226522267515848,0.0443484944060256,0.525639849342394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.00399293808414352,0.00640763426087963,-0.00856602506718056,0.0165519012354676,0.533194606167144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1,Integrin beta-1,39862,0.00134215639745302,0.00216336030272135,-0.00289802979588083,0.00558234259078687,0.535000975299193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA2,Adenosine deaminase 2,39782,-0.00254857634250011,0.00410793483198269,-0.0106001286131862,0.00550297592818597,0.535001177239365
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESR1,Estrogen receptor,37056,0.00366350842921481,0.00593076628805313,-0.00796079349536933,0.0152878103537989,0.536775534754016
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00403235803364092,0.00654432164978533,-0.0168592284672202,0.00879451239993832,0.537798575291031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RUVBL1,RuvB-like 1,39477,0.00622750925931922,0.0101237900557196,-0.0136151192498913,0.0260701377685297,0.538473771875491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00185812588923597,0.00302265042542132,-0.00406626894458982,0.00778252072306175,0.538740762647525
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",39489,0.00330435246907533,0.00538118544482371,-0.00724277100277915,0.0138514759409298,0.539186859988818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00302597606699175,0.00494313013264902,-0.00666255899300033,0.0127145111269838,0.54044355673582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNB2,Ephrin-B2,37039,-0.00367118683928882,0.00600999825769946,-0.0154507834243798,0.00810840974580213,0.541311692066419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00302431089025493,0.00507627777090976,-0.0129738153212381,0.0069251935407282,0.551336796671778
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00203353845534647,0.00341785961146624,-0.00466546638312736,0.0087325432938203,0.55187079944889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRP15,RRP15-like protein,36991,0.00536377287059308,0.00902458322014089,-0.0123244102408831,0.0230519559820692,0.552287406002377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.003381047888242,0.00569589493984314,-0.00778290619385055,0.0145450019703346,0.552792215039134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF9,Fibroblast growth factor 9,36931,0.00238208429466329,0.00404025521526848,-0.00553681592726293,0.0103009845165895,0.555477370957301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2,T-cell surface antigen CD2,37021,0.00224419942714008,0.00382864033910545,-0.0052599356375066,0.00974833449178676,0.557777418358084
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,-0.00264446815545912,0.0045198570302584,-0.0115033879347656,0.00621445162384735,0.558503606802583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3A,Uroplakin-3a,36991,-0.00278652601211853,0.00476439374618918,-0.0121247377546493,0.00655168573041225,0.558648703646281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00284673682347697,0.0049245609505353,-0.0124988762865262,0.00680540263957222,0.563225618117014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAN,Neurocan core protein,40009,-0.00209966840962952,0.00365758182039926,-0.00926852877761206,0.00506919195835302,0.565935752170704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,-0.00175614688251929,0.00306306677121078,-0.00775975775409242,0.00424746398905384,0.566429593020857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABO,Histo-blood group ABO system transferase,37445,-0.00816047022690237,0.0143068387397695,-0.0362018741568505,0.0198809337030458,0.568423000434976
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRING1,SREBP regulating gene protein,36962,0.00339972024058998,0.00597002616664923,-0.00830153104604252,0.0151009715272225,0.569050459821201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKIV2L,Helicase SKI2W,37021,0.00227434461211896,0.00401598642597494,-0.00559698878279192,0.0101456780070298,0.571184031427485
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00383949833875546,0.00678051165894932,-0.0171293011902961,0.00945030451278521,0.571230023100541
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,-0.0040347916105935,0.00714423989380463,-0.0180375018024506,0.00996791858126356,0.572245625184704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00284645873795793,0.00506767795139419,-0.0127791075226905,0.00708619004677468,0.574337524691653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00188306336926015,0.00337914042990719,-0.00850617861187824,0.00474005187335794,0.577358576923949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00458493357510782,0.00837499834101011,-0.011830063173272,0.0209999303234876,0.58407554235319
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00563129068958612,0.0103185904461372,-0.0145931465848429,0.0258557279640151,0.585252367205445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,0.00250487728863946,0.004600475310306,-0.00651205431956029,0.0115218088968392,0.586117260870859
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDAN1,Codanin-1,37388,0.00122229344886566,0.00224860332121391,-0.00318496906071361,0.00562955595844493,0.586740200542975
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00148585424692445,0.00273575419819564,-0.00387622398153901,0.0068479324753879,0.587051848487006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00287116625566995,0.0052953104022377,-0.0132499746440558,0.00750764213271594,0.587683588548479
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00414242891430465,0.0077076235911156,-0.0192493711528912,0.0109645133242819,0.590968629909757
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00211609644899345,0.00394711058939255,-0.00562024030621596,0.00985243320420285,0.591889665401459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AREG,Amphiregulin,39788,0.00248504666524189,0.00465298028597645,-0.00663479469527195,0.0116048880257557,0.593296174349334
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00214797491052454,0.00409288787105066,-0.00587408531673476,0.0101700351377838,0.599726210036947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.00282636039443741,0.00541956627986225,-0.0134487103029674,0.00779598951409261,0.602020049808549
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.00181154894944587,0.003477269962553,-0.00862699807604976,0.00500390017715801,0.602395934787486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00327994153475619,0.00637377680714444,-0.00921266100724691,0.0157725440767593,0.606841685055715
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC5D,Netrin receptor UNC5D,37056,-0.00134112172603699,0.00265494578017376,-0.00654481545517756,0.00386257200310358,0.613468305810307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00258487054125782,0.00514355212024064,-0.0126662326969295,0.00749649161441384,0.615292048856067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.0038637369784011,0.00781315818971822,-0.0191775270302488,0.0114500530734466,0.620949498077821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRC,Chymotrypsin-C,39856,0.00302390992167068,0.0061497121220727,-0.00902952583759181,0.0150773456809332,0.622927094133607
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR4,Toll-like receptor 4,37056,0.00134579685960389,0.00275073360736794,-0.00404564101083727,0.00673723473004505,0.624672732854072
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.0033051362896244,0.00677665653073095,-0.00997711051060826,0.0165873830898571,0.625753565576132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00215591943721471,0.00443628050128064,-0.0108510292197248,0.00653919034529533,0.626991801427513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGN,Cingulin,37039,0.00187895860014525,0.0038778633541078,-0.00572165357390604,0.00947957077419654,0.628014634926591
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB7,Integrin beta-7,40030,-0.00218564112761342,0.00453130751804266,-0.011067003862977,0.0066957216077502,0.629569357228538
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0014168814546989,0.00294293764596676,-0.00718503924079374,0.00435127633139594,0.630203502762849
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.0019059348008813,0.00397416288497794,-0.00969529405543807,0.00588342445367546,0.631533026161378
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00397108034914252,0.00835526830338008,-0.0124052455254824,0.0203474062237675,0.634596199009389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.0026530970707413,0.00559760916226922,-0.013624411028789,0.00831821688730636,0.635529403198717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,39477,0.00218446443184976,0.00463259112720208,-0.00689541417746633,0.0112643430411658,0.637259836679004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00181623532485457,0.0038904209669583,-0.00944146042009284,0.00580898977038371,0.640614950722219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.00295354059488904,0.00634348957984494,-0.00947969898160704,0.0153867801713851,0.641508245108311
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRNN,Cornulin,39397,0.00297900443514372,0.00644585526334313,-0.00965487188100881,0.0156128807512963,0.643974395570921
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00176541383206528,0.00382825141845433,-0.00926878661223576,0.0057379589481052,0.644695661239471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00618233465614312,0.0134197000617814,-0.0324849467772346,0.0201202774649483,0.645027712298683
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00196121336773495,0.00426874193516255,-0.0103279475606536,0.00640552082518366,0.645928738458719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,40052,-0.00137562462087143,0.00299909514696041,-0.00725385110891383,0.00450260186717097,0.646470216366842
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00234168969336648,0.00513843289511394,-0.00772963878105684,0.0124130181677898,0.648598236166981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00336668752123613,0.00740067042851795,-0.0178720015611313,0.0111386265186591,0.649176690032377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00289010880996721,0.00640932832153163,-0.0154523923201692,0.00967217470023478,0.652051673589489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00157195986963685,0.00352399190970835,-0.00847898401266521,0.00533506427339151,0.655551447920786
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN15,Lipocalin-15,37411,0.00269508856859486,0.00618362019759276,-0.00942480701868695,0.0148149841558767,0.662957469475808
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MB,Myoglobin,40052,0.00220111272363147,0.00516585546360275,-0.00792396398502992,0.0123261894322929,0.670048865687103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00175465499124322,0.00412619681722755,-0.00984200075300921,0.00633269077052277,0.670663182322634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRAS,GTPase Hras,37161,0.00412912732490762,0.00974678094486214,-0.0149745633270222,0.0232328179768374,0.6718351508678
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00113838867957573,0.00270243085855543,-0.00643515316234437,0.00415837580319292,0.673580964879831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00315117740610749,0.00749730986709812,-0.0115435499334048,0.0178459047456198,0.674267530042435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.0019746262417686,0.0047352789482859,-0.011255772980409,0.00730652049687177,0.676682945419917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDSN,Corneodesmosin,39992,0.00174925700821174,0.00421386592853378,-0.00650992021171446,0.0100084342281379,0.678060103649225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,0.00241458328801129,0.00583756414318805,-0.00902704243263728,0.0138562090086599,0.679151789123367
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSG1,Tryptase gamma,37056,-0.001103201727012,0.0026838716928589,-0.00636359024501545,0.00415718679099145,0.681043566437236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR5,Proline-rich protein 5,37056,-0.0019488718251633,0.00474978864979449,-0.0112584575787605,0.0073607139284339,0.681587373730004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD177,CD177 antigen,39844,-0.00508320161695596,0.0124316423236887,-0.0294492205713858,0.0192828173374739,0.682624249372235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00169909155797917,0.00417529403995231,-0.0098826678762857,0.00648448476032737,0.684059122280102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00196454434979718,0.00486413959142951,-0.011498257948999,0.00756916924940465,0.686305189526097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00308963632408405,0.00767152103707217,-0.0119465449085774,0.0181258175567455,0.687145275311254
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMP,Olfactory marker protein,36991,0.00195365124909002,0.00485251804875202,-0.00755728412646393,0.011464586624644,0.687244896460162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00214727356358209,0.00533512688156701,-0.0126041222514534,0.00830957512428924,0.687338318427444
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00164808306301737,0.004139394574677,-0.00976129642938429,0.00646513030334954,0.690529013149446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLLT1,Protein ENL,36962,-0.00281121880183355,0.00711615524870187,-0.0167588830892892,0.0111364454856221,0.692814319928443
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,-0.00127930925539139,0.00326564721184391,-0.00767997779060546,0.00512135927982268,0.695251104123581
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00173180685163308,0.0044314388069344,-0.00695381320995833,0.0104174269132245,0.695951143699601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22,Interleukin-22,37368,0.00253778057835224,0.00653325436187992,-0.0102673979709324,0.0153429591276369,0.697696201057915
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00102938150559355,0.00266599243104067,-0.00419596365924617,0.00625472667043327,0.69941614847246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2BP,LRP2-binding protein,37039,-0.00306358281274514,0.00795580811514424,-0.0186569667184279,0.0125298010929376,0.700188063601504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.00113533290795155,0.00296548201167452,-0.0046770118349305,0.0069476776508336,0.701836509779857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL6B,Myosin light chain 6B,37039,0.00347150803871519,0.00922493131864246,-0.014609357345824,0.0215523734232544,0.706686529952462
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL25,Interleukin-25,36903,-0.00128462611401826,0.00342348602194754,-0.00799465871703544,0.00542540648899892,0.70748868987152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNPO1,Transportin-1,37169,-0.00132082758281958,0.00353201905088112,-0.00824358492254657,0.00560192975690741,0.708441351953477
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP1,Retinol-binding protein 1,37039,0.00260355246714681,0.00700783038924985,-0.0111317950957829,0.0163389000300765,0.710255881963319
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.00108645736012029,0.00297798300243969,-0.0047503893246615,0.00692330404490207,0.715244036715693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00127141602639516,0.00351113741019738,-0.00561041329759171,0.00815324535038202,0.717276050153163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00164654249637697,0.00455826757548194,-0.00728766195156763,0.0105807469443216,0.717939941502758
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,-0.00134148910146341,0.00372230380179207,-0.00863720455297586,0.00595422635004905,0.718559673390426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,39913,-0.00102486311484311,0.0028463775177967,-0.00660376304972464,0.00455403682003841,0.71880794057703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,0.00244325056283679,0.0068145887434829,-0.0109133433743897,0.0157998445000633,0.719950532376608
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKKL1,Dickkopf-like protein 1,39788,-0.0029988032642007,0.00837389501516041,-0.0194116374939151,0.0134140309655137,0.720263264138673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTR,Methionine synthase,37021,0.00227978227377437,0.00642449678384598,-0.0103122314225638,0.0148717959701125,0.722701871100352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00178977556906217,0.00509413033928814,-0.0117742710340669,0.00819471989594258,0.725338344252471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00227207661688713,0.00650284778844093,-0.0104735050484571,0.0150176582822313,0.726795835361554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTF,Ciliary neurotrophic factor,36991,-0.00114964394205827,0.003387214324819,-0.0077885840187035,0.00548929613458697,0.734308642940364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLNS1A,Methylosome subunit pICln,37039,0.00113906125958052,0.00336034282562771,-0.00544721067864979,0.00772533319781083,0.734636418862785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GJA8,Gap junction alpha-8 protein,36962,0.00195373397137862,0.0059557077177876,-0.00971945315548507,0.0136269210982423,0.742883663249618
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHC1,SHC-transforming protein 1,36962,-0.00377656354155122,0.0115237319520821,-0.0263630781676321,0.0188099510845297,0.74312821560124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.0026924178771432,0.00825617633982389,-0.0134896877489116,0.018874523503198,0.74434667541104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00134055103690627,0.00413404882944425,-0.009443286742617,0.00676218466880446,0.745738216183221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX2,Transcription factor SOX-2,37391,0.00076783700214394,0.00236983844332709,-0.00387704634677716,0.00541272035106504,0.74594005621499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX101,Testis-expressed protein 101,37039,0.00156256444022097,0.00485167487450543,-0.00794671831380967,0.0110718471942516,0.747407035193843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TG,Thyroglobulin,37368,0.00349030499986935,0.0108448088989354,-0.017765520442044,0.0247461304417827,0.747578072038127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00237608279387171,0.00743973202830145,-0.0122057919815991,0.0169579575693426,0.749444565005226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRND,Prion-like protein doppel,37388,-0.00161403040178777,0.0050674299215919,-0.0115461930481079,0.00831813224453236,0.75010253391407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.000991051123788544,0.00316994092908316,-0.00522203309721444,0.00720413534479153,0.754558140829007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL2,Interferon lambda-2,36991,0.00192639063145658,0.00618486732416851,-0.0101959493239137,0.0140487305868269,0.755449518852392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGF,Beta-nerve growth factor,39749,0.000377425163191532,0.00122404827034542,-0.00202170944668549,0.00277655977306855,0.757826356820821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00302310614943789,0.00986163684337578,-0.0223519143624544,0.0163057020635786,0.759189064812125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00110709611955474,0.00362558019718907,-0.00599904106693584,0.00821323330604532,0.760099126542913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALLD,Palladin,37056,-0.00122129474435793,0.00406392965933965,-0.00918659687666364,0.00674400738794779,0.76378478894258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00142902662521027,0.00488584551081728,-0.0081472305759916,0.0110052838264121,0.769921234720399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH4,Cadherin-4,36991,-0.0013489975530796,0.00467184816335978,-0.0105058199532648,0.00780782484710557,0.772777026465453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00172101875903756,0.00599769912856133,-0.0100344715329426,0.0134765090510178,0.774157792067323
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000918203310339274,0.00320947011315559,-0.00720876473212423,0.00537235811144568,0.774812280401235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSTN,Osteocrin,37039,-0.00117894324427584,0.00417272456561913,-0.00935748339288933,0.00699959690433765,0.777537289104012
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00144251196624605,0.0051216809707802,-0.0114810066689752,0.00859598273648314,0.778217738458373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.00100044885018525,0.003595672555176,-0.0080479670583302,0.0060470693579597,0.780834741894703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00184434318987775,0.00679692310359837,-0.0114776260931751,0.0151663124729306,0.786126318323413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00108260915221826,0.00404473685193556,-0.00684507507757543,0.00901029338201196,0.788966203844525
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00130838984719068,0.00489835058610926,-0.00829237730158347,0.0109091569959648,0.789390001778217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,39477,0.000834101235421975,0.00312710116057266,-0.00529501703930044,0.00696321951014439,0.789678225743109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000947159094193454,0.00357237541983447,-0.00794901491706902,0.00605469672868211,0.790910186592621
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF6,Fibroblast growth factor 6,37056,0.00108231715759345,0.00408892144075299,-0.00693196886628241,0.00909660318146932,0.791248545371606
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00120673263597008,0.00462915923857389,-0.0102798847435749,0.00786641947163474,0.794342089776268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,0.0010191418558561,0.00392343869752777,-0.00667079799129834,0.00870908170301054,0.795055005580399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00148178590940296,0.00572020265328948,-0.00972981129104442,0.0126933831098503,0.795605005195818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,0.000700106167099487,0.00271428962376203,-0.0046199014954741,0.00602011382967307,0.796461548620125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5L,CD5 antigen-like,37380,0.00118230582186949,0.00466000427951939,-0.00795130256598851,0.0103159142097275,0.799720790551939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.0011293122754659,0.00446732669253532,-0.00762664804190333,0.00988527259283514,0.800431500320219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN2,Transcobalamin-2,40012,0.000735034828568053,0.00291431718383638,-0.00497702685175125,0.00644709650888736,0.800878008740723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.000977804638459217,0.00397343351542629,-0.00681012505177632,0.00876573432869475,0.80561920713048
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM25,RNA-binding protein 25,36962,-0.00111764804782742,0.00455350908423992,-0.0100425258529377,0.00780722975728282,0.8061136916256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC4A1,Band 3 anion transport protein,37437,0.00111637144078152,0.00465456137298737,-0.00800656885027372,0.0102393117318368,0.810454345854304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,39587,0.00156962976342317,0.00655618843540181,-0.0112804995699644,0.0144197590968107,0.810789295684803
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00120556545508833,0.00505556453173566,-0.0111144719372902,0.00870334102711357,0.811525633350251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN7,Tetraspanin-7,36991,0.00219550613191428,0.0094052444478435,-0.016238772985859,0.0206297852496875,0.815427863065008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00108652234108532,0.00466304560718414,-0.00805304704899559,0.0102260917311662,0.815759468345977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCLN,Nicalin,39587,-0.00120591686667669,0.00525365279648711,-0.0115030763477914,0.00909124261443804,0.818453195655708
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00207273922299432,0.00907671102194839,-0.0157176143800245,0.0198630928260132,0.819371506538527
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPN3,Calpain-3,37368,0.000849446865818596,0.00375719899650276,-0.00651466316732681,0.008213556898964,0.821138621624483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.000592298369283804,0.00267025085311586,-0.00464139330282328,0.00582599004139089,0.824461675765374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSCA,Prostate stem cell antigen,37382,-0.00555822171641977,0.0253218647155714,-0.0551890765589397,0.0440726331261002,0.826261665724641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00140962261780485,0.00642600745989606,-0.0140045972392011,0.0111853520035914,0.826371377291413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.0017033034301281,0.00777505369717187,-0.016942408676585,0.0135358018163288,0.826596666301332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN6,Prefoldin subunit 6,37039,-0.00143891091237902,0.00658453525903742,-0.0143446000200924,0.0114667781953343,0.827020466760463
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN1,Neuroligin-1,37039,-0.00144281423354037,0.00671251954369265,-0.014599352539178,0.0117137240720972,0.829814487373354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,36991,-0.000937949673555841,0.00443990548583852,-0.00964016442579933,0.00776426507868765,0.832692023461951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSV,Cathepsin L2,39967,-0.000857389267882355,0.00407888947938624,-0.00885201264747939,0.00713723411171468,0.833512956492573
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,-0.000658820521272066,0.00327922526087806,-0.00708610203259307,0.00576846099004893,0.84077412371419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD2,Leiomodin-2,36991,-0.00128302786078851,0.00640201710156345,-0.0138309813798529,0.0112649256582759,0.841163090169307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN4,Nectin-4,39913,0.000581729442362137,0.00292818828998762,-0.00515751960601361,0.00632097849073788,0.842527075396511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00046373025538922,0.0023730994569528,-0.00418754468023827,0.00511500519101671,0.845073512665987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGR,Progesterone receptor,37056,-0.00194075359864553,0.0104793685424088,-0.0224803159417667,0.0185988087444757,0.853076920486116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000754087971607909,0.00407686641067123,-0.00874474613652352,0.0072365701933077,0.853257337792771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPO,Lactoperoxidase,39344,-0.00109808437979681,0.00595364868111816,-0.0127672357947884,0.0105710670351948,0.853671575310664
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",37368,-0.000745753100892612,0.00437733210363301,-0.00932532402401331,0.00783381782222809,0.864724045218113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000403786125261389,0.00238227859451761,-0.00426547991999312,0.0050730521705159,0.865409235737073
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.000680956254348737,0.00408336267378737,-0.00732243458627451,0.00868434709497198,0.867558168094252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00148652386421064,0.0091505471154934,-0.0164485484821564,0.0194215962105777,0.87095249443027
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK3,Prostate-specific antigen,37437,-0.00125649258184255,0.00785284476971288,-0.0166480683304798,0.0141350831667947,0.872879700925107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBR1,T-box brain protein 1,37039,-0.000761155270509988,0.00480950864921589,-0.0101877922229731,0.00866548168195315,0.874253952618926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2,Interleukin-2,39587,0.000480045872525401,0.00310569665353004,-0.00560711956839347,0.00656721131344427,0.877162726887653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HK2,Hexokinase-2,39585,-0.000418791836130213,0.00272331581181381,-0.00575649082728528,0.00491890715502486,0.877785081549352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN7,Septin-7,37169,-0.000760743736011947,0.00511843863307029,-0.0107928834568297,0.00927139598480583,0.881849361705271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53BP1,TP53-binding protein 1,37056,0.00130319232820141,0.00877611750619735,-0.0158979979839454,0.0185043826403482,0.881955950852572
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.000886295674301404,0.00597235851469303,-0.0108195270144969,0.0125921183630997,0.882029619685924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.000329391279314567,0.00224774650018198,-0.00407619186104211,0.00473497441967125,0.88349506862504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,0.000856538442107306,0.00591868246336961,-0.0107440791860971,0.0124571560703117,0.884935940837649
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.00110234023992106,0.00765206330275715,-0.013895703833483,0.0161003843133251,0.885456922734416
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,-0.000818590487226187,0.0058622086114989,-0.012308519365764,0.0106713383913117,0.888947698254076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,37056,0.00102812949136788,0.00766601728267494,-0.013997264382675,0.0160535233654108,0.89331352043748
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKZF2,Zinc finger protein Helios,39477,-0.00120774916502655,0.0093737562738658,-0.0195803114618035,0.0171648131317504,0.897483008565727
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2B,Alpha-amylase 2B,38832,0.000604983368546661,0.00479247267275907,-0.00878826307006112,0.00999822980715445,0.899546680288797
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO1,R-spondin-1,39749,-0.000429168717331475,0.00351321065996965,-0.00731506161087198,0.00645672417620903,0.902774998344177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.000765776968980491,0.00632807637463386,-0.0131688066632629,0.0116372527253019,0.903682911627246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL24,Interleukin-24,39587,-0.000569062396329516,0.00470600343121083,-0.00979282912150274,0.0086547043288437,0.903753848086483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.000470590337022722,0.00409225248816252,-0.00755022453977582,0.00849140521382126,0.908450169771282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L,Seizure 6-like protein,39913,-0.000307978447042642,0.00268124236843596,-0.00556321348917712,0.00494725659509183,0.908554290493146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC9,Histone deacetylase 9,36991,-0.000728247237241434,0.00641126923197499,-0.0132943349319124,0.0118378404574295,0.909565643826312
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5,Interleukin-5,39587,0.00155643133769428,0.0143804734796189,-0.0266292966823588,0.0297421593577473,0.913812825530829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4C,Semaphorin-4C,39788,0.000302075678560389,0.00281894936676823,-0.00522306508030535,0.00582721643742613,0.914664223775671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A16,Protein S100-A16,39456,-0.000641436856818844,0.00619401967266616,-0.0127817154152445,0.0114988417016068,0.917521890842881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.000606267163038693,0.00588374454803646,-0.0109258721511128,0.0121384064771902,0.917931704857958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.000473481253819159,0.00535675147416581,-0.0100257516355458,0.0109727141431841,0.929568316041583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.000751037412439316,0.00864830267799378,-0.0161996358364285,0.0177017106613071,0.930798290704894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,-0.000285558274095194,0.00333965419466667,-0.00683128049564186,0.00626016394745147,0.931860911926234
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.000289277165045122,0.00353352865550567,-0.00721499332983624,0.006636438999746,0.934754218938998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF174,Zinc finger protein 174,37056,-0.000303576575342037,0.00380975494918246,-0.00777069627573967,0.00716354312505559,0.93648978049725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRX,Cone-rod homeobox protein,39585,-0.000856996127617675,0.0107766577042952,-0.0219792452280363,0.0202652529728009,0.936617356584863
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR1,Toll-like receptor 1,37056,-0.000201424763347214,0.00260351016212189,-0.00530430468110612,0.00490145515441169,0.938333073006171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAGE2A,G antigen 2A,36962,-0.000456352151362555,0.00608162444212707,-0.0123763360579316,0.0114636317552065,0.940185725588854
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,0.000179828072518205,0.00243292504977832,-0.0045887050250473,0.00494836117008371,0.941079627892644
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.00027040517632746,0.00379422983791551,-0.00770709565864186,0.00716628530598694,0.943185773717285
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.000273795636308447,0.00388026086024999,-0.00733151564978152,0.00787910692239842,0.943748101497369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.000152958953045514,0.00217256547478633,-0.00410526937753569,0.00441118728362672,0.943872568769147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.000383625168506919,0.00552738931566038,-0.0104500578901874,0.0112173082272013,0.94466877541071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAX,Integrin alpha-X,37169,0.000360532642086583,0.00527333255468391,-0.00997519916509388,0.010696264449267,0.945492900097895
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.000364643223401406,0.00556914159566859,-0.010550874304109,0.0112801607509118,0.947796253920979
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.000780555773028972,0.0143551650874877,-0.0289166793445049,0.0273555677984469,0.956637576762948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF830,Zinc finger protein 830,37368,-0.000427126381575304,0.00804289560679506,-0.0161912017708936,0.015336949007743,0.957648199795548
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.000189977691635787,0.00468842516791192,-0.00899933563747158,0.00937929102074315,0.967678628428524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.000119736819836598,0.0031591772545351,-0.00607225059905221,0.0063117242387254,0.969766977902387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.000388234685205935,0.0115558679823608,-0.0230377359306331,0.0222612665602212,0.973199563088589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHDC3L,KH domain-containing protein 3,36962,0.000129730125368663,0.00662842900313872,-0.0128619907207832,0.0131214509715206,0.98438527731158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY96,Lymphocyte antigen 96,39749,-6.4885905328979e-05,0.00351742869884525,-0.00695904615506567,0.00682927434440772,0.9852825129603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,6.963943461288e-05,0.00502365916031064,-0.00977673251959598,0.00991601138882174,0.988940054321047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUOX2,Dual oxidase 2,39585,3.45376586630876e-05,0.00710166632102591,-0.0138847283305477,0.0139538036478739,0.996119710976531
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF3,Fibroblast growth factor 3,37056,-1.09638659530835e-05,0.00307100729451682,-0.00603013816320605,0.00600821043129988,0.997151516027459
